<?xml version="1.0"?>
<!DOCTYPE BlastOutput PUBLIC "-//NCBI//NCBI BlastOutput/EN" "http://www.ncbi.nlm.nih.gov/dtd/NCBI_BlastOutput.dtd">
<BlastOutput>
  <BlastOutput_program>blastp</BlastOutput_program>
  <BlastOutput_version>BLASTP 2.12.0+</BlastOutput_version>
  <BlastOutput_reference>Stephen F. Altschul, Thomas L. Madden, Alejandro A. Sch&amp;auml;ffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), &quot;Gapped BLAST and PSI-BLAST: a new generation of protein database search programs&quot;, Nucleic Acids Res. 25:3389-3402.</BlastOutput_reference>
  <BlastOutput_db>/project/bowmanlab/borowsky.jonathan/installations/pdbaa</BlastOutput_db>
  <BlastOutput_query-ID>Query_1</BlastOutput_query-ID>
  <BlastOutput_query-def>1BAI_1|Chains A, B|PROTEASE|Rous sarcoma virus (11886)</BlastOutput_query-def>
  <BlastOutput_query-len>124</BlastOutput_query-len>
  <BlastOutput_param>
    <Parameters>
      <Parameters_matrix>BLOSUM62</Parameters_matrix>
      <Parameters_expect>10</Parameters_expect>
      <Parameters_gap-open>11</Parameters_gap-open>
      <Parameters_gap-extend>1</Parameters_gap-extend>
      <Parameters_filter>F</Parameters_filter>
    </Parameters>
  </BlastOutput_param>
<BlastOutput_iterations>
<Iteration>
  <Iteration_iter-num>1</Iteration_iter-num>
  <Iteration_query-ID>Query_1</Iteration_query-ID>
  <Iteration_query-def>1BAI_1|Chains A, B|PROTEASE|Rous sarcoma virus (11886)</Iteration_query-def>
  <Iteration_query-len>124</Iteration_query-len>
<Iteration_hits>
<Hit>
  <Hit_num>1</Hit_num>
  <Hit_id>pdb|1BAI|A</Hit_id>
  <Hit_def>Crystal structure of Rous sarcoma virus protease in complex with inhibitor [Rous sarcoma virus] &gt;pdb|1BAI|B Crystal structure of Rous sarcoma virus protease in complex with inhibitor [Rous sarcoma virus]</Hit_def>
  <Hit_accession>1BAI_A</Hit_accession>
  <Hit_len>124</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>251.136</Hsp_bit-score>
      <Hsp_score>640</Hsp_score>
      <Hsp_evalue>1.23419e-87</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>124</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>124</Hsp_identity>
      <Hsp_positive>124</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>124</Hsp_align-len>
      <Hsp_qseq>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRLTNL</Hsp_qseq>
      <Hsp_hseq>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRLTNL</Hsp_hseq>
      <Hsp_midline>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRLTNL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>2</Hit_num>
  <Hit_id>pdb|2RSP|A</Hit_id>
  <Hit_def>Structure Of The Aspartic Protease From Rous Sarcoma Retrovirus Refined At 2 Angstroms Resolution [Rous sarcoma virus] &gt;pdb|2RSP|B Structure Of The Aspartic Protease From Rous Sarcoma Retrovirus Refined At 2 Angstroms Resolution [Rous sarcoma virus]</Hit_def>
  <Hit_accession>2RSP_A</Hit_accession>
  <Hit_len>124</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>233.802</Hsp_bit-score>
      <Hsp_score>595</Hsp_score>
      <Hsp_evalue>1.06501e-80</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>124</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>115</Hsp_identity>
      <Hsp_positive>119</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>124</Hsp_align-len>
      <Hsp_qseq>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRLTNL</Hsp_qseq>
      <Hsp_hseq>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDSGADITIISEEDWPTDWPVMEAANPQIHGIGGGIPMRKSRDMIELGVINRDGSLERPLLLFPAVAMVRGSILGRDCLQGLGLRLTNL</Hsp_hseq>
      <Hsp_midline>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLD+GAD T+ISEEDWPTDWPVMEAANPQIHGIGGGIP+RKSRDMIELGVINRDGSLERPLLLFP VAM   +ILGRDCLQGLGLRLTNL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>3</Hit_num>
  <Hit_id>pdb|1MVP|A</Hit_id>
  <Hit_def>STRUCTURAL STUDIES OF THE RETROVIRAL PROTEINASE FROM AVIAN MYELOBLASTOSIS ASSOCIATED VIRUS [Avian myeloblastosis-associated virus] &gt;pdb|1MVP|B STRUCTURAL STUDIES OF THE RETROVIRAL PROTEINASE FROM AVIAN MYELOBLASTOSIS ASSOCIATED VIRUS [Avian myeloblastosis-associated virus]</Hit_def>
  <Hit_accession>1MVP_A</Hit_accession>
  <Hit_len>124</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>232.646</Hsp_bit-score>
      <Hsp_score>592</Hsp_score>
      <Hsp_evalue>3.05444e-80</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>124</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>114</Hsp_identity>
      <Hsp_positive>119</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>124</Hsp_align-len>
      <Hsp_qseq>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRLTNL</Hsp_qseq>
      <Hsp_hseq>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLDSGADITIISEEDWPTDWPVMEAANPQIHGIGGGIPMRKSRDMIEVGVINRDGSLERPLLLFPAVAMVRGSILGRDCLQGLGLRLTNL</Hsp_hseq>
      <Hsp_midline>LAMTMEHKDRPLVRVILTNTGSHPVKQRSVYITALLD+GAD T+ISEEDWPTDWPVMEAANPQIHGIGGGIP+RKSRDMIE+GVINRDGSLERPLLLFP VAM   +ILGRDCLQGLGLRLTNL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>4</Hit_num>
  <Hit_id>pdb|1A9M|A</Hit_id>
  <Hit_def>G48h Mutant Of Hiv-1 Protease In Complex With A Peptidic Inhibitor U-89360e [Human immunodeficiency virus] &gt;pdb|1A9M|B G48h Mutant Of Hiv-1 Protease In Complex With A Peptidic Inhibitor U-89360e [Human immunodeficiency virus]</Hit_def>
  <Hit_accession>1A9M_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.6026</Hsp_bit-score>
      <Hsp_score>122</Hsp_score>
      <Hsp_evalue>3.56049e-09</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IHGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      IHGIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>5</Hit_num>
  <Hit_id>pdb|1FG6|C</Hit_id>
  <Hit_def>Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1FG6|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1FG8|C Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1FG8|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|3VFB|A Crystal Structure of HIV-1 Protease Mutant N88D with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3VFB|B Crystal Structure of HIV-1 Protease Mutant N88D with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>1FG6_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>9.2009e-09</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRDLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GRD L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>6</Hit_num>
  <Hit_id>pdb|2FXE|A</Hit_id>
  <Hit_def>X-ray crystal structure of HIV-1 protease CRM mutant complexed with atazanavir (BMS-232632) [Human immunodeficiency virus 1] &gt;pdb|2FXE|B X-ray crystal structure of HIV-1 protease CRM mutant complexed with atazanavir (BMS-232632) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FXE_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>9.6017e-09</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>7</Hit_num>
  <Hit_id>pdb|4DQF|A</Hit_id>
  <Hit_def>Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQF|B Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4DQF_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>1.00199e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNAPGKWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>8</Hit_num>
  <Hit_id>pdb|4DQC|A</Hit_id>
  <Hit_def>Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQC|B Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQE|A Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQE|B Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQG|A Crystal Structure of apo(G16C/L38C) HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|4DQG|B Crystal Structure of apo(G16C/L38C) HIV-1 Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4DQC_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.0618</Hsp_bit-score>
      <Hsp_score>118</Hsp_score>
      <Hsp_evalue>1.10287e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNCPGKWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>9</Hit_num>
  <Hit_id>pdb|4DQB|A</Hit_id>
  <Hit_def>Crystal Structure of wild-type HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQB|B Crystal Structure of wild-type HIV-1 Protease in Complex with DRV [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4DQB_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.0618</Hsp_bit-score>
      <Hsp_score>118</Hsp_score>
      <Hsp_evalue>1.16322e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>10</Hit_num>
  <Hit_id>pdb|1K2B|A</Hit_id>
  <Hit_def>Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1] &gt;pdb|1K2B|B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1K2B_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>1.78123e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRDLMTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GRD +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>11</Hit_num>
  <Hit_id>pdb|4EJ8|A</Hit_id>
  <Hit_def>Apo HIV Protease (PR) dimer in closed form with fragment 1F1 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4EJ8|B Apo HIV Protease (PR) dimer in closed form with fragment 1F1 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4EJL|A Apo HIV Protease (PR) dimer in closed form with fragment 1F1-N in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4EJL|B Apo HIV Protease (PR) dimer in closed form with fragment 1F1-N in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|5VJ3|A HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site [Human immunodeficiency virus 1] &gt;pdb|5W5W|A HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site [Human immunodeficiency virus 1] &gt;pdb|5W5W|B HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4EJ8_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>1.91907e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>12</Hit_num>
  <Hit_id>pdb|3U71|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of South African wild type HIV-1 Subtype C Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3U71_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>2.20395e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEINLPGKWKPKM------IGGIGGFIKVRQYDQILIEICGKKAIGTV--------LVGPTPVNIIGRNMLTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>13</Hit_num>
  <Hit_id>pdb|3TKG|A</Hit_id>
  <Hit_def>crystal structure of HIV model protease precursor/saquinavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TKG|B crystal structure of HIV model protease precursor/saquinavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TKG|C crystal structure of HIV model protease precursor/saquinavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TKG|D crystal structure of HIV model protease precursor/saquinavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TKW|A Crystal structure of HIV protease model precursor/Darunavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TKW|B Crystal structure of HIV protease model precursor/Darunavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TL9|A crystal structure of HIV protease model precursor/Saquinavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TL9|B crystal structure of HIV protease model precursor/Saquinavir complex [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3TKG_A</Hit_accession>
  <Hit_len>103</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>2.44931e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>26</Hsp_hit-from>
      <Hsp_hit-to>101</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>14</Hit_num>
  <Hit_id>pdb|1EBK|C</Hit_id>
  <Hit_def>Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1EBK|D Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1EBK|E Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1EBK|F Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|4HEG|A Crystal Structure of HIV-1 protease mutants R8Q complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HEG|B Crystal Structure of HIV-1 protease mutants R8Q complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>1EBK_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>2.72679e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>15</Hit_num>
  <Hit_id>pdb|2ZYE|A</Hit_id>
  <Hit_def>Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by Neutron Crystallography [Human immunodeficiency virus 1] &gt;pdb|2ZYE|B Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by Neutron Crystallography [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2ZYE_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>2.90657e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>16</Hit_num>
  <Hit_id>pdb|5YOK|A</Hit_id>
  <Hit_def>Structure of HIV-1 Protease in Complex with Inhibitor KNI-1657 [Human immunodeficiency virus 1] &gt;pdb|5YOK|B Structure of HIV-1 Protease in Complex with Inhibitor KNI-1657 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5YOK_A</Hit_accession>
  <Hit_len>100</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>2.96865e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>17</Hit_num>
  <Hit_id>pdb|1FGC|C</Hit_id>
  <Hit_def>Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1FGC|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1SDT|A Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site. [Human immunodeficiency virus 1] &gt;pdb|1SDT|B Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site. [Human immunodeficiency virus 1] &gt;pdb|2A1E|A High resolution structure of HIV-1 PR with TS-126 [Human immunodeficiency virus 1] &gt;pdb|2A1E|B High resolution structure of HIV-1 PR with TS-126 [Human immunodeficiency virus 1] &gt;pdb|2AOD|A Crystal structure analysis of HIV-1 protease with a substrate analog P2-NC [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOD|B Crystal structure analysis of HIV-1 protease with a substrate analog P2-NC [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOI|A Crystal structure analysis of HIV-1 protease with a substrate analog P1-P6 [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOI|B Crystal structure analysis of HIV-1 protease with a substrate analog P1-P6 [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOJ|A Crystal structure analysis of HIV-1 protease with a substrate analog P6-PR [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOJ|B Crystal structure analysis of HIV-1 protease with a substrate analog P6-PR [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2HB3|A Wild-type HIV-1 Protease in complex with potent inhibitor GRL06579 [Human immunodeficiency virus 1] &gt;pdb|2HB3|B Wild-type HIV-1 Protease in complex with potent inhibitor GRL06579 [Human immunodeficiency virus 1] &gt;pdb|2IEN|A Crystal structure analysis of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) [Human immunodeficiency virus 1] &gt;pdb|2IEN|B Crystal structure analysis of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) [Human immunodeficiency virus 1] &gt;pdb|2Z4O|A Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|2Z4O|B Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|3A2O|A Crystal Structure of HIV-1 Protease Complexed with KNI-1689 [Human immunodeficiency virus 1] &gt;pdb|3A2O|B Crystal Structure of HIV-1 Protease Complexed with KNI-1689 [Human immunodeficiency virus 1] &gt;pdb|3B7V|A HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate NLLTQI [Human immunodeficiency virus type 1 BH10] &gt;pdb|3B7V|B HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate NLLTQI [Human immunodeficiency virus type 1 BH10] &gt;pdb|3DJK|A Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-0255A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3DJK|B Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-0255A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3DK1|A Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-0105A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3DK1|B Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-0105A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3FX5|A Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by High Resolution X-ray Crystallography [Human immunodeficiency virus 1] &gt;pdb|3FX5|B Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by High Resolution X-ray Crystallography [Human immunodeficiency virus 1] &gt;pdb|3H5B|A Crystal structure of wild type HIV-1 protease with novel P1&apos;-ligand GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3H5B|B Crystal structure of wild type HIV-1 protease with novel P1&apos;-ligand GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3I6O|A Crystal structure of wild type HIV-1 protease with macrocyclic inhibitor GRL-0216A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3I6O|B Crystal structure of wild type HIV-1 protease with macrocyclic inhibitor GRL-0216A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3K4V|C New crystal form of HIV-1 Protease/Saquinavir structure reveals carbamylation of N-terminal proline [Human immunodeficiency virus type 1 BH10] &gt;pdb|3K4V|D New crystal form of HIV-1 Protease/Saquinavir structure reveals carbamylation of N-terminal proline [Human immunodeficiency virus type 1 BH10] &gt;pdb|3NDW|A HIV-1 Protease Saquinavir:Ritonavir 1:15 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NDW|B HIV-1 Protease Saquinavir:Ritonavir 1:15 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NDX|A HIV-1 Protease Saquinavir:Ritonavir 1:50 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NDX|B HIV-1 Protease Saquinavir:Ritonavir 1:50 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NU3|A Wild Type HIV-1 Protease with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NU3|B Wild Type HIV-1 Protease with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3OK9|A Crystal structure of wild-type HIV-1 protease with new oxatricyclic designed inhibitor GRL-0519A [Human immunodeficiency virus 1] &gt;pdb|3OK9|B Crystal structure of wild-type HIV-1 protease with new oxatricyclic designed inhibitor GRL-0519A [Human immunodeficiency virus 1] &gt;pdb|3OXC|A Wild Type HIV-1 Protease with Antiviral Drug Saquinavir [Human immunodeficiency virus 1] &gt;pdb|3OXC|B Wild Type HIV-1 Protease with Antiviral Drug Saquinavir [Human immunodeficiency virus 1] &gt;pdb|3QAA|A HIV-1 wild type protease with a substituted bis-Tetrahydrofuran inhibitor, GRL-044-10A [Human immunodeficiency virus 1] &gt;pdb|3QAA|B HIV-1 wild type protease with a substituted bis-Tetrahydrofuran inhibitor, GRL-044-10A [Human immunodeficiency virus 1] &gt;pdb|3ST5|A Crystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Urethane as P2-Ligand, GRL-0489A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3ST5|B Crystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Urethane as P2-Ligand, GRL-0489A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOF|A HIV-1 Protease - Epoxydic Inhibitor Complex (pH 6 - Orthorombic Crystal form P212121) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOF|B HIV-1 Protease - Epoxydic Inhibitor Complex (pH 6 - Orthorombic Crystal form P212121) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOG|A HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Monoclinic Crystal form P21) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOG|B HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Monoclinic Crystal form P21) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOG|C HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Monoclinic Crystal form P21) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOG|D HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Monoclinic Crystal form P21) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOH|A HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Orthorombic Crystal form P212121) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TOH|B HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Orthorombic Crystal form P212121) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4DFG|A Crystal Structure of Wild-type HIV-1 Protease with Cyclopentyltetrahydro- furanyl Urethanes as P2-ligand, GRL-0249A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4DFG|B Crystal Structure of Wild-type HIV-1 Protease with Cyclopentyltetrahydro- furanyl Urethanes as P2-ligand, GRL-0249A [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4FL8|A HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate [Human immunodeficiency virus 1] &gt;pdb|4FL8|B HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate [Human immunodeficiency virus 1] &gt;pdb|4KB9|A Crystal structure of wild-type HIV-1 protease with novel tricyclic P2-ligands GRL-0739A [Human immunodeficiency virus 1] &gt;pdb|4KB9|B Crystal structure of wild-type HIV-1 protease with novel tricyclic P2-ligands GRL-0739A [Human immunodeficiency virus 1] &gt;pdb|4U8W|A HIV-1 wild Type protease with GRL-050-10A (a Gem-difluoro-bis-Tetrahydrofuran as P2-Ligand) [Human immunodeficiency virus type 1 BH10] &gt;pdb|4U8W|B HIV-1 wild Type protease with GRL-050-10A (a Gem-difluoro-bis-Tetrahydrofuran as P2-Ligand) [Human immunodeficiency virus type 1 BH10] &gt;pdb|4ZIP|A HIV-1 wild Type protease with GRL-0648A (a isophthalamide-derived P2-Ligand) [Human immunodeficiency virus type 1 BH10] &gt;pdb|4ZIP|B HIV-1 wild Type protease with GRL-0648A (a isophthalamide-derived P2-Ligand) [Human immunodeficiency virus type 1 BH10] &gt;pdb|4ZLS|A HIV-1 wild Type protease with GRL-096-13A (a Boc-derivative P2-Ligand, 3,-5-dimethylbiphenyl P1-Ligand) [Human immunodeficiency virus type 1 BH10] &gt;pdb|4ZLS|B HIV-1 wild Type protease with GRL-096-13A (a Boc-derivative P2-Ligand, 3,-5-dimethylbiphenyl P1-Ligand) [Human immunodeficiency virus type 1 BH10] &gt;pdb|5BRY|A HIV-1 wild Type protease with GRL-011-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, sulfonamide isostere derivate) [Human immunodeficiency virus type 1 BH10] &gt;pdb|5BRY|B HIV-1 wild Type protease with GRL-011-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, sulfonamide isostere derivate) [Human immunodeficiency virus type 1 BH10] &gt;pdb|5BS4|A HIV-1 wild Type protease with GRL-047-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, 4-amino sulfonamide derivative) [Human immunodeficiency virus type 1 BH10] &gt;pdb|5BS4|B HIV-1 wild Type protease with GRL-047-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, 4-amino sulfonamide derivative) [Human immunodeficiency virus type 1 BH10] &gt;pdb|5DGU|A Crystal Structure of HIV-1 Protease Inhibitors Containing Substituted fused-Tetrahydropyranyl Tetrahydrofuran as P2-Ligand GRL-004-11A [Human immunodeficiency virus 1] &gt;pdb|5DGU|B Crystal Structure of HIV-1 Protease Inhibitors Containing Substituted fused-Tetrahydropyranyl Tetrahydrofuran as P2-Ligand GRL-004-11A [Human immunodeficiency virus 1] &gt;pdb|5DGW|A Crystal Structure of HIV-1 Protease Inhibitor GRL-105-11A Containing Substituted fused-Tetrahydropyranyl Tetrahydrofuran as P2-Ligand [Human immunodeficiency virus 1] &gt;pdb|5DGW|B Crystal Structure of HIV-1 Protease Inhibitor GRL-105-11A Containing Substituted fused-Tetrahydropyranyl Tetrahydrofuran as P2-Ligand [Human immunodeficiency virus 1] &gt;pdb|5JFP|A HIV-1 wild Type protease with GRL-097-13A (a Adamantane P1-Ligand with bis-THF in P2 and isobutylamine in P1&apos;) [Human immunodeficiency virus 1] &gt;pdb|5JFP|B HIV-1 wild Type protease with GRL-097-13A (a Adamantane P1-Ligand with bis-THF in P2 and isobutylamine in P1&apos;) [Human immunodeficiency virus 1] &gt;pdb|5JFU|A HIV-1 wild Type protease with GRL-007-14A (a Adamantane P1-Ligand with bis-THF in P2 and benzylamine in P1&apos;) [Human immunodeficiency virus 1] &gt;pdb|5JFU|B HIV-1 wild Type protease with GRL-007-14A (a Adamantane P1-Ligand with bis-THF in P2 and benzylamine in P1&apos;) [Human immunodeficiency virus 1] &gt;pdb|5JG1|A HIV-1 wild Type protease with GRL-031-14A (a Adamantane P1-Ligand with tetrahydropyrano-tetrahydrofuran in P2 and isobutylamine in P1&apos;) [Human immunodeficiency virus 1] &gt;pdb|5JG1|B HIV-1 wild Type protease with GRL-031-14A (a Adamantane P1-Ligand with tetrahydropyrano-tetrahydrofuran in P2 and isobutylamine in P1&apos;) [Human immunodeficiency virus 1] &gt;pdb|5ULT|A HIV-1 wild Type protease with GRL-100-13A (a Crown-like Oxotricyclic Core as the P2-Ligand with the sulfonamide isostere as the P2&apos; group) [Human immunodeficiency virus 1] &gt;pdb|5ULT|B HIV-1 wild Type protease with GRL-100-13A (a Crown-like Oxotricyclic Core as the P2-Ligand with the sulfonamide isostere as the P2&apos; group) [Human immunodeficiency virus 1] &gt;pdb|5UOV|A HIV-1 wild Type protease with GRL-1118A, an isophthalamide-derived P2-P3 ligand with the sulfonamide isostere as the P2&apos; group [Human immunodeficiency virus 1] &gt;pdb|5UOV|B HIV-1 wild Type protease with GRL-1118A, an isophthalamide-derived P2-P3 ligand with the sulfonamide isostere as the P2&apos; group [Human immunodeficiency virus 1] &gt;pdb|5UPZ|A HIV-1 wild Type protease with GRL-0518A, an isophthalamide-derived P2-P3 ligand with the para-hydoxymethyl sulfonamide isostere as the P2&apos; group [Human immunodeficiency virus 1] &gt;pdb|5UPZ|B HIV-1 wild Type protease with GRL-0518A, an isophthalamide-derived P2-P3 ligand with the para-hydoxymethyl sulfonamide isostere as the P2&apos; group [Human immunodeficiency virus 1] &gt;pdb|5WLO|A a novel 13-ring macrocyclic HIV-1 protease inhibitors involving the P1&apos;-P2&apos; ligands [Human immunodeficiency virus 1] &gt;pdb|5WLO|B a novel 13-ring macrocyclic HIV-1 protease inhibitors involving the P1&apos;-P2&apos; ligands [Human immunodeficiency virus 1] &gt;pdb|6B4N|A a hydroxymethyl functionality at the 4-position of the 2-phenyloxazole moiety of HIV-1 protease inhibitors involving the P2&apos; ligands [Human immunodeficiency virus 1] &gt;pdb|6B4N|B a hydroxymethyl functionality at the 4-position of the 2-phenyloxazole moiety of HIV-1 protease inhibitors involving the P2&apos; ligands [Human immunodeficiency virus 1] &gt;pdb|6BZ2|A Crystal structure of wild-type HIV-1 protease with a novel HIV-1 inhibitor GRL-14213A of 6-5-5-ring fused crown-like tetrahydropyranofuran as the P2-ligand, a cyclopropylaminobenzothiazole as the P2&apos;-ligand and 3,5-difluorophenylmethyl as the P1-ligand [Human immunodeficiency virus 1] &gt;pdb|6BZ2|B Crystal structure of wild-type HIV-1 protease with a novel HIV-1 inhibitor GRL-14213A of 6-5-5-ring fused crown-like tetrahydropyranofuran as the P2-ligand, a cyclopropylaminobenzothiazole as the P2&apos;-ligand and 3,5-difluorophenylmethyl as the P1-ligand [Human immunodeficiency virus 1] &gt;pdb|6C8X|A Wild-type HIV-1 protease in complex with a phenylboronic acid (P2&apos;) analog of darunavir [Human immunodeficiency virus 1] &gt;pdb|6C8X|B Wild-type HIV-1 protease in complex with a phenylboronic acid (P2&apos;) analog of darunavir [Human immunodeficiency virus 1] &gt;pdb|6CDJ|A HIV-1 wild type protease with GRL-03314A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as the P2-ligand, a cyclopropylaminobenzothiazole as the P2&apos;-ligand and 3,5-difluorophenylmethyl as the P1-ligand [Human immunodeficiency virus 1] &gt;pdb|6CDJ|B HIV-1 wild type protease with GRL-03314A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as the P2-ligand, a cyclopropylaminobenzothiazole as the P2&apos;-ligand and 3,5-difluorophenylmethyl as the P1-ligand [Human immunodeficiency virus 1] &gt;pdb|6CDL|A HIV-1 wild type protease with GRL-03214A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as the P2-ligand, a cyclopropylaminobenzothiazole as the P2&apos;-ligand and 3,5-difluorophenylmethyl as the P1-ligand [Human immunodeficiency virus 1] &gt;pdb|6CDL|B HIV-1 wild type protease with GRL-03214A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as the P2-ligand, a cyclopropylaminobenzothiazole as the P2&apos;-ligand and 3,5-difluorophenylmethyl as the P1-ligand [Human immunodeficiency virus 1] &gt;pdb|6DIF|A Wild-type HIV-1 protease in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|6DIF|B Wild-type HIV-1 protease in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|6DJ1|A Wild-type HIV-1 protease in complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|6DJ1|B Wild-type HIV-1 protease in complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|6DV0|A HIV-1 wild type protease with GRL-02815A, a thiochroman heterocycle with (S)-Boc-amine functionality as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6DV0|B HIV-1 wild type protease with GRL-02815A, a thiochroman heterocycle with (S)-Boc-amine functionality as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6DV4|A HIV-1 wild type protease with GRL-04315A, a tetrahydronaphthalene carboxamide with (R)-Boc-amine and (S)-hydroxyl functionalities as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6DV4|B HIV-1 wild type protease with GRL-04315A, a tetrahydronaphthalene carboxamide with (R)-Boc-amine and (S)-hydroxyl functionalities as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6E7J|A HIV-1 wild type protease with GRL-042-17A, 3-phenylhexahydro-2h-cyclopenta[d]oxazol-2-one with a bicyclic oxazolidinone scaffold as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6E7J|B HIV-1 wild type protease with GRL-042-17A, 3-phenylhexahydro-2h-cyclopenta[d]oxazol-2-one with a bicyclic oxazolidinone scaffold as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6E9A|A HIV-1 WILD TYPE PROTEASE WITH GRL-034-17A, (3aS, 5R, 6aR)-2-OXOHEXAHYD CYCLOPENTA[D]-5-OXAZOLYL URETHANE WITH A BICYCLIC OXAZOLIDINONE SCAFF AS THE P2 LIGAND [Human immunodeficiency virus 1] &gt;pdb|6E9A|B HIV-1 WILD TYPE PROTEASE WITH GRL-034-17A, (3aS, 5R, 6aR)-2-OXOHEXAHYD CYCLOPENTA[D]-5-OXAZOLYL URETHANE WITH A BICYCLIC OXAZOLIDINONE SCAFF AS THE P2 LIGAND [Human immunodeficiency virus 1] &gt;pdb|6IXD|A X-ray crystal structure of bPI-11 hiv-1 protease complex [Human immunodeficiency virus 1] &gt;pdb|6IXD|B X-ray crystal structure of bPI-11 hiv-1 protease complex [Human immunodeficiency virus 1] &gt;pdb|6O48|A Wild-type HIV-1 protease in complex with a substrate analog CA-p2 [Human immunodeficiency virus 1] &gt;pdb|6O48|B Wild-type HIV-1 protease in complex with a substrate analog CA-p2 [Human immunodeficiency virus 1] &gt;pdb|6U7O|A HIV-1 wild type protease with GRL-00819A, with phenyl-boronic-acid as P2&apos;-ligand and with a 6-5-5-ring fused crown-like tetrahydropyranofuran as the P2-ligand [Human immunodeficiency virus 1] &gt;pdb|6U7O|B HIV-1 wild type protease with GRL-00819A, with phenyl-boronic-acid as P2&apos;-ligand and with a 6-5-5-ring fused crown-like tetrahydropyranofuran as the P2-ligand [Human immunodeficiency virus 1] &gt;pdb|6U7P|A HIV-1 wild type protease with GRL-03119A, with phenyl-boronic-acid as P2&apos;-ligand and with a hexahydro-4H-furo-pyran as the P2-ligand [Human immunodeficiency virus 1] &gt;pdb|6U7P|B HIV-1 wild type protease with GRL-03119A, with phenyl-boronic-acid as P2&apos;-ligand and with a hexahydro-4H-furo-pyran as the P2-ligand [Human immunodeficiency virus 1] &gt;pdb|6VCE|A HIV-1 wild type protease with GRL-026-18A, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6VCE|B HIV-1 wild type protease with GRL-026-18A, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6VOD|A HIV-1 wild type protease with GRL-052-16A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf-THF) derivative as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6VOD|B HIV-1 wild type protease with GRL-052-16A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf-THF) derivative as the P2 ligand [Human immunodeficiency virus 1] &gt;pdb|6VOE|A HIV-1 wild type protease with GRL-019-17A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf-THF) derivative as the P2 ligand and a aminobenzothiazole(Abt)-based P2&apos;-ligand [Human immunodeficiency virus 1] &gt;pdb|6VOE|B HIV-1 wild type protease with GRL-019-17A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf-THF) derivative as the P2 ligand and a aminobenzothiazole(Abt)-based P2&apos;-ligand [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1FGC_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>3.16481e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>18</Hit_num>
  <Hit_id>pdb|3K4V|A</Hit_id>
  <Hit_def>New crystal form of HIV-1 Protease/Saquinavir structure reveals carbamylation of N-terminal proline [Human immunodeficiency virus type 1 BH10] &gt;pdb|3K4V|B New crystal form of HIV-1 Protease/Saquinavir structure reveals carbamylation of N-terminal proline [Human immunodeficiency virus type 1 BH10] &gt;pdb|3NDT|A HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structure [Human immunodeficiency virus type 1 BH10] &gt;pdb|3NDT|B HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structure [Human immunodeficiency virus type 1 BH10] &gt;pdb|3NDT|C HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structure [Human immunodeficiency virus type 1 BH10] &gt;pdb|3NDT|D HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structure [Human immunodeficiency virus type 1 BH10] &gt;pdb|3NDU|A HIV-1 Protease Saquinavir:Ritonavir 1:5 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NDU|B HIV-1 Protease Saquinavir:Ritonavir 1:5 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NDU|C HIV-1 Protease Saquinavir:Ritonavir 1:5 complex structure [Human immunodeficiency virus 1] &gt;pdb|3NDU|D HIV-1 Protease Saquinavir:Ritonavir 1:5 complex structure [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3K4V_A</Hit_accession>
  <Hit_len>100</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>3.23232e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>19</Hit_num>
  <Hit_id>pdb|1A94|A</Hit_id>
  <Hit_def>STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES [Human immunodeficiency virus 1] &gt;pdb|1A94|B STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES [Human immunodeficiency virus 1] &gt;pdb|1A94|D STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES [Human immunodeficiency virus 1] &gt;pdb|1A94|E STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1A94_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>3.44595e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWEPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>20</Hit_num>
  <Hit_id>pdb|3CYW|A</Hit_id>
  <Hit_def>Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir [Human immunodeficiency virus 1] &gt;pdb|3CYW|B Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3CYW_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>3.79215e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IVGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>21</Hit_num>
  <Hit_id>pdb|1B6K|A</Hit_id>
  <Hit_def>Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 5 [Human immunodeficiency virus 1] &gt;pdb|1B6K|B Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 5 [Human immunodeficiency virus 1] &gt;pdb|1B6L|A Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 4 [Human immunodeficiency virus 1] &gt;pdb|1B6L|B Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 4 [Human immunodeficiency virus 1] &gt;pdb|1B6M|A Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 6 [Human immunodeficiency virus 1] &gt;pdb|1B6M|B Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 6 [Human immunodeficiency virus 1] &gt;pdb|1B6P|A Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 7 [Human immunodeficiency virus 1] &gt;pdb|1B6P|B Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 7 [Human immunodeficiency virus 1] &gt;pdb|1D4K|A HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR [synthetic construct] &gt;pdb|1D4K|B HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR [synthetic construct] &gt;pdb|1D4L|A HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR [synthetic construct] &gt;pdb|1D4L|B HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR [synthetic construct] &gt;pdb|1MTR|A Hiv-1 Protease Complexed With A Cyclic Phe-Ile-Val Peptidomimetic Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1MTR|B Hiv-1 Protease Complexed With A Cyclic Phe-Ile-Val Peptidomimetic Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1Z1H|A HIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 3 [Human immunodeficiency virus 1] &gt;pdb|1Z1H|B HIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 3 [Human immunodeficiency virus 1] &gt;pdb|1Z1R|A HIV-1 protease complexed with Macrocyclic peptidomimetic inhibitor 2 [Human immunodeficiency virus 1] &gt;pdb|1Z1R|B HIV-1 protease complexed with Macrocyclic peptidomimetic inhibitor 2 [Human immunodeficiency virus 1] &gt;pdb|3BXS|A Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease. Implications For Catalytic Mechanism [synthetic construct] &gt;pdb|3BXS|B Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease. Implications For Catalytic Mechanism [synthetic construct]</Hit_def>
  <Hit_accession>1B6K_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>4.08524e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>22</Hit_num>
  <Hit_id>pdb|4K4P|A</Hit_id>
  <Hit_def>TL-3 inhibited Trp6Ala HIV Protease [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|4K4P|B TL-3 inhibited Trp6Ala HIV Protease [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|4K4Q|A TL-3 inhibited Trp6Ala HIV Protease with 3-bromo-2,6-dimethoxybenzoic acid bound in flap site [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|4K4Q|B TL-3 inhibited Trp6Ala HIV Protease with 3-bromo-2,6-dimethoxybenzoic acid bound in flap site [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|4K4R|A TL-3 inhibited Trp6Ala HIV Protease with 1-bromo-2-napthoic acid bound in exosite [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|4K4R|B TL-3 inhibited Trp6Ala HIV Protease with 1-bromo-2-napthoic acid bound in exosite [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)]</Hit_def>
  <Hit_accession>4K4P_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>4.44799e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>23</Hit_num>
  <Hit_id>pdb|2HS2|A</Hit_id>
  <Hit_def>Crystal structure of M46L mutant of HIV-1 protease complexed with TMC114 (darunavir) [Human immunodeficiency virus 1] &gt;pdb|2HS2|B Crystal structure of M46L mutant of HIV-1 protease complexed with TMC114 (darunavir) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2HS2_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>4.89466e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRW------KPKLIGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W       P+ I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>24</Hit_num>
  <Hit_id>pdb|2R5P|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Indinavir [Human immunodeficiency virus 1] &gt;pdb|2R5P|B Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Indinavir [Human immunodeficiency virus 1] &gt;pdb|2R5P|C Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Indinavir [Human immunodeficiency virus 1] &gt;pdb|2R5P|D Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Indinavir [Human immunodeficiency virus 1] &gt;pdb|2R5Q|A Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2R5Q|B Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2R5Q|C Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2R5Q|D Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2R8N|A Chain A, Pol protein [unidentified]</Hit_def>
  <Hit_accession>2R5P_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>4.94697e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEIALPGRWKPKM------IGGIGGFIKVRQYDQIIIEICGKKAIGTV--------LVGPTPVNIIGRNMLTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>25</Hit_num>
  <Hit_id>pdb|2HS1|A</Hit_id>
  <Hit_def>Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir) inhibitor [Human immunodeficiency virus 1] &gt;pdb|2HS1|B Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir) inhibitor [Human immunodeficiency virus 1] &gt;pdb|3NU4|A Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NU4|B Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|4FM6|A HIV-1 protease mutant V32I complexed with reaction intermediate [Human immunodeficiency virus 1] &gt;pdb|4FM6|B HIV-1 protease mutant V32I complexed with reaction intermediate [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2HS1_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>4.99985e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+I E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>26</Hit_num>
  <Hit_id>pdb|2AOC|A</Hit_id>
  <Hit_def>Crystal structure analysis of HIV-1 protease mutant I84V with a substrate analog P2-NC [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOC|B Crystal structure analysis of HIV-1 protease mutant I84V with a substrate analog P2-NC [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2IEO|A Crystal structure analysis of HIV-1 protease mutant I84V with a potent non-peptide inhibitor (UIC-94017) [Human immunodeficiency virus 1] &gt;pdb|2IEO|B Crystal structure analysis of HIV-1 protease mutant I84V with a potent non-peptide inhibitor (UIC-94017) [Human immunodeficiency virus 1] &gt;pdb|2NNK|A Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2NNK|B Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2NNP|A Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2NNP|B Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2QD8|A HIV-1 Protease Mutant I84V with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|2QD8|B HIV-1 Protease Mutant I84V with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|3NU9|A Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NU9|B Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AOC_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.16187e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNVIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVN++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>27</Hit_num>
  <Hit_id>pdb|3B80|A</Hit_id>
  <Hit_def>HIV-1 protease mutant I54V complexed with gem-diol-amine intermediate NLLTQI [Human immunodeficiency virus type 1 BH10] &gt;pdb|3B80|B HIV-1 protease mutant I54V complexed with gem-diol-amine intermediate NLLTQI [Human immunodeficiency virus type 1 BH10] &gt;pdb|3D1Y|A Crystal structure of HIV-1 mutant I54V and inhibitor SAQUINA [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|3D1Y|B Crystal structure of HIV-1 mutant I54V and inhibitor SAQUINA [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|3D20|A Crystal structure of HIV-1 mutant I54V and inhibitor DARUNAVIA [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|3D20|B Crystal structure of HIV-1 mutant I54V and inhibitor DARUNAVIA [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|3NUJ|A Crystal Structure of HIV-1 Protease Mutant I54V with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NUJ|B Crystal Structure of HIV-1 Protease Mutant I54V with Antiviral Drug Amprenavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3B80_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.16187e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFVKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG + VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>28</Hit_num>
  <Hit_id>pdb|3VF5|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 Protease Mutant I47V with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3VF5|B Crystal Structure of HIV-1 Protease Mutant I47V with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4FLG|A HIV-1 protease mutant I47V complexed with reaction intermediate [Human immunodeficiency virus 1] &gt;pdb|4FLG|B HIV-1 protease mutant I47V complexed with reaction intermediate [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3VF5_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.16187e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------VGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      + GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>29</Hit_num>
  <Hit_id>pdb|2AVQ|A</Hit_id>
  <Hit_def>Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AVQ|B Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AVS|A kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S [Human immunodeficiency virus 1] &gt;pdb|2AVS|B kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S [Human immunodeficiency virus 1] &gt;pdb|2F8G|A HIV-1 protease mutant I50V complexed with inhibitor TMC114 [Human immunodeficiency virus 1] &gt;pdb|2F8G|B HIV-1 protease mutant I50V complexed with inhibitor TMC114 [Human immunodeficiency virus 1] &gt;pdb|2QD6|A HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|2QD6|B HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|3CYX|A Crystal structure of HIV-1 mutant I50V and inhibitor saquinavira [Human immunodeficiency virus 1] &gt;pdb|3CYX|B Crystal structure of HIV-1 mutant I50V and inhibitor saquinavira [Human immunodeficiency virus 1] &gt;pdb|3NU5|A Crystal Structure of HIV-1 Protease Mutant I50V with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NU5|B Crystal Structure of HIV-1 Protease Mutant I50V with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|4HDP|A Crystal Structure of HIV-1 protease mutants I50V complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HDP|B Crystal Structure of HIV-1 protease mutants I50V complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>2AVQ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.16187e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGVGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I G+GG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>30</Hit_num>
  <Hit_id>pdb|2NPH|A</Hit_id>
  <Hit_def>Crystal structure of HIV1 protease in situ product complex [Human immunodeficiency virus 1] &gt;pdb|2NPH|B Crystal structure of HIV1 protease in situ product complex [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2NPH_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.38609e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>31</Hit_num>
  <Hit_id>pdb|2I4D|A</Hit_id>
  <Hit_def>Crystal structure of WT HIV-1 protease with GS-8373 [Human immunodeficiency virus 1] &gt;pdb|2I4D|B Crystal structure of WT HIV-1 protease with GS-8373 [Human immunodeficiency virus 1] &gt;pdb|2I4U|A HIV-1 protease with TMC-126 [Human immunodeficiency virus 1] &gt;pdb|2I4U|B HIV-1 protease with TMC-126 [Human immunodeficiency virus 1] &gt;pdb|2I4W|A HIV-1 protease WT with GS-8374 [Human immunodeficiency virus 1] &gt;pdb|2I4W|B HIV-1 protease WT with GS-8374 [Human immunodeficiency virus 1] &gt;pdb|5UFZ|A HIV-1 Protease complexed with Inhibitor: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2S)-1-(1-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}cyclopropyl)-1-hydroxy-3-phenylpropan-2-yl]carbamate [Human immunodeficiency virus 1] &gt;pdb|5UFZ|B HIV-1 Protease complexed with Inhibitor: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2S)-1-(1-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}cyclopropyl)-1-hydroxy-3-phenylpropan-2-yl]carbamate [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2I4D_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.50182e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>32</Hit_num>
  <Hit_id>pdb|1Q9P|A</Hit_id>
  <Hit_def>Solution structure of the mature HIV-1 protease monomer [Homo sapiens]</Hit_def>
  <Hit_accession>1Q9P_A</Hit_accession>
  <Hit_len>95</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>5.68273e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>118</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>94</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLG</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIG</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>33</Hit_num>
  <Hit_id>pdb|5KAO|A</Hit_id>
  <Hit_def>Crystal structure of wild type HIV-1 protease in complex with GRL-10413 [Human immunodeficiency virus 1] &gt;pdb|5KAO|B Crystal structure of wild type HIV-1 protease in complex with GRL-10413 [Human immunodeficiency virus 1] &gt;pdb|5V4Y|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-09510 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5KAO_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>5.86412e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>34</Hit_num>
  <Hit_id>pdb|1HEF|E</Hit_id>
  <Hit_def>The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations [Human immunodeficiency virus 1] &gt;pdb|1HEG|E The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1HEF_E</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>5.92678e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEENSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>35</Hit_num>
  <Hit_id>pdb|6OOU|A</Hit_id>
  <Hit_def>Crystal structure of HIV-1 Protease NL4-3 L89V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OOU|B Crystal structure of HIV-1 Protease NL4-3 L89V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OOU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>5.9901e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNVLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>36</Hit_num>
  <Hit_id>pdb|1NSO|A</Hit_id>
  <Hit_def>Folded monomer of protease from Mason-Pfizer monkey virus [Simian retrovirus 1]</Hit_def>
  <Hit_accession>1NSO_A</Hit_accession>
  <Hit_len>107</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>6.08478e-08</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>105</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>FTGLINTGADVTIIKLEDWPPNWPITDTLT-NLRGIGQSNNPKQSSKYLTWRDKENNSGLIKPFVIPNL----PVNLWGRDLLSQMKIMM</Hsp_hseq>
      <Hsp_midline> T L++TGAD T+I  EDWP +WP+ +     + GIG     ++S   +       +  L +P ++  L    PVN+ GRD L  + + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>37</Hit_num>
  <Hit_id>pdb|1DW6|C</Hit_id>
  <Hit_def>Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1DW6|D Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1FEJ|C Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1FEJ|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1SDU|A Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site. [Human immunodeficiency virus 1] &gt;pdb|1SDU|B Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site. [Human immunodeficiency virus 1] &gt;pdb|2F81|A HIV-1 Protease mutant L90M complexed with inhibitor TMC114 [Human immunodeficiency virus 1] &gt;pdb|2F81|B HIV-1 Protease mutant L90M complexed with inhibitor TMC114 [Human immunodeficiency virus 1] &gt;pdb|3NUO|A Crystal Structure of HIV-1 Protease Mutant L90M with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NUO|B Crystal Structure of HIV-1 Protease Mutant L90M with Antiviral Drug Amprenavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1DW6_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>6.11879e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLMTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>38</Hit_num>
  <Hit_id>pdb|2G69|A</Hit_id>
  <Hit_def>Structure of Unliganded HIV-1 Protease F53L Mutant [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2G69_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>6.25023e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGLIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>39</Hit_num>
  <Hit_id>pdb|1A30|A</Hit_id>
  <Hit_def>Hiv-1 Protease Complexed With A Tripeptide Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1A30|B Hiv-1 Protease Complexed With A Tripeptide Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1A8K|A CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2&apos; POSITION OF SUBSTRATES [Human immunodeficiency virus 1] &gt;pdb|1A8K|B CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2&apos; POSITION OF SUBSTRATES [Human immunodeficiency virus 1] &gt;pdb|1A8K|D CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2&apos; POSITION OF SUBSTRATES [Human immunodeficiency virus 1] &gt;pdb|1A8K|E CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2&apos; POSITION OF SUBSTRATES [Human immunodeficiency virus 1] &gt;pdb|1D4Y|A Hiv-1 Protease Triple Mutant/tipranavir Complex [Human immunodeficiency virus 1] &gt;pdb|1D4Y|B Hiv-1 Protease Triple Mutant/tipranavir Complex [Human immunodeficiency virus 1] &gt;pdb|1HPO|A HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX [Human immunodeficiency virus 1] &gt;pdb|1HPO|B HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX [Human immunodeficiency virus 1] &gt;pdb|1MRW|A Structure of HIV protease (Mutant Q7K L33I L63I) complexed with KNI-577 [Human immunodeficiency virus 1] &gt;pdb|1MRW|B Structure of HIV protease (Mutant Q7K L33I L63I) complexed with KNI-577 [Human immunodeficiency virus 1] &gt;pdb|1MSM|A The HIV protease (mutant Q7K L33I L63I) complexed with KNI-764 (an inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1MSM|B The HIV protease (mutant Q7K L33I L63I) complexed with KNI-764 (an inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1ZTZ|A Crystal structure of HIV protease- metallacarborane complex [Human immunodeficiency virus 1] &gt;pdb|1ZTZ|B Crystal structure of HIV protease- metallacarborane complex [Human immunodeficiency virus 1] &gt;pdb|2PK5|A Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10075 [Human immunodeficiency virus 1] &gt;pdb|2PK5|B Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10075 [Human immunodeficiency virus 1] &gt;pdb|2PK6|A Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10033 [Human immunodeficiency virus 1] &gt;pdb|2PK6|B Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10033 [Human immunodeficiency virus 1] &gt;pdb|3I8W|A Crystal structure of a metallacarborane inhibitor bound to HIV protease [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3KDB|A Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10006 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3KDB|B Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10006 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3KDC|A Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10074 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3KDC|B Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10074 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3KDD|A Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10265 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3KDD|B Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10265 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3NLS|A Crystal Structure of HIV-1 Protease in Complex with KNI-10772 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3NLS|B Crystal Structure of HIV-1 Protease in Complex with KNI-10772 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QBF|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QBF|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QIH|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QIH|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QN8|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QN8|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QP0|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QP0|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QPJ|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QPJ|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QRM|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QRM|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QRO|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QRO|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QRS|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3QRS|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TH9|A Crystal Structure of HIV-1 Protease Mutant Q7K V32I L63I with a cyclic sulfonamide inhibitor [Human immunodeficiency virus type 1 lw12.3 isolate] &gt;pdb|3TH9|B Crystal Structure of HIV-1 Protease Mutant Q7K V32I L63I with a cyclic sulfonamide inhibitor [Human immunodeficiency virus type 1 lw12.3 isolate] &gt;pdb|4GB2|A HIV-1 protease (mutant Q7K L33I L63I) in complex with a bicyclic pyrrolidine inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4GB2|B HIV-1 protease (mutant Q7K L33I L63I) in complex with a bicyclic pyrrolidine inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4MC1|A HIV protease in complex with SA526P [Human immunodeficiency virus 1] &gt;pdb|4MC1|B HIV protease in complex with SA526P [Human immunodeficiency virus 1] &gt;pdb|4MC2|A HIV protease in complex with SA525P [Human immunodeficiency virus 1] &gt;pdb|4MC2|B HIV protease in complex with SA525P [Human immunodeficiency virus 1] &gt;pdb|4MC6|A HIV protease in complex with SA499 [Human immunodeficiency virus 1] &gt;pdb|4MC6|B HIV protease in complex with SA499 [Human immunodeficiency virus 1] &gt;pdb|4MC9|A HIV protease in complex with AA74 [Human immunodeficiency virus 1] &gt;pdb|4MC9|B HIV protease in complex with AA74 [Human immunodeficiency virus 1] &gt;pdb|4U7Q|A Structure of wild-type HIV protease in complex with photosensitive inhibitor PDI-6 [Human immunodeficiency virus 1] &gt;pdb|4U7Q|B Structure of wild-type HIV protease in complex with photosensitive inhibitor PDI-6 [Human immunodeficiency virus 1] &gt;pdb|4U7V|A Structure of wild-type HIV protease in complex with degraded photosensitive inhibitor [Human immunodeficiency virus 1] &gt;pdb|4U7V|B Structure of wild-type HIV protease in complex with degraded photosensitive inhibitor [Human immunodeficiency virus 1] &gt;pdb|5IVT|A Crystal Structure of HIV Protease complexed with [(1S)-1-[(S)-(4-chlorophenyl)-(3,5-difluorophenyl)methyl]-2-[[5-fluoro-4-[2-[(2R,5S)-5-(2,2,2-trifluoroethylcarbamoyloxymethyl)morpholin-4-ium-2-yl]ethyl]pyridin-1-ium-3-yl]amino]-2-oxo-ethyl]ammonium [Human immunodeficiency virus 1] &gt;pdb|5IVT|B Crystal Structure of HIV Protease complexed with [(1S)-1-[(S)-(4-chlorophenyl)-(3,5-difluorophenyl)methyl]-2-[[5-fluoro-4-[2-[(2R,5S)-5-(2,2,2-trifluoroethylcarbamoyloxymethyl)morpholin-4-ium-2-yl]ethyl]pyridin-1-ium-3-yl]amino]-2-oxo-ethyl]ammonium [Human immunodeficiency virus 1] &gt;pdb|6B36|A Crystal Structure of HIV Protease complexed with (S)-N-(3-fluoro-2-(2-(1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B36|B Crystal Structure of HIV Protease complexed with (S)-N-(3-fluoro-2-(2-(1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B38|A Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6R)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B38|B Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6R)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3C|A Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6R)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3C|B Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6R)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3F|A Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,5S)-5-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3F|B Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,5S)-5-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3G|A Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6S)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3G|B Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6S)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3H|A Crystal Structure of HIV Protease complexed with N-(2-(2-((6R,9S)-2,2-dioxido-2-thia-1,7-diazabicyclo[4.3.1]decan-9-yl)ethyl)-3-fluorophenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1] &gt;pdb|6B3H|B Crystal Structure of HIV Protease complexed with N-(2-(2-((6R,9S)-2,2-dioxido-2-thia-1,7-diazabicyclo[4.3.1]decan-9-yl)ethyl)-3-fluorophenyl)-3,3-bis(4-fluorophenyl)propanamide [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1A30_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>6.4527e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>40</Hit_num>
  <Hit_id>pdb|2AVM|A</Hit_id>
  <Hit_def>Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S [Human immunodeficiency virus 1] &gt;pdb|2AVM|B Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S [Human immunodeficiency virus 1] &gt;pdb|2AVO|A Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S [Human immunodeficiency virus 1] &gt;pdb|2AVO|B Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AVM_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>6.52164e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALIDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>AL+DTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>41</Hit_num>
  <Hit_id>pdb|2F3K|A</Hit_id>
  <Hit_def>Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease [Human immunodeficiency virus 1] &gt;pdb|2F3K|B Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease [Human immunodeficiency virus 1] &gt;pdb|2I0A|A Crystal Structure of KB-19 complexed with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2I0A|B Crystal Structure of KB-19 complexed with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2I0D|A Crystal structure of AD-81 complexed with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2I0D|B Crystal structure of AD-81 complexed with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2PSU|A Crystal Structure of wild type HIV-1 protease in complex with CARB-AD37 [Human immunodeficiency virus 1] &gt;pdb|2PSU|B Crystal Structure of wild type HIV-1 protease in complex with CARB-AD37 [Human immunodeficiency virus 1] &gt;pdb|2PSV|A Crystal Structure of wild type HIV-1 protease in complex with CARB-KB45 [Human immunodeficiency virus 1] &gt;pdb|2PSV|B Crystal Structure of wild type HIV-1 protease in complex with CARB-KB45 [Human immunodeficiency virus 1] &gt;pdb|2Q3K|A Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|2Q3K|B Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|2Q54|A Crystal structure of KB73 bound to HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2Q54|B Crystal structure of KB73 bound to HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2Q55|A Crystal structure of KK44 bound to HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2Q55|B Crystal structure of KK44 bound to HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2Q5K|A Crystal structure of lopinavir bound to wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2Q5K|B Crystal structure of lopinavir bound to wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QHY|A Crystal Structure of protease inhibitor, MIT-1-AC86 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QHY|B Crystal Structure of protease inhibitor, MIT-1-AC86 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QHZ|A Crystal structure of protease inhibitor, MIT-1-AC87 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QHZ|B Crystal structure of protease inhibitor, MIT-1-AC87 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI0|A Crystal structure of protease inhibitor, MIT-1-KK80 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI0|B Crystal structure of protease inhibitor, MIT-1-KK80 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI1|A Crystal structure of protease inhibitor, MIT-1-KK81 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI1|B Crystal structure of protease inhibitor, MIT-1-KK81 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI3|A Crystal structure of protease inhibitor, MIT-2-AD94 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI3|B Crystal structure of protease inhibitor, MIT-2-AD94 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI4|A Crystal structure of protease inhibitor, MIT-2-AD93 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI4|B Crystal structure of protease inhibitor, MIT-2-AD93 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI5|A Crystal structure of protease inhibitor, MIT-2-KC08 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI5|B Crystal structure of protease inhibitor, MIT-2-KC08 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI6|A Crystal structure of protease inhibitor, MIT-2-KB98 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI6|B Crystal structure of protease inhibitor, MIT-2-KB98 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI7|A Crystal structure of protease inhibitor, MIT-2-AD86 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|2QI7|B Crystal structure of protease inhibitor, MIT-2-AD86 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3EKV|A Crystal structure of the wild type HIV-1 protease with the inhibitor, Amprenavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKV|B Crystal structure of the wild type HIV-1 protease with the inhibitor, Amprenavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKX|A Crystal structure of the wild-type HIV-1 protease with the inhibitor, Nelfinavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKX|B Crystal structure of the wild-type HIV-1 protease with the inhibitor, Nelfinavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKY|A Crystal Structure of wild-type HIV protease in complex with the inhibitor, Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKY|B Crystal Structure of wild-type HIV protease in complex with the inhibitor, Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3GI4|A Crystal structure of protease inhibitor, KB60 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3GI4|B Crystal structure of protease inhibitor, KB60 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3GI5|A Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3GI5|B Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3GI6|A Crystal structure of protease inhibitor, AD78 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3GI6|B Crystal structure of protease inhibitor, AD78 in complex with wild type HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3MXD|A Crystal structure of HIV-1 protease inhibitor KC53 in complex with wild-type protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3MXD|B Crystal structure of HIV-1 protease inhibitor KC53 in complex with wild-type protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3MXE|A Crystal structure of HIV-1 protease inhibitor, KC32 complexed with wild-type protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3MXE|B Crystal structure of HIV-1 protease inhibitor, KC32 complexed with wild-type protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3O99|A Crystal Structure of wild-type HIV-1 Protease in complex with kd13 [Human immunodeficiency virus 1] &gt;pdb|3O99|B Crystal Structure of wild-type HIV-1 Protease in complex with kd13 [Human immunodeficiency virus 1] &gt;pdb|3O9A|A Crystal Structure of wild-type HIV-1 Protease in complex with kd14 [Human immunodeficiency virus 1] &gt;pdb|3O9A|B Crystal Structure of wild-type HIV-1 Protease in complex with kd14 [Human immunodeficiency virus 1] &gt;pdb|3O9B|A Crystal Structure of wild-type HIV-1 Protease in Complex with kd25 [Human immunodeficiency virus 1] &gt;pdb|3O9B|B Crystal Structure of wild-type HIV-1 Protease in Complex with kd25 [Human immunodeficiency virus 1] &gt;pdb|3O9C|A Crystal Structure of wild-type HIV-1 Protease in complex with kd20 [Human immunodeficiency virus 1] &gt;pdb|3O9C|B Crystal Structure of wild-type HIV-1 Protease in complex with kd20 [Human immunodeficiency virus 1] &gt;pdb|3O9D|A Crystal Structure of wild-type HIV-1 Protease in complex with kd19 [Human immunodeficiency virus 1] &gt;pdb|3O9D|B Crystal Structure of wild-type HIV-1 Protease in complex with kd19 [Human immunodeficiency virus 1] &gt;pdb|3O9E|A Crystal Structure of wild-type HIV-1 Protease in complex with af60 [Human immunodeficiency virus 1] &gt;pdb|3O9E|B Crystal Structure of wild-type HIV-1 Protease in complex with af60 [Human immunodeficiency virus 1] &gt;pdb|3O9F|A Crystal Structure of wild-type HIV-1 Protease in complex with kd27 [Human immunodeficiency virus 1] &gt;pdb|3O9F|B Crystal Structure of wild-type HIV-1 Protease in complex with kd27 [Human immunodeficiency virus 1] &gt;pdb|3O9G|A Crystal Structure of wild-type HIV-1 Protease in complex with af53 [Human immunodeficiency virus 1] &gt;pdb|3O9G|B Crystal Structure of wild-type HIV-1 Protease in complex with af53 [Human immunodeficiency virus 1] &gt;pdb|3O9H|A Crystal Structure of wild-type HIV-1 Protease in complex with kd26 [Human immunodeficiency virus 1] &gt;pdb|3O9H|B Crystal Structure of wild-type HIV-1 Protease in complex with kd26 [Human immunodeficiency virus 1] &gt;pdb|3O9I|A Crystal Structure of wild-type HIV-1 Protease in complex with af61 [Human immunodeficiency virus 1] &gt;pdb|3O9I|B Crystal Structure of wild-type HIV-1 Protease in complex with af61 [Human immunodeficiency virus 1] &gt;pdb|3R4B|A Crystal Structure of Wild-type HIV-1 Protease in Complex With TMC310911 [Human immunodeficiency virus 1] &gt;pdb|3R4B|B Crystal Structure of Wild-type HIV-1 Protease in Complex With TMC310911 [Human immunodeficiency virus 1] &gt;pdb|3SA3|A Crystal structure of wild-type HIV-1 protease in complex with AG23 [Human immunodeficiency virus 1] &gt;pdb|3SA3|B Crystal structure of wild-type HIV-1 protease in complex with AG23 [Human immunodeficiency virus 1] &gt;pdb|3SA4|A Crystal structure of wild-type HIV-1 protease in complex with AF72 [Human immunodeficiency virus 1] &gt;pdb|3SA4|B Crystal structure of wild-type HIV-1 protease in complex with AF72 [Human immunodeficiency virus 1] &gt;pdb|3SA5|A Crystal structure of wild-type HIV-1 protease in complex with AF69 [Human immunodeficiency virus 1] &gt;pdb|3SA5|B Crystal structure of wild-type HIV-1 protease in complex with AF69 [Human immunodeficiency virus 1] &gt;pdb|3SA6|A Crystal structure of wild-type HIV-1 protease in complex with AF71 [Human immunodeficiency virus 1] &gt;pdb|3SA6|B Crystal structure of wild-type HIV-1 protease in complex with AF71 [Human immunodeficiency virus 1] &gt;pdb|3SA7|A Crystal structure of wild-type HIV-1 protease in complex with AF55 [Human immunodeficiency virus 1] &gt;pdb|3SA7|B Crystal structure of wild-type HIV-1 protease in complex with AF55 [Human immunodeficiency virus 1] &gt;pdb|3SA8|A Crystal structure of wild-type HIV-1 protease in complex with KB83 [Human immunodeficiency virus 1] &gt;pdb|3SA8|B Crystal structure of wild-type HIV-1 protease in complex with KB83 [Human immunodeficiency virus 1] &gt;pdb|3SA9|A Crystal structure of Wild-type HIV-1 protease in complex With AF68 [Human immunodeficiency virus 1] &gt;pdb|3SA9|B Crystal structure of Wild-type HIV-1 protease in complex With AF68 [Human immunodeficiency virus 1] &gt;pdb|3SAA|A Crystal structure of Wild-type HIV-1 protease in complex With AF77 [Human immunodeficiency virus 1] &gt;pdb|3SAA|B Crystal structure of Wild-type HIV-1 protease in complex With AF77 [Human immunodeficiency virus 1] &gt;pdb|3SAB|A Crystal structure of wild-type HIV-1 protease in complex with AF78 [Human immunodeficiency virus 1] &gt;pdb|3SAB|B Crystal structure of wild-type HIV-1 protease in complex with AF78 [Human immunodeficiency virus 1] &gt;pdb|3SAC|A Crystal structure of wild-type HIV-1 protease in complex with AF80 [Human immunodeficiency virus 1] &gt;pdb|3SAC|B Crystal structure of wild-type HIV-1 protease in complex with AF80 [Human immunodeficiency virus 1] &gt;pdb|4DJO|A Crystal Structure of wild-type HIV-1 Protease in Complex with MKP56 [Human immunodeficiency virus 1] &gt;pdb|4DJO|B Crystal Structure of wild-type HIV-1 Protease in Complex with MKP56 [Human immunodeficiency virus 1] &gt;pdb|4DJP|A Crystal Structure of wild-type HIV-1 Protease in Complex with MKP73 [Human immunodeficiency virus 1] &gt;pdb|4DJP|B Crystal Structure of wild-type HIV-1 Protease in Complex with MKP73 [Human immunodeficiency virus 1] &gt;pdb|4DJQ|A Crystal Structure of wild-type HIV-1 Protease in Complex with MKP86 [Human immunodeficiency virus 1] &gt;pdb|4DJQ|B Crystal Structure of wild-type HIV-1 Protease in Complex with MKP86 [Human immunodeficiency virus 1] &gt;pdb|4DJR|A Crystal Structure of wild-type HIV-1 Protease in Complex with MKP97 [Human immunodeficiency virus 1] &gt;pdb|4DJR|B Crystal Structure of wild-type HIV-1 Protease in Complex with MKP97 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2F3K_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>6.66172e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>42</Hit_num>
  <Hit_id>pdb|3SQF|A</Hit_id>
  <Hit_def>Crystal structure of monomeric M-PMV retroviral protease [Mason-Pfizer monkey virus] &gt;pdb|3SQF|B Crystal structure of monomeric M-PMV retroviral protease [Mason-Pfizer monkey virus] &gt;pdb|6S1U|A Crystal structure of dimeric M-PMV protease C7A/D26N/C106A mutant in complex with inhibitor [Mason-Pfizer monkey virus] &gt;pdb|6S1U|B Crystal structure of dimeric M-PMV protease C7A/D26N/C106A mutant in complex with inhibitor [Mason-Pfizer monkey virus]</Hit_def>
  <Hit_accession>3SQF_A</Hit_accession>
  <Hit_len>114</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>7.05866e-08</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>105</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>FTGLINTGADVTIIKLEDWPPNWPITDTLT-NLRGIGQSNNPKQSSKYLTWRDKENNSGLIKPFVIPNL----PVNLWGRDLLSQMKIMM</Hsp_hseq>
      <Hsp_midline> T L++TGAD T+I  EDWP +WP+ +     + GIG     ++S   +       +  L +P ++  L    PVN+ GRD L  + + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>43</Hit_num>
  <Hit_id>pdb|2AZ8|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 in complex with inhibitor, TL-3 [Human immunodeficiency virus 1] &gt;pdb|2HB4|A Structure of HIV Protease NL4-3 in an Unliganded State [Human immunodeficiency virus 1] &gt;pdb|2PC0|A Apo Wild-type HIV Protease in the open conformation [Human immunodeficiency virus 1] &gt;pdb|3KF0|A HIV Protease with fragment 4D9 bound [Human immunodeficiency virus 1] &gt;pdb|3KF0|B HIV Protease with fragment 4D9 bound [Human immunodeficiency virus 1] &gt;pdb|3KFN|A HIV Protease (PR) with inhibitor TL-3 and fragment hit 4D9 by soaking [Human immunodeficiency virus 1] &gt;pdb|3KFN|B HIV Protease (PR) with inhibitor TL-3 and fragment hit 4D9 by soaking [Human immunodeficiency virus 1] &gt;pdb|3KFP|A HIV Protease (PR) with inhibitor TL-3 bound, and DMSOs in exo site [Human immunodeficiency virus 1] &gt;pdb|3KFR|A HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 1F1 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|3KFR|B HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 1F1 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|3KFS|A HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 2F4 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|3KFS|B HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 2F4 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4E43|A HIV protease (PR) dimer with acetate in exo site and peptide in active site [Human immunodeficiency virus 1] &gt;pdb|4E43|B HIV protease (PR) dimer with acetate in exo site and peptide in active site [Human immunodeficiency virus 1] &gt;pdb|4EJD|A HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4EJD|B HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4EJK|A HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1-N in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4EJK|B HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1-N in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4TVG|A HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment AK-2097 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4TVG|B HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment AK-2097 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4TVH|A HIV Protease (PR) dimer in closed form with TL-3 in active site and fragment AK-2097 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|4TVH|B HIV Protease (PR) dimer in closed form with TL-3 in active site and fragment AK-2097 in the outside/top of flap [Human immunodeficiency virus 1] &gt;pdb|5VCK|A HIV Protease (PR) with TL-3 in the active site and (Z)-N-(thiazol-2-yl)-N&apos;-tosylcarbamimidate in the exosite [Human immunodeficiency virus 1] &gt;pdb|5VCK|B HIV Protease (PR) with TL-3 in the active site and (Z)-N-(thiazol-2-yl)-N&apos;-tosylcarbamimidate in the exosite [Human immunodeficiency virus 1] &gt;pdb|5VEA|A HIV Protease (PR) with TL-3 in active site and 4-methylbenzene-1,2-diamine in exosite [Human immunodeficiency virus 1] &gt;pdb|6DGX|A Crystal structure of HIV-1 Protease NL4-3 WT in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DGX|B Crystal structure of HIV-1 Protease NL4-3 WT in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DGY|A Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DGY|B Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DGZ|A Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass6 [Human immunodeficiency virus 1] &gt;pdb|6DGZ|B Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass6 [Human immunodeficiency virus 1] &gt;pdb|6OPS|A HIV-1 Protease NL4-3 WT in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPS|B HIV-1 Protease NL4-3 WT in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OXO|A HIV-1 Protease NL4-3 WT in Complex with LR2-91 [Human immunodeficiency virus 1] &gt;pdb|6OXO|B HIV-1 Protease NL4-3 WT in Complex with LR2-91 [Human immunodeficiency virus 1] &gt;pdb|6OXP|A HIV-1 Protease NL4-3 WT in Complex with UMass3 [Human immunodeficiency virus 1] &gt;pdb|6OXP|B HIV-1 Protease NL4-3 WT in Complex with UMass3 [Human immunodeficiency virus 1] &gt;pdb|6OXQ|A HIV-1 Protease NL4-3 WT in Complex with UMass8 [Human immunodeficiency virus 1] &gt;pdb|6OXQ|B HIV-1 Protease NL4-3 WT in Complex with UMass8 [Human immunodeficiency virus 1] &gt;pdb|6OXR|A HIV-1 Protease NL4-3 WT in Complex with LR-82 [Human immunodeficiency virus 1] &gt;pdb|6OXR|B HIV-1 Protease NL4-3 WT in Complex with LR-82 [Human immunodeficiency virus 1] &gt;pdb|6OXS|A HIV-1 Protease NL4-3 WT in Complex with LR-76 [Human immunodeficiency virus 1] &gt;pdb|6OXS|B HIV-1 Protease NL4-3 WT in Complex with LR-76 [Human immunodeficiency virus 1] &gt;pdb|6OXT|A HIV-1 Protease NL4-3 WT in Complex with LR-84 [Human immunodeficiency virus 1] &gt;pdb|6OXT|B HIV-1 Protease NL4-3 WT in Complex with LR-84 [Human immunodeficiency virus 1] &gt;pdb|6OXU|A HIV-1 Protease NL4-3 WT in Complex with LR-99 [Human immunodeficiency virus 1] &gt;pdb|6OXU|B HIV-1 Protease NL4-3 WT in Complex with LR-99 [Human immunodeficiency virus 1] &gt;pdb|6OXV|A HIV-1 Protease NL4-3 WT in Complex with LR-85 [Human immunodeficiency virus 1] &gt;pdb|6OXV|B HIV-1 Protease NL4-3 WT in Complex with LR-85 [Human immunodeficiency virus 1] &gt;pdb|6OXW|A HIV-1 Protease NL4-3 WT in Complex with LR-100 [Human immunodeficiency virus 1] &gt;pdb|6OXW|B HIV-1 Protease NL4-3 WT in Complex with LR-100 [Human immunodeficiency virus 1] &gt;pdb|6OXX|A HIV-1 Protease NL4-3 WT in Complex with LR2-18 [Human immunodeficiency virus 1] &gt;pdb|6OXX|B HIV-1 Protease NL4-3 WT in Complex with LR2-18 [Human immunodeficiency virus 1] &gt;pdb|6OXY|A HIV-1 Protease NL4-3 WT in Complex with LR2-19 [Human immunodeficiency virus 1] &gt;pdb|6OXY|B HIV-1 Protease NL4-3 WT in Complex with LR2-19 [Human immunodeficiency virus 1] &gt;pdb|6OXZ|A HIV-1 Protease NL4-3 WT in Complex with LR2-20 [Human immunodeficiency virus 1] &gt;pdb|6OXZ|B HIV-1 Protease NL4-3 WT in Complex with LR2-20 [Human immunodeficiency virus 1] &gt;pdb|6OY0|A HIV-1 Protease NL4-3 WT in Complex with LR2-21 [Human immunodeficiency virus 1] &gt;pdb|6OY0|B HIV-1 Protease NL4-3 WT in Complex with LR2-21 [Human immunodeficiency virus 1] &gt;pdb|6OY1|A HIV-1 Protease NL4-3 WT in Complex with LR2-26 [Human immunodeficiency virus 1] &gt;pdb|6OY1|B HIV-1 Protease NL4-3 WT in Complex with LR2-26 [Human immunodeficiency virus 1] &gt;pdb|6OY2|A HIV-1 Protease NL4-3 WT in Complex with LR2-25 [Human immunodeficiency virus 1] &gt;pdb|6OY2|B HIV-1 Protease NL4-3 WT in Complex with LR2-25 [Human immunodeficiency virus 1] &gt;pdb|6PJB|A HIV-1 Protease NL4-3 WT in Complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|6PJB|B HIV-1 Protease NL4-3 WT in Complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|6PJC|A HIV-1 Protease NL4-3 WT in Complex with LR4-41 [Human immunodeficiency virus 1] &gt;pdb|6PJC|B HIV-1 Protease NL4-3 WT in Complex with LR4-41 [Human immunodeficiency virus 1] &gt;pdb|6PJC|C HIV-1 Protease NL4-3 WT in Complex with LR4-41 [Human immunodeficiency virus 1] &gt;pdb|6PJC|D HIV-1 Protease NL4-3 WT in Complex with LR4-41 [Human immunodeficiency virus 1] &gt;pdb|6PJD|A HIV-1 Protease NL4-3 WT in Complex with LR2-32 [Human immunodeficiency virus 1] &gt;pdb|6PJD|B HIV-1 Protease NL4-3 WT in Complex with LR2-32 [Human immunodeficiency virus 1] &gt;pdb|6PJE|A HIV-1 Protease NL4-3 WT in Complex with LR2-43 [Human immunodeficiency virus 1] &gt;pdb|6PJE|B HIV-1 Protease NL4-3 WT in Complex with LR2-43 [Human immunodeficiency virus 1] &gt;pdb|6PJF|A HIV-1 Protease NL4-3 WT in Complex with LR2-44 [Human immunodeficiency virus 1] &gt;pdb|6PJF|B HIV-1 Protease NL4-3 WT in Complex with LR2-44 [Human immunodeficiency virus 1] &gt;pdb|6PJG|A HIV-1 Protease NL4-3 WT in Complex with LR3-97 [Human immunodeficiency virus 1] &gt;pdb|6PJG|B HIV-1 Protease NL4-3 WT in Complex with LR3-97 [Human immunodeficiency virus 1] &gt;pdb|6PJH|A HIV-1 Protease NL4-3 WT in Complex with LR3-28 [Human immunodeficiency virus 1] &gt;pdb|6PJH|B HIV-1 Protease NL4-3 WT in Complex with LR3-28 [Human immunodeficiency virus 1] &gt;pdb|6PJI|A HIV-1 Protease NL4-3 WT in Complex with LR3-43 [Human immunodeficiency virus 1] &gt;pdb|6PJI|B HIV-1 Protease NL4-3 WT in Complex with LR3-43 [Human immunodeficiency virus 1] &gt;pdb|6PJK|A HIV-1 Protease NL4-3 WT in Complex with LR3-29 [Human immunodeficiency virus 1] &gt;pdb|6PJK|B HIV-1 Protease NL4-3 WT in Complex with LR3-29 [Human immunodeficiency virus 1] &gt;pdb|6PJL|A HIV-1 Protease NL4-3 WT in Complex with LR3-95 [Human immunodeficiency virus 1] &gt;pdb|6PJL|B HIV-1 Protease NL4-3 WT in Complex with LR3-95 [Human immunodeficiency virus 1] &gt;pdb|6PJM|A HIV-1 Protease NL4-3 WT in Complex with LR2-35 [Human immunodeficiency virus 1] &gt;pdb|6PJM|B HIV-1 Protease NL4-3 WT in Complex with LR2-35 [Human immunodeficiency virus 1] &gt;pdb|6PJN|A HIV-1 Protease NL4-3 WT in Complex with LR2-41 [Human immunodeficiency virus 1] &gt;pdb|6PJN|B HIV-1 Protease NL4-3 WT in Complex with LR2-41 [Human immunodeficiency virus 1] &gt;pdb|6PJO|A HIV-1 Protease NL4-3 WT in Complex with LR2-42 [Human immunodeficiency virus 1] &gt;pdb|6PJO|B HIV-1 Protease NL4-3 WT in Complex with LR2-42 [Human immunodeficiency virus 1] &gt;pdb|6W6T|A Chain A, Protease [Human immunodeficiency virus 1] &gt;pdb|6W6T|B Chain B, Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AZ8_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>7.40849e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>44</Hit_num>
  <Hit_id>pdb|1A8G|A</Hit_id>
  <Hit_def>HIV-1 PROTEASE IN COMPLEX WITH SDZ283-910 [Human immunodeficiency virus 1] &gt;pdb|1A8G|B HIV-1 PROTEASE IN COMPLEX WITH SDZ283-910 [Human immunodeficiency virus 1] &gt;pdb|1EBY|A HIV-1 protease in complex with the inhibitor BEA369 [Human immunodeficiency virus 1] &gt;pdb|1EBY|B HIV-1 protease in complex with the inhibitor BEA369 [Human immunodeficiency virus 1] &gt;pdb|1HXW|A HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538 [Human immunodeficiency virus 1] &gt;pdb|1HXW|B HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538 [Human immunodeficiency virus 1] &gt;pdb|1IZH|A Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mutants [Human immunodeficiency virus 1] &gt;pdb|1IZH|B Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mutants [Human immunodeficiency virus 1] &gt;pdb|1PRO|A Hiv-1 Protease Dimer Complexed With A-98881 [Human immunodeficiency virus 1] &gt;pdb|1PRO|B Hiv-1 Protease Dimer Complexed With A-98881 [Human immunodeficiency virus 1] &gt;pdb|1SBG|A AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS [Human immunodeficiency virus type 1 BH10] &gt;pdb|1SBG|B AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS [Human immunodeficiency virus type 1 BH10] &gt;pdb|1VIJ|A Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793 Hexagonal Form [Human immunodeficiency virus 1] &gt;pdb|1VIJ|B Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793 Hexagonal Form [Human immunodeficiency virus 1] &gt;pdb|1VIK|A Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793 Orthorhombic Form [Human immunodeficiency virus 1] &gt;pdb|1VIK|B Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793 Orthorhombic Form [Human immunodeficiency virus 1] &gt;pdb|2HVP|A Three-Dimensional Structure Of Aspartyl Protease From Human Immunodeficiency Virus Hiv-1 [Human immunodeficiency virus 1] &gt;pdb|2QMP|A Crystal Structure of HIV-1 protease complexed with PL-100 [Human immunodeficiency virus 1] &gt;pdb|2QMP|B Crystal Structure of HIV-1 protease complexed with PL-100 [Human immunodeficiency virus 1] &gt;pdb|3M9F|A HIV protease complexed with compound 10b [Human immunodeficiency virus 1] &gt;pdb|3M9F|B HIV protease complexed with compound 10b [Human immunodeficiency virus 1] &gt;pdb|3S85|A Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|B Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|C Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|D Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|E Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|F Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|G Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|H Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|I Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|J Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|K Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|3S85|L Discovery of New HIV Protease Inhibitors with Potential for Convenient Dosing and Reduced Side Effects: A-790742 and A-792611. [Human immunodeficiency virus 1] &gt;pdb|4LL3|A Structure of wild-type HIV protease in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|4LL3|B Structure of wild-type HIV protease in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|4PHV|A X-Ray Crystal Structure Of The Hiv Protease Complex With L- 700,417, An Inhibitor With Pseudo C2 Symmetry [Human immunodeficiency virus 1] &gt;pdb|4PHV|B X-Ray Crystal Structure Of The Hiv Protease Complex With L- 700,417, An Inhibitor With Pseudo C2 Symmetry [Human immunodeficiency virus 1] &gt;pdb|5HVP|A CRYSTALLOGRAPHIC ANALYSIS OF A COMPLEX BETWEEN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AND ACETYL-PEPSTATIN AT 2.0-ANGSTROMS RESOLUTION [Human immunodeficiency virus 1] &gt;pdb|5HVP|B CRYSTALLOGRAPHIC ANALYSIS OF A COMPLEX BETWEEN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AND ACETYL-PEPSTATIN AT 2.0-ANGSTROMS RESOLUTION [Human immunodeficiency virus 1] &gt;pdb|5IVQ|A Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-(3-morpholin-4-ium-2-ylpropylamino)-2-oxo-ethyl]carbamate [Human immunodeficiency virus 1] &gt;pdb|5IVQ|B Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-(3-morpholin-4-ium-2-ylpropylamino)-2-oxo-ethyl]carbamate [Human immunodeficiency virus 1] &gt;pdb|5IVR|A Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-[[2-[(3S)-3-[(4-aminophenyl)methylamino]-4-hydroxy-butyl]phenyl]carbamoyl]-2,2-diphenyl-ethyl]carbamate [Human immunodeficiency virus 1] &gt;pdb|5IVR|B Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-[[2-[(3S)-3-[(4-aminophenyl)methylamino]-4-hydroxy-butyl]phenyl]carbamoyl]-2,2-diphenyl-ethyl]carbamate [Human immunodeficiency virus 1] &gt;pdb|5IVS|A Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-[2-[2-[(2R,5S)-5-(benzylcarbamoyloxymethyl)morpholin-2-yl]ethyl]anilino]-2-oxo-ethyl]carbamate [Human immunodeficiency virus 1] &gt;pdb|5IVS|B Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-[2-[2-[(2R,5S)-5-(benzylcarbamoyloxymethyl)morpholin-2-yl]ethyl]anilino]-2-oxo-ethyl]carbamate [Human immunodeficiency virus 1] &gt;pdb|6MCR|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-001 [Human immunodeficiency virus 1] &gt;pdb|6MCS|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-003 [Human immunodeficiency virus 1] &gt;pdb|6OGP|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-063 [Human immunodeficiency virus 1] &gt;pdb|6OYD|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-004 [Human immunodeficiency virus 1] &gt;pdb|6OYR|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-002 [Human immunodeficiency virus 1] &gt;pdb|9HVP|A Design, activity and 2.8 Angstroms crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|9HVP|B Design, activity and 2.8 Angstroms crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1A8G_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>7.81264e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>45</Hit_num>
  <Hit_id>pdb|3PWM|A</Hit_id>
  <Hit_def>HIV-1 Protease Mutant L76V with Darunavir [Human immunodeficiency virus 1] &gt;pdb|3PWM|B HIV-1 Protease Mutant L76V with Darunavir [Human immunodeficiency virus 1] &gt;pdb|3PWR|A HIV-1 Protease Mutant L76V complexed with Saquinavir [Human immunodeficiency virus 1] &gt;pdb|3PWR|B HIV-1 Protease Mutant L76V complexed with Saquinavir [Human immunodeficiency virus 1] &gt;pdb|3VF7|A Crystal Structure of HIV-1 Protease Mutant L76V with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3VF7|B Crystal Structure of HIV-1 Protease Mutant L76V with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|6DIL|A HIV-1 protease with single mutation L76V in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|6DIL|B HIV-1 protease with single mutation L76V in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|6DJ2|A HIV-1 protease with single mutation L76V in complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|6DJ2|B HIV-1 protease with single mutation L76V in complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|6DJ5|A HIV-1 protease with mutation L76V in complex with GRL-0519 (tris-tetrahydrofuran as P2 ligand) [Human immunodeficiency virus 1] &gt;pdb|6DJ5|B HIV-1 protease with mutation L76V in complex with GRL-0519 (tris-tetrahydrofuran as P2 ligand) [Human immunodeficiency virus 1] &gt;pdb|6DJ7|A HIV-1 protease with mutation L76V in complex with GRL-5010 (gem-difluoro-bis-tetrahydrofuran as P2 ligand) [Human immunodeficiency virus 1] &gt;pdb|6DJ7|B HIV-1 protease with mutation L76V in complex with GRL-5010 (gem-difluoro-bis-tetrahydrofuran as P2 ligand) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3PWM_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>7.9804e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------VVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        +V  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>46</Hit_num>
  <Hit_id>pdb|5YRS|A</Hit_id>
  <Hit_def>X-ray Snapshot of HIV-1 Protease in Action: Observation of Tetrahedral Intermediate and Its SIHB with Catalytic Aspartate [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>5YRS_A</Hit_accession>
  <Hit_len>104</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>8.38827e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>47</Hit_num>
  <Hit_id>pdb|3S43|A</Hit_id>
  <Hit_def>HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3S43_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>8.68817e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRD-MIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIIEEMSLPGRWKPKM------VGGIGGFIKVRQYDEIIIEIAGHKAIGTV--------LVGPTPINIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+I E   P  W P M      + GIGG I VR+  + +IE+      G++        LV  TP+NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>48</Hit_num>
  <Hit_id>pdb|6S1V|A</Hit_id>
  <Hit_def>Crystal structure of dimeric M-PMV protease D26N mutant in complex with inhibitor [Mason-Pfizer monkey virus] &gt;pdb|6S1V|B Crystal structure of dimeric M-PMV protease D26N mutant in complex with inhibitor [Mason-Pfizer monkey virus] &gt;pdb|6S1W|A Crystal structure of dimeric M-PMV protease D26N mutant [Mason-Pfizer monkey virus] &gt;pdb|6S1W|B Crystal structure of dimeric M-PMV protease D26N mutant [Mason-Pfizer monkey virus]</Hit_def>
  <Hit_accession>6S1V_A</Hit_accession>
  <Hit_len>114</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>8.81269e-08</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>105</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>FTGLINTGADVTIIKLEDWPPNWPITDTLT-NLRGIGQSNNPKQSSKYLTWRDKENNSGLIKPFVIPNL----PVNLWGRDLLSQMKIMM</Hsp_hseq>
      <Hsp_midline> T L++TGAD T+I  EDWP +WP+ +     + GIG     ++S   +       +  L +P ++  L    PVN+ GRD L  + + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>49</Hit_num>
  <Hit_id>pdb|4JEC|A</Hit_id>
  <Hit_def>Joint neutron and X-ray structure of per-deuterated HIV-1 protease in complex with clinical inhibitor amprenavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4JEC_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>8.96945e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWXPKM------IGGIGGFIKVRQYDQII----IEIAG---HKAIXTVLVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+   +I    I   G      +   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>50</Hit_num>
  <Hit_id>pdb|3D1X|A</Hit_id>
  <Hit_def>Crystal structure of HIV-1 mutant I54M and inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|3D1X|B Crystal structure of HIV-1 mutant I54M and inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|3D1Z|A Crystal structure of HIV-1 mutant I54M and inhibitor DARUNAVIR [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|3D1Z|B Crystal structure of HIV-1 mutant I54M and inhibitor DARUNAVIR [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|3NU6|A Crystal Structure of HIV-1 Protease Mutant I54M with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|3NU6|B Crystal Structure of HIV-1 Protease Mutant I54M with Antiviral Drug Amprenavir [Human immunodeficiency virus 1] &gt;pdb|4HE9|A Crystal Structure of HIV-1 protease mutants I54M complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HE9|B Crystal Structure of HIV-1 protease mutants I54M complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3D1X_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>9.06522e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFMKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG + VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>51</Hit_num>
  <Hit_id>pdb|3KT2|A</Hit_id>
  <Hit_def>Crystal Structure of N88D mutant HIV-1 Protease [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>3KT2_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>9.54162e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRDLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GRD L  +G+ L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>9.54162e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRDLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GRD L  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>52</Hit_num>
  <Hit_id>pdb|1ODY|A</Hit_id>
  <Hit_def>Hiv-1 Protease Complexed With An Inhibitor Lp-130 [HIV-1 M:B_HXB2R] &gt;pdb|1ODY|B Hiv-1 Protease Complexed With An Inhibitor Lp-130 [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>1ODY_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>9.76477e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGAWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>53</Hit_num>
  <Hit_id>pdb|2PYM|A</Hit_id>
  <Hit_def>HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2PYM|B HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2PYM_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>9.86901e-08</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMSLPGAWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRDLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GRD L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>54</Hit_num>
  <Hit_id>pdb|1B6J|A</Hit_id>
  <Hit_def>Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 1 [Human immunodeficiency virus 1] &gt;pdb|1B6J|B Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 1 [Human immunodeficiency virus 1] &gt;pdb|1CPI|A Regioselective Structural And Functional Mimicry Of Peptides. Design Of Hydrolytically Stable Cyclic Peptidomimetic Inhibitors Of Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1CPI|B Regioselective Structural And Functional Mimicry Of Peptides. Design Of Hydrolytically Stable Cyclic Peptidomimetic Inhibitors Of Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|3HVP|A CONSERVED FOLDING IN RETROVIRAL PROTEASES. CRYSTAL STRUCTURE OF A SYNTHETIC HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|4HVP|A Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Angstroms resolution [Human immunodeficiency virus 1] &gt;pdb|4HVP|B Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Angstroms resolution [Human immunodeficiency virus 1] &gt;pdb|7HVP|A X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR [Human immunodeficiency virus 1] &gt;pdb|7HVP|B X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR [Human immunodeficiency virus 1] &gt;pdb|8HVP|A STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE COMPLEXED WITH A HYDROXYETHYLENE*-BASED INHIBITOR [Human immunodeficiency virus 1] &gt;pdb|8HVP|B STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE COMPLEXED WITH A HYDROXYETHYLENE*-BASED INHIBITOR [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1B6J_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.04071e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>55</Hit_num>
  <Hit_id>pdb|4QGI|A</Hit_id>
  <Hit_def>X-ray crystal structure of HIV-1 protease variant G48T/L89M in complex with Saquinavir [Human immunodeficiency virus type 1 lw12.3 isolate] &gt;pdb|4QGI|B X-ray crystal structure of HIV-1 protease variant G48T/L89M in complex with Saquinavir [Human immunodeficiency virus type 1 lw12.3 isolate]</Hit_def>
  <Hit_accession>4QGI_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.05182e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------ITGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>56</Hit_num>
  <Hit_id>pdb|1SDV|A</Hit_id>
  <Hit_def>Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site. [Human immunodeficiency virus 1] &gt;pdb|1SDV|B Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site. [Human immunodeficiency virus 1] &gt;pdb|2AOE|A crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog CA-P2 [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOE|B crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog CA-P2 [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOF|A Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6 [Human immunodeficiency virus 1] &gt;pdb|2AOF|B Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6 [Human immunodeficiency virus 1] &gt;pdb|2AOG|A Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOG|B Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOH|A Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P6-PR [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2AOH|B Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P6-PR [Human immunodeficiency virus type 1 (BH5 ISOLATE)] &gt;pdb|2IDW|A Crystal structure analysis of HIV-1 protease mutant V82A with a potent non-peptide inhibitor (UIC-94017) [Human immunodeficiency virus 1] &gt;pdb|2IDW|B Crystal structure analysis of HIV-1 protease mutant V82A with a potent non-peptide inhibitor (UIC-94017) [Human immunodeficiency virus 1] &gt;pdb|2NMY|A Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2NMY|B Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2NMZ|A Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2NMZ|B Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir [Human immunodeficiency virus 1] &gt;pdb|2QD7|A HIV-1 Protease Mutant V82A with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|2QD7|B HIV-1 Protease Mutant V82A with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|3VFA|A Crystal Structure of HIV-1 Protease Mutant V82A with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 lw12.3 isolate] &gt;pdb|3VFA|B Crystal Structure of HIV-1 Protease Mutant V82A with novel P1&apos;-Ligands GRL-02031 [Human immunodeficiency virus type 1 lw12.3 isolate] &gt;pdb|4HDF|A Crystal Structure of HIV-1 protease mutants V82A complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HDF|B Crystal Structure of HIV-1 protease mutants V82A complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>1SDV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.07439e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPANIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>57</Hit_num>
  <Hit_id>pdb|3LZV|A</Hit_id>
  <Hit_def>Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Darunavir. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3LZV|B Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Darunavir. [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3LZV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.07439e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPVNIIGRDLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GRD L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>58</Hit_num>
  <Hit_id>pdb|3BVA|A</Hit_id>
  <Hit_def>Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor [Human immunodeficiency virus 1] &gt;pdb|3BVA|B Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor [Human immunodeficiency virus 1] &gt;pdb|3BVB|A Cystal structure of HIV-1 Active Site Mutant D25N and inhibitor Darunavir [Human immunodeficiency virus 1] &gt;pdb|3BVB|B Cystal structure of HIV-1 Active Site Mutant D25N and inhibitor Darunavir [Human immunodeficiency virus 1] &gt;pdb|6BRA|A HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETS [Human immunodeficiency virus 1] &gt;pdb|6BRA|B HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETS [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3BVA_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.07439e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>59</Hit_num>
  <Hit_id>pdb|1KZK|A</Hit_id>
  <Hit_def>JE-2147-HIV Protease Complex [Human immunodeficiency virus] &gt;pdb|1KZK|B JE-2147-HIV Protease Complex [Human immunodeficiency virus] &gt;pdb|1T3R|A HIV protease wild-type in complex with TMC114 inhibitor [Human immunodeficiency virus 1] &gt;pdb|1T3R|B HIV protease wild-type in complex with TMC114 inhibitor [Human immunodeficiency virus 1] &gt;pdb|1YTG|A Siv Protease Crystallized With Peptide Product [Human immunodeficiency virus 1] &gt;pdb|1YTG|B Siv Protease Crystallized With Peptide Product [Human immunodeficiency virus 1] &gt;pdb|1YTH|A Siv Protease Crystallized With Peptide Product [Human immunodeficiency virus 1] &gt;pdb|1YTH|B Siv Protease Crystallized With Peptide Product [Human immunodeficiency virus 1] &gt;pdb|2AID|A Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1 Protease: Developing A Cycle Of Structure-Based Drug Design [Human immunodeficiency virus 1] &gt;pdb|2AID|B Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1 Protease: Developing A Cycle Of Structure-Based Drug Design [Human immunodeficiency virus 1] &gt;pdb|3AID|A A NEW CLASS OF HIV-1 PROTEASE INHIBITOR: THE CRYSTALLOGRAPHIC STRUCTURE, INHIBITION AND CHEMICAL SYNTHESIS OF AN AMINIMIDE PEPTIDE ISOSTERE [Human immunodeficiency virus 1] &gt;pdb|3AID|B A NEW CLASS OF HIV-1 PROTEASE INHIBITOR: THE CRYSTALLOGRAPHIC STRUCTURE, INHIBITION AND CHEMICAL SYNTHESIS OF AN AMINIMIDE PEPTIDE ISOSTERE [Human immunodeficiency virus 1] &gt;pdb|3EL1|A Crystal Structure of wild-type HIV protease in complex with the inhibitor, Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EL1|B Crystal Structure of wild-type HIV protease in complex with the inhibitor, Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3I7E|A Co-crystal structure of HIV-1 protease bound to a mutant resistant inhibitor UIC-98038 [Human immunodeficiency virus 1] &gt;pdb|3I7E|B Co-crystal structure of HIV-1 protease bound to a mutant resistant inhibitor UIC-98038 [Human immunodeficiency virus 1] &gt;pdb|4F73|A Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of CA-p2 cleavage site [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F73|B Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of CA-p2 cleavage site [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F74|A Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of the substrate MA-CA. [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F74|B Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of the substrate MA-CA. [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F75|A Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of the substrate RH-IN [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F75|B Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of the substrate RH-IN [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F76|A Crystal Structure of the active HIV-1 Protease in Complex with the products of p1-p6 substrate [HIV-1 M:B_ARV2/SF2] &gt;pdb|4F76|B Crystal Structure of the active HIV-1 Protease in Complex with the products of p1-p6 substrate [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>1KZK_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.07439e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>60</Hit_num>
  <Hit_id>pdb|1HIV|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A DIHYDROETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH MOLECULAR MODELING [Human immunodeficiency virus 1] &gt;pdb|1HIV|B CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A DIHYDROETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH MOLECULAR MODELING [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1HIV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.07439e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>61</Hit_num>
  <Hit_id>pdb|1FFF|C</Hit_id>
  <Hit_def>Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease : High Resolution Crystal Structures Of The Mutant Protease/substrate Analog Complexes. [Human immunodeficiency virus 1] &gt;pdb|1FFF|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease : High Resolution Crystal Structures Of The Mutant Protease/substrate Analog Complexes. [Human immunodeficiency virus 1] &gt;pdb|1FFI|C Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|1FFI|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes [Human immunodeficiency virus 1] &gt;pdb|2F80|A HIV-1 Protease mutant D30N complexed with inhibitor TMC114 [Human immunodeficiency virus 1] &gt;pdb|2F80|B HIV-1 Protease mutant D30N complexed with inhibitor TMC114 [Human immunodeficiency virus 1] &gt;pdb|2QCI|A HIV-1 Protease mutant D30N with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|2QCI|B HIV-1 Protease mutant D30N with potent Antiviral inhibitor GRL-98065 [Human immunodeficiency virus 1] &gt;pdb|4HDB|A Crystal Structure of HIV-1 protease mutants D30N complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HDB|B Crystal Structure of HIV-1 protease mutants D30N complexed with inhibitor GRL-0519 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|6C8Y|A D30N HIV-1 protease in complex with a phenylboronic acid (P2&apos;) analog of darunavir [Human immunodeficiency virus 1] &gt;pdb|6C8Y|B D30N HIV-1 protease in complex with a phenylboronic acid (P2&apos;) analog of darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1FFF_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.07439e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>62</Hit_num>
  <Hit_id>pdb|1DMP|A</Hit_id>
  <Hit_def>STRUCTURE OF HIV-1 PROTEASE COMPLEX [Human immunodeficiency virus 1] &gt;pdb|1DMP|B STRUCTURE OF HIV-1 PROTEASE COMPLEX [Human immunodeficiency virus 1] &gt;pdb|1HVR|A RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS [Human immunodeficiency virus 1] &gt;pdb|1HVR|B RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS [Human immunodeficiency virus 1] &gt;pdb|1QBS|A HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1] &gt;pdb|1QBS|B HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1DMP_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.10916e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>63</Hit_num>
  <Hit_id>pdb|1AID|A</Hit_id>
  <Hit_def>Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1 Protease: Developing A Cycle Of Structure-Based Drug Design [Human immunodeficiency virus 1] &gt;pdb|1AID|B Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1 Protease: Developing A Cycle Of Structure-Based Drug Design [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1AID_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.121e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>64</Hit_num>
  <Hit_id>pdb|1W5V|A</Hit_id>
  <Hit_def>HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5V|B HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5W|A HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5W|B HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5X|A HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5X|B HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5Y|A HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus] &gt;pdb|1W5Y|B HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor [Human immunodeficiency virus]</Hit_def>
  <Hit_accession>1W5V_A</Hit_accession>
  <Hit_len>110</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>1.13187e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>108</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>65</Hit_num>
  <Hit_id>pdb|4Q1Y|A</Hit_id>
  <Hit_def>Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance [Human immunodeficiency virus 1] &gt;pdb|4Q1Y|B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4Q1Y_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.13297e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>66</Hit_num>
  <Hit_id>pdb|4Q1X|A</Hit_id>
  <Hit_def>Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance [Human immunodeficiency virus 1] &gt;pdb|4Q1X|B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4Q1X_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.13297e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTILEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT++ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>67</Hit_num>
  <Hit_id>pdb|5T84|A</Hit_id>
  <Hit_def>HIV-1 protease, unbound subtype B L63P construct [Human immunodeficiency virus 1] &gt;pdb|5T84|B HIV-1 protease, unbound subtype B L63P construct [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5T84_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.13297e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIPIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTVI E   P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>68</Hit_num>
  <Hit_id>pdb|1ZSF|A</Hit_id>
  <Hit_def>Crystal Structure of Complex of a Hydroxyethylamine Inhibitor with HIV-1 Protease at 2.0A Resolution [Human immunodeficiency virus 1] &gt;pdb|1ZSF|B Crystal Structure of Complex of a Hydroxyethylamine Inhibitor with HIV-1 Protease at 2.0A Resolution [Human immunodeficiency virus 1] &gt;pdb|1ZSR|A Crystal structure of wild type HIV-1 protease (BRU isolate) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1ZSR|B Crystal structure of wild type HIV-1 protease (BRU isolate) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1ZSF_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.14506e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>69</Hit_num>
  <Hit_id>pdb|2P3B|B</Hit_id>
  <Hit_def>Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2P3B_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.16963e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>70</Hit_num>
  <Hit_id>pdb|6DH3|A</Hit_id>
  <Hit_def>Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DH3|B Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DH4|A Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DH4|B Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DH5|A Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with UMass6 [Human immunodeficiency virus 1] &gt;pdb|6DH5|B Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with UMass6 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6DH3_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.18211e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPINIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP+NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>71</Hit_num>
  <Hit_id>pdb|2FDE|A</Hit_id>
  <Hit_def>Wild type HIV protease bound with GW0385 [Human immunodeficiency virus 1] &gt;pdb|2FDE|B Wild type HIV protease bound with GW0385 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FDE_A</Hit_accession>
  <Hit_len>100</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.19404e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>72</Hit_num>
  <Hit_id>pdb|6DH6|A</Hit_id>
  <Hit_def>Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DH6|B Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DH7|A Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DH7|B Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DH8|A Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass6 [Human immunodeficiency virus 1] &gt;pdb|6DH8|B Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass6 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6DH6_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.19472e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGVGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I G+GG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>73</Hit_num>
  <Hit_id>pdb|6DH0|A</Hit_id>
  <Hit_def>Crystal structure of HIV-1 Protease NL4-3 I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DH0|B Crystal structure of HIV-1 Protease NL4-3 I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6DH1|A Crystal structure of HIV-1 Protease NL4-3 I84V Mutant in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DH1|B Crystal structure of HIV-1 Protease NL4-3 I84V Mutant in complex with UMass1 [Human immunodeficiency virus 1] &gt;pdb|6DH2|A Crystal structure of HIV-1 Protease NL4-3 I84V Mutant in complex with UMass6 [Human immunodeficiency virus 1] &gt;pdb|6DH2|B Crystal structure of HIV-1 Protease NL4-3 I84V Mutant in complex with UMass6 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6DH0_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.19472e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVN++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>74</Hit_num>
  <Hit_id>pdb|6OOT|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 L89V, L90M Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OOT|B HIV-1 Protease NL4-3 L89V, L90M Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OOT_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.19472e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNVMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>75</Hit_num>
  <Hit_id>pdb|5YOJ|A</Hit_id>
  <Hit_def>Structure of A17 HIV-1 Protease in Complex with Inhibitor KNI-1657 [Human immunodeficiency virus 1] &gt;pdb|5YOJ|B Structure of A17 HIV-1 Protease in Complex with Inhibitor KNI-1657 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5YOJ_A</Hit_accession>
  <Hit_len>100</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.23266e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQI-HGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIIEEMSLPGRW------KPKIVGGIGGFIKVREYDQIIIEIAGHKAIGTV--------LVGPTPVNVIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+I E   P  W       P+I  GIGG I VR+  + +IE+      G++        LV  TPVN++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>76</Hit_num>
  <Hit_id>pdb|4DQH|A</Hit_id>
  <Hit_def>Crystal Structure of (R14C/E65C) HIV-1 Protease in complex with DRV [Human immunodeficiency virus 1] &gt;pdb|4DQH|B Crystal Structure of (R14C/E65C) HIV-1 Protease in complex with DRV [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4DQH_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.23338e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNLPGKWKPKM------IGGIGGFIKVRQ-YDQIIICIAGHKA------IGTVLVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W P M      I GIGG I VR+  D I + +           +   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>77</Hit_num>
  <Hit_id>pdb|1HXB|A</Hit_id>
  <Hit_def>HIV-1 proteinase complexed with RO 31-8959 [Human immunodeficiency virus type 1 (CLONE 12)] &gt;pdb|1HXB|B HIV-1 proteinase complexed with RO 31-8959 [Human immunodeficiency virus type 1 (CLONE 12)] &gt;pdb|1ODW|A Native HIV-1 Proteinase [Human immunodeficiency virus 1] &gt;pdb|1ODW|B Native HIV-1 Proteinase [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1HXB_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.24654e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>78</Hit_num>
  <Hit_id>pdb|4Q1W|A</Hit_id>
  <Hit_def>Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance [Human immunodeficiency virus 1] &gt;pdb|4Q1W|B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4Q1W_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.25984e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPVNIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>79</Hit_num>
  <Hit_id>pdb|3T3C|A</Hit_id>
  <Hit_def>Structure of HIV PR resistant patient derived mutant (comprising 22 mutations) in complex with DRV [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3T3C|B Structure of HIV PR resistant patient derived mutant (comprising 22 mutations) in complex with DRV [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3T3C_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.27329e-07</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>IEVLLDTGADDTVIEDIDLPGKW-----SPKMIAGIGGFVKVRQYDQILIEFCGKKAIGSV--------LVGPTPANVIGRNIMSQIGCTL</Hsp_hseq>
      <Hsp_midline>I  LLDTGADDTVI + D P  W     +   I GIGG + VR+  + +IE       GS+        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>80</Hit_num>
  <Hit_id>pdb|1AJV|A</Hit_id>
  <Hit_def>Hiv-1 Protease In Complex With The Cyclic Sulfamide Inhibitor Aha006 [Human immunodeficiency virus 1] &gt;pdb|1AJV|B Hiv-1 Protease In Complex With The Cyclic Sulfamide Inhibitor Aha006 [Human immunodeficiency virus 1] &gt;pdb|1AJX|A Hiv-1 Protease In Complex With The Cyclic Urea Inhibitor Aha001 [Human immunodeficiency virus 1] &gt;pdb|1AJX|B Hiv-1 Protease In Complex With The Cyclic Urea Inhibitor Aha001 [Human immunodeficiency virus 1] &gt;pdb|1C70|A Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1C70|B Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1D4H|A HIV-1 Protease in complex with the inhibitor BEA435 [Human immunodeficiency virus] &gt;pdb|1D4H|B HIV-1 Protease in complex with the inhibitor BEA435 [Human immunodeficiency virus] &gt;pdb|1D4I|A HIV-1 protease in complex with the inhibitor BEA425 [Human immunodeficiency virus] &gt;pdb|1D4I|B HIV-1 protease in complex with the inhibitor BEA425 [Human immunodeficiency virus] &gt;pdb|1D4J|A HIV-1 protease in complex with the inhibitor MSL370 [Human immunodeficiency virus] &gt;pdb|1D4J|B HIV-1 protease in complex with the inhibitor MSL370 [Human immunodeficiency virus] &gt;pdb|1DIF|A HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285 [Human immunodeficiency virus 1] &gt;pdb|1DIF|B HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285 [Human immunodeficiency virus 1] &gt;pdb|1EBW|A HIV-1 protease in complex with the inhibitor BEA322 [Human immunodeficiency virus 1] &gt;pdb|1EBW|B HIV-1 protease in complex with the inhibitor BEA322 [Human immunodeficiency virus 1] &gt;pdb|1EBZ|A HIV-1 protease in complex with the inhibitor BEA388 [Human immunodeficiency virus 1] &gt;pdb|1EBZ|B HIV-1 protease in complex with the inhibitor BEA388 [Human immunodeficiency virus 1] &gt;pdb|1EC0|A HIV-1 protease in complex with the inhibitor bea403 [Human immunodeficiency virus 1] &gt;pdb|1EC0|B HIV-1 protease in complex with the inhibitor bea403 [Human immunodeficiency virus 1] &gt;pdb|1EC1|A HIV-1 protease in complex with the inhibitor BEA409 [Human immunodeficiency virus 1] &gt;pdb|1EC1|B HIV-1 protease in complex with the inhibitor BEA409 [Human immunodeficiency virus 1] &gt;pdb|1EC2|A HIV-1 protease in complex with the inhibitor BEA428 [Human immunodeficiency virus 1] &gt;pdb|1EC2|B HIV-1 protease in complex with the inhibitor BEA428 [Human immunodeficiency virus 1] &gt;pdb|1EC3|A HIV-1 protease in complex with the inhibitor MSA367 [Human immunodeficiency virus 1] &gt;pdb|1EC3|B HIV-1 protease in complex with the inhibitor MSA367 [Human immunodeficiency virus 1] &gt;pdb|1FQX|A Crystal Structure Of The Complex Of Hiv-1 Protease With A Peptidomimetic Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1FQX|B Crystal Structure Of The Complex Of Hiv-1 Protease With A Peptidomimetic Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1G2K|A Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047 [Human immunodeficiency virus 1] &gt;pdb|1G2K|B Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047 [Human immunodeficiency virus 1] &gt;pdb|1G35|A CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024 [Human immunodeficiency virus 1] &gt;pdb|1G35|B CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024 [Human immunodeficiency virus 1] &gt;pdb|1GNO|A Hiv-1 Protease (Wild Type) Complexed With U89360e (Inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1GNO|B Hiv-1 Protease (Wild Type) Complexed With U89360e (Inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1HBV|A A Check On Rational Drug Design. Crystal Structure Of A Complex Of Hiv-1 Protease With A Novel Gamma-Turn Mimetic [Human immunodeficiency virus 1] &gt;pdb|1HBV|B A Check On Rational Drug Design. Crystal Structure Of A Complex Of Hiv-1 Protease With A Novel Gamma-Turn Mimetic [Human immunodeficiency virus 1] &gt;pdb|1HHP|A The Three-Dimensional Structure Of The Aspartyl Protease From The Hiv- 1 Isolate Bru [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|1HIH|A COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR [Human immunodeficiency virus 1] &gt;pdb|1HIH|B COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR [Human immunodeficiency virus 1] &gt;pdb|1HOS|A INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRIC PHOSPHINATE SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS [Human immunodeficiency virus 1] &gt;pdb|1HOS|B INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRIC PHOSPHINATE SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS [Human immunodeficiency virus 1] &gt;pdb|1HPS|A RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE INHIBITOR CONTAINING A HETEROCYCLIC P1&apos;-P2&apos; AMIDE BOND ISOSTERE [Human immunodeficiency virus 1] &gt;pdb|1HPS|B RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE INHIBITOR CONTAINING A HETEROCYCLIC P1&apos;-P2&apos; AMIDE BOND ISOSTERE [Human immunodeficiency virus 1] &gt;pdb|1HPV|A Crystal Structure Of Hiv-1 Protease In Complex With Vx-478, A Potent And Orally Bioavailable Inhibitor Of The Enzyme [Human immunodeficiency virus 1] &gt;pdb|1HPV|B Crystal Structure Of Hiv-1 Protease In Complex With Vx-478, A Potent And Orally Bioavailable Inhibitor Of The Enzyme [Human immunodeficiency virus 1] &gt;pdb|1HPX|A Hiv-1 Protease Complexed With The Inhibitor Kni-272 [Human immunodeficiency virus 1] &gt;pdb|1HPX|B Hiv-1 Protease Complexed With The Inhibitor Kni-272 [Human immunodeficiency virus 1] &gt;pdb|1HSG|A Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 1] &gt;pdb|1HSG|B Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 1] &gt;pdb|1HTE|A X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HTE|B X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HTF|A X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HTF|B X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HTG|A X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HTG|B X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVI|A INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVI|B INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVJ|A INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVJ|B INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVK|A INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVK|B INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVL|A INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1HVL|B INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1IIQ|A Crystal Structure Of Hiv-1 Protease Complexed With A Hydroxyethylamine Peptidomimetic Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1IIQ|B Crystal Structure Of Hiv-1 Protease Complexed With A Hydroxyethylamine Peptidomimetic Inhibitor [Human immunodeficiency virus 1] &gt;pdb|1M0B|A HIV-1 protease in complex with an ethyleneamine inhibitor [Human immunodeficiency virus 1] &gt;pdb|1M0B|B HIV-1 protease in complex with an ethyleneamine inhibitor [Human immunodeficiency virus 1] &gt;pdb|1MUI|A Crystal structure of HIV-1 protease complexed with Lopinavir. [Human immunodeficiency virus 1] &gt;pdb|1MUI|B Crystal structure of HIV-1 protease complexed with Lopinavir. [Human immunodeficiency virus 1] &gt;pdb|1NH0|A 1.03 A structure of HIV-1 protease: inhibitor binding inside and outside the active site [Human immunodeficiency virus 1] &gt;pdb|1NH0|B 1.03 A structure of HIV-1 protease: inhibitor binding inside and outside the active site [Human immunodeficiency virus 1] &gt;pdb|1NPA|A crystal structure of HIV-1 protease-hup [Human immunodeficiency virus 1] &gt;pdb|1NPA|B crystal structure of HIV-1 protease-hup [Human immunodeficiency virus 1] &gt;pdb|1NPV|A Crystal structure of HIV-1 protease complexed with LDC271 [Human immunodeficiency virus 1] &gt;pdb|1NPV|B Crystal structure of HIV-1 protease complexed with LDC271 [Human immunodeficiency virus 1] &gt;pdb|1NPW|A Crystal structure of HIV protease complexed with LGZ479 [Human immunodeficiency virus 1] &gt;pdb|1NPW|B Crystal structure of HIV protease complexed with LGZ479 [Human immunodeficiency virus 1] &gt;pdb|1OHR|A VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1OHR|B VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE [Human immunodeficiency virus 1] &gt;pdb|1SP5|A Crystal structure of HIV-1 protease complexed with a product of autoproteolysis [Human immunodeficiency virus 1] &gt;pdb|1SP5|B Crystal structure of HIV-1 protease complexed with a product of autoproteolysis [Human immunodeficiency virus 1] &gt;pdb|1T7K|A Crystal Structure of HIV Protease complexed with Arylsulfonamide azacyclic urea [Human immunodeficiency virus 1] &gt;pdb|1T7K|B Crystal Structure of HIV Protease complexed with Arylsulfonamide azacyclic urea [Human immunodeficiency virus 1] &gt;pdb|1U8G|A Crystal structure of a HIV-1 Protease in complex with peptidomimetic inhibitor KI2-PHE-GLU-GLU-NH2 [Human immunodeficiency virus 1] &gt;pdb|1U8G|B Crystal structure of a HIV-1 Protease in complex with peptidomimetic inhibitor KI2-PHE-GLU-GLU-NH2 [Human immunodeficiency virus 1] &gt;pdb|1UPJ|A Hiv-1 Protease Complex With U095438 [3-[1-(4-Bromophenyl) Isobutyl]-4- Hydroxycoumarin [Human immunodeficiency virus 1] &gt;pdb|1WBK|A HIV-1 protease in complex with asymmetric inhibitor, BEA568 [Human immunodeficiency virus 1] &gt;pdb|1WBK|B HIV-1 protease in complex with asymmetric inhibitor, BEA568 [Human immunodeficiency virus 1] &gt;pdb|1WBM|A HIV-1 protease in complex with symmetric inhibitor, BEA450 [Human immunodeficiency virus 1] &gt;pdb|1WBM|B HIV-1 protease in complex with symmetric inhibitor, BEA450 [Human immunodeficiency virus 1] &gt;pdb|1XL2|A HIV-1 Protease in complex with pyrrolidinmethanamine [Human immunodeficiency virus 1] &gt;pdb|1XL2|B HIV-1 Protease in complex with pyrrolidinmethanamine [Human immunodeficiency virus 1] &gt;pdb|1XL5|A HIV-1 Protease in complex with amidhyroxysulfone [Human immunodeficiency virus 1] &gt;pdb|1XL5|B HIV-1 Protease in complex with amidhyroxysulfone [Human immunodeficiency virus 1] &gt;pdb|1YT9|A HIV Protease with oximinoarylsulfonamide bound [Human immunodeficiency virus 1] &gt;pdb|1YT9|B HIV Protease with oximinoarylsulfonamide bound [Human immunodeficiency virus 1] &gt;pdb|2A4F|A Synthesis and Activity of N-Axyl Azacyclic Urea HIV-1 Protease Inhibitors with High Potency Against Multiple Drug Resistant Viral Strains. [Human immunodeficiency virus 1] &gt;pdb|2A4F|B Synthesis and Activity of N-Axyl Azacyclic Urea HIV-1 Protease Inhibitors with High Potency Against Multiple Drug Resistant Viral Strains. [Human immunodeficiency virus 1] &gt;pdb|2AQU|A Structure of HIV-1 protease bound to atazanavir [Human immunodeficiency virus 1] &gt;pdb|2AQU|B Structure of HIV-1 protease bound to atazanavir [Human immunodeficiency virus 1] &gt;pdb|2BB9|A Structure of HIV1 protease and AKC4p_133a complex. [Human immunodeficiency virus 1] &gt;pdb|2BB9|B Structure of HIV1 protease and AKC4p_133a complex. [Human immunodeficiency virus 1] &gt;pdb|2BBB|A Structure of HIV1 protease and hh1_173_3a complex. [Human immunodeficiency virus 1] &gt;pdb|2BBB|B Structure of HIV1 protease and hh1_173_3a complex. [Human immunodeficiency virus 1] &gt;pdb|2BPV|A HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPV|B HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPW|A HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPW|B HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPX|A HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPX|B HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPY|A HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPY|B HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPZ|A HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BPZ|B HIV-1 protease-inhibitor complex [Human immunodeficiency virus 1] &gt;pdb|2BQV|A HIV-1 protease in complex with inhibitor AHA455 [Human immunodeficiency virus 1] &gt;pdb|2BQV|B HIV-1 protease in complex with inhibitor AHA455 [Human immunodeficiency virus 1] &gt;pdb|2CEJ|A P1&apos; Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold [Human immunodeficiency virus 1] &gt;pdb|2CEJ|B P1&apos; Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold [Human immunodeficiency virus 1] &gt;pdb|2CEM|A P1&apos; Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold [Human immunodeficiency virus 1] &gt;pdb|2CEM|B P1&apos; Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold [Human immunodeficiency virus 1] &gt;pdb|2CEN|A P1&apos; Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold [Human immunodeficiency virus 1] &gt;pdb|2CEN|B P1&apos; Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold [Human immunodeficiency virus 1] &gt;pdb|2PQZ|A HIV-1 Protease in complex with a pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2PQZ|B HIV-1 Protease in complex with a pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2PWC|A HIV-1 protease in complex with a amino decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2PWC|B HIV-1 protease in complex with a amino decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2PWR|A HIV-1 protease in complex with a carbamoyl decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2PWR|B HIV-1 protease in complex with a carbamoyl decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2QNN|A HIV-1 protease in complex with a multiple decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2QNN|B HIV-1 protease in complex with a multiple decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2QNP|A HIV-1 Protease in complex with a iodo decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2QNP|B HIV-1 Protease in complex with a iodo decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2QNQ|A HIV-1 Protease in complex with a chloro decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2QNQ|B HIV-1 Protease in complex with a chloro decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2UPJ|A Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl [4-Hydroxy- 2oxo-6-[1-(Phenylmethyl)propyl]-2h-Pyran-3-Yl] Methyl]phenyl]amino]- 3-Oxo-Propyl]carbamic Acid Tert-Butyl Ester) [Human immunodeficiency virus 1] &gt;pdb|2UPJ|B Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl [4-Hydroxy- 2oxo-6-[1-(Phenylmethyl)propyl]-2h-Pyran-3-Yl] Methyl]phenyl]amino]- 3-Oxo-Propyl]carbamic Acid Tert-Butyl Ester) [Human immunodeficiency virus 1] &gt;pdb|2UXZ|A Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State Mimic [Human immunodeficiency virus 1] &gt;pdb|2UXZ|B Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State Mimic [Human immunodeficiency virus 1] &gt;pdb|2UY0|A Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State Mimic [Human immunodeficiency virus 1] &gt;pdb|2UY0|B Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State Mimic [Human immunodeficiency virus 1] &gt;pdb|2WKZ|A HIV-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-State Mimic with Improved Cell-Based Antiviral Activity [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2WKZ|B HIV-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-State Mimic with Improved Cell-Based Antiviral Activity [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2ZGA|A HIV-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (hexagonal space group) [Human immunodeficiency virus 1] &gt;pdb|3BGB|A HIV-1 protease in complex with a isobutyl decorated oligoamine [Human immunodeficiency virus 1] &gt;pdb|3BGB|B HIV-1 protease in complex with a isobutyl decorated oligoamine [Human immunodeficiency virus 1] &gt;pdb|3BGC|A HIV-1 protease in complex with a benzyl decorated oligoamine [Human immunodeficiency virus 1] &gt;pdb|3BGC|B HIV-1 protease in complex with a benzyl decorated oligoamine [Human immunodeficiency virus 1] &gt;pdb|3BHE|A HIV-1 protease in complex with a three armed pyrrolidine derivative [Human immunodeficiency virus 1] &gt;pdb|3BHE|B HIV-1 protease in complex with a three armed pyrrolidine derivative [Human immunodeficiency virus 1] &gt;pdb|3CKT|A HIV-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (orthorombic space group) [Human immunodeficiency virus 1] &gt;pdb|3CKT|B HIV-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (orthorombic space group) [Human immunodeficiency virus 1] &gt;pdb|3GGA|A HIV Protease inhibitors with pseudo-symmetric cores [Human immunodeficiency virus 1] &gt;pdb|3GGA|B HIV Protease inhibitors with pseudo-symmetric cores [Human immunodeficiency virus 1] &gt;pdb|3GGA|C HIV Protease inhibitors with pseudo-symmetric cores [Human immunodeficiency virus 1] &gt;pdb|3GGA|D HIV Protease inhibitors with pseudo-symmetric cores [Human immunodeficiency virus 1] &gt;pdb|3GGA|G HIV Protease inhibitors with pseudo-symmetric cores [Human immunodeficiency virus 1] &gt;pdb|3GGA|H HIV Protease inhibitors with pseudo-symmetric cores [Human immunodeficiency virus 1] &gt;pdb|3GGV|A HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|B HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|C HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|D HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|E HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|F HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|G HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|H HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGV|I HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|A HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|B HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|C HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|D HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|E HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|F HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|G HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3GGX|H HIV Protease, pseudo-symmetric inhibitors [Human immunodeficiency virus 1] &gt;pdb|3PHV|A X-RAY ANALYSIS OF HIV-1 PROTEINASE AT 2.7 ANGSTROMS RESOLUTION CONFIRMS STRUCTURAL HOMOLOGY AMONG RETROVIRAL ENZYMES [HIV-1 M:B_HXB2R] &gt;pdb|3PSU|A HIV-1 protease in complex with an isobutyl decorated oligoamine (symmetric binding mode) [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3T11|A Dimeric inhibitor of HIV-1 protease. [Human immunodeficiency virus 1] &gt;pdb|3T11|B Dimeric inhibitor of HIV-1 protease. [Human immunodeficiency virus 1] &gt;pdb|4FE6|A Crystal Structure of HIV-1 Protease in Complex with an enamino-oxindole inhibitor [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HLA|A Crystal structure of wild type HIV-1 protease in complex with darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4HLA|B Crystal structure of wild type HIV-1 protease in complex with darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|4I8W|A Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL007 [Human immunodeficiency virus 1] &gt;pdb|4I8W|B Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL007 [Human immunodeficiency virus 1] &gt;pdb|4I8Z|A Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL008 [Human immunodeficiency virus 1] &gt;pdb|4I8Z|B Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL008 [Human immunodeficiency virus 1] &gt;pdb|5TYR|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-121 [Human immunodeficiency virus 1] &gt;pdb|5TYR|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-121 [Human immunodeficiency virus 1] &gt;pdb|5TYS|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-142 [Human immunodeficiency virus 1] &gt;pdb|5TYS|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-142 [Human immunodeficiency virus 1] &gt;pdb|6D0D|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-087-13 [Human immunodeficiency virus 1] &gt;pdb|6D0D|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-087-13 [Human immunodeficiency virus 1] &gt;pdb|6D0E|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-084-13 [Human immunodeficiency virus 1] &gt;pdb|6D0E|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-084-13 [Human immunodeficiency virus 1] &gt;pdb|6UWB|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-08513 [Human immunodeficiency virus 1] &gt;pdb|6UWB|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-08513 [Human immunodeficiency virus 1] &gt;pdb|6UWC|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-08613 [Human immunodeficiency virus 1] &gt;pdb|6UWC|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-08613 [Human immunodeficiency virus 1] &gt;pdb|7UPJ|A Hiv-1 ProteaseU101935 COMPLEX [Human immunodeficiency virus 1] &gt;pdb|7UPJ|B Hiv-1 ProteaseU101935 COMPLEX [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1AJV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.28687e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>81</Hit_num>
  <Hit_id>pdb|2AVV|A</Hit_id>
  <Hit_def>Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S [Human immunodeficiency virus 1] &gt;pdb|2AVV|B Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S [Human immunodeficiency virus 1] &gt;pdb|2AVV|D Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S [Human immunodeficiency virus 1] &gt;pdb|2AVV|E Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AVV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.3006e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQII----IEIAG---HKAISTVLVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+   +I    I   G      +   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>82</Hit_num>
  <Hit_id>pdb|3S43|B</Hit_id>
  <Hit_def>HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir [Human immunodeficiency virus 1] &gt;pdb|3S53|A HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P212121 [Human immunodeficiency virus 1] &gt;pdb|3S53|B HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P212121 [Human immunodeficiency virus 1] &gt;pdb|3S54|A HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P21212 [Human immunodeficiency virus 1] &gt;pdb|3S54|B HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P21212 [Human immunodeficiency virus 1] &gt;pdb|3S56|A HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug saquinavir [Human immunodeficiency virus 1] &gt;pdb|3S56|B HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug saquinavir [Human immunodeficiency virus 1] &gt;pdb|5E5J|A Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH 6.0 [Human immunodeficiency virus 1] &gt;pdb|5E5J|B Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH 6.0 [Human immunodeficiency virus 1] &gt;pdb|5E5K|A Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH 4.3 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|5E5K|B Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH 4.3 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|5T8H|A Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with amprenavir at pH 6.0 [Human immunodeficiency virus 1] &gt;pdb|6KMP|A 100K X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate mimic KVS-1 [Human immunodeficiency virus 1] &gt;pdb|6KMP|B 100K X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate mimic KVS-1 [Human immunodeficiency virus 1] &gt;pdb|6OTG|A HIV-1 protease triple mutants V32I, I47V, V82I with GRL-011-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, sulfonamide isostere derivate) [Human immunodeficiency virus 1] &gt;pdb|6OTG|B HIV-1 protease triple mutants V32I, I47V, V82I with GRL-011-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, sulfonamide isostere derivate) [Human immunodeficiency virus 1] &gt;pdb|6PTP|A Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate mimic KVS-1 [Human immunodeficiency virus 1] &gt;pdb|6PTP|B Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate mimic KVS-1 [Human immunodeficiency virus 1] &gt;pdb|6PU8|A Room temperature X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate of keto-darunavir [Human immunodeficiency virus 1] &gt;pdb|6PU8|B Room temperature X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate of keto-darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3S43_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.3006e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIIEEMSLPGRWKPKM------VGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPINIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+I E   P  W P M      + GIGG I VR+  + +IE+      G++        LV  TP+NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>83</Hit_num>
  <Hit_id>pdb|1ZP8|A</Hit_id>
  <Hit_def>HIV Protease with inhibitor AB-2 [Human immunodeficiency virus 1] &gt;pdb|1ZPA|A HIV Protease with Scripps AB-3 Inhibitor [Human immunodeficiency virus 1] &gt;pdb|2O4K|A Crystal Structure of HIV-1 Protease (Q7K) in Complex with Atazanavir [Human immunodeficiency virus 1] &gt;pdb|2O4K|B Crystal Structure of HIV-1 Protease (Q7K) in Complex with Atazanavir [Human immunodeficiency virus 1] &gt;pdb|2O4P|A Crystal Structure of HIV-1 Protease (Q7K) in Complex with Tipranavir [Human immunodeficiency virus 1] &gt;pdb|2O4P|B Crystal Structure of HIV-1 Protease (Q7K) in Complex with Tipranavir [Human immunodeficiency virus 1] &gt;pdb|2O4S|A Crystal Structure of HIV-1 Protease (Q7K) in Complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|2O4S|B Crystal Structure of HIV-1 Protease (Q7K) in Complex with Lopinavir [Human immunodeficiency virus 1] &gt;pdb|2P3B|A Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1] &gt;pdb|3TLH|A Structural Studies Of Hiv And Fiv Proteases Complexed Withan Efficient Inhibitor Of Fiv Pr [Human immunodeficiency virus type 1 (CLONE 12)]</Hit_def>
  <Hit_accession>1ZP8_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.3006e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>84</Hit_num>
  <Hit_id>pdb|3BXR|A</Hit_id>
  <Hit_def>Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease. Implications For Catalytic Mechanism [synthetic construct] &gt;pdb|3BXR|B Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease. Implications For Catalytic Mechanism [synthetic construct]</Hit_def>
  <Hit_accession>3BXR_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.31448e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVIEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTVI E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>85</Hit_num>
  <Hit_id>pdb|1BVE|A</Hit_id>
  <Hit_def>HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES [Human immunodeficiency virus 1] &gt;pdb|1BVE|B HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES [Human immunodeficiency virus 1] &gt;pdb|1BVG|A HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE [Human immunodeficiency virus 1] &gt;pdb|1BVG|B HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE [Human immunodeficiency virus 1] &gt;pdb|1HVH|A NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS [Human immunodeficiency virus 1] &gt;pdb|1HVH|B NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS [Human immunodeficiency virus 1] &gt;pdb|1HWR|A MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS [Human immunodeficiency virus 1] &gt;pdb|1HWR|B MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS [Human immunodeficiency virus 1] &gt;pdb|1QBR|A HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1] &gt;pdb|1QBR|B HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1] &gt;pdb|1QBT|A HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1] &gt;pdb|1QBT|B HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1] &gt;pdb|1QBU|A HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1] &gt;pdb|1QBU|B HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1BVE_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.46164e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>86</Hit_num>
  <Hit_id>pdb|6OOS|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 L90M Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OOS|B HIV-1 Protease NL4-3 L90M Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OOS|C HIV-1 Protease NL4-3 L90M Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OOS|D HIV-1 Protease NL4-3 L90M Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OOS_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.47723e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>87</Hit_num>
  <Hit_id>pdb|3JVW|A</Hit_id>
  <Hit_def>HIV-1 Protease Mutant G86A with symmetric inhibitor DMP323 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3JVW|B HIV-1 Protease Mutant G86A with symmetric inhibitor DMP323 [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3JVY|A HIV-1 Protease Mutant G86A with DARUNAVIR [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3JVY|B HIV-1 Protease Mutant G86A with DARUNAVIR [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3JVW_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>1.50892e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIARNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+ R+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>88</Hit_num>
  <Hit_id>pdb|1AAQ|A</Hit_id>
  <Hit_def>HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY ANALYSIS USING ENZYME KINETICS, X-RAY CRYSTALLOGRAPHY, AND INFECTED T-CELL ASSAYS [Human immunodeficiency virus 1] &gt;pdb|1AAQ|B HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY ANALYSIS USING ENZYME KINETICS, X-RAY CRYSTALLOGRAPHY, AND INFECTED T-CELL ASSAYS [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1AAQ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>1.59113e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>89</Hit_num>
  <Hit_id>pdb|3OXV|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXV|B Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXV|C Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXV|D Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir. [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3OXV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>1.62525e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGVGGFIKVRQY-DQIPIEICGHK------VIGTVLVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I G+GG I VR+  D I + +          ++   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>90</Hit_num>
  <Hit_id>pdb|2I4V|A</Hit_id>
  <Hit_def>HIV-1 protease I84V, L90M with TMC126 [Human immunodeficiency virus 1] &gt;pdb|2I4V|B HIV-1 protease I84V, L90M with TMC126 [Human immunodeficiency virus 1] &gt;pdb|2I4X|A HIV-1 Protease I84V, L90M with GS-8374 [Human immunodeficiency virus 1] &gt;pdb|2I4X|B HIV-1 Protease I84V, L90M with GS-8374 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2I4V_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>1.75053e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNVIGRNLMTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVN++GR+ +  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>91</Hit_num>
  <Hit_id>pdb|3OY4|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 L76V Protease in Complex with the Protease Inhibitor Darunavir. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OY4|B Crystal Structure of HIV-1 L76V Protease in Complex with the Protease Inhibitor Darunavir. [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3OY4_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>1.84587e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------VVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + IE+      G++        +V  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>92</Hit_num>
  <Hit_id>pdb|3OXW|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Darunavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXW|B Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Darunavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXW|C Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Darunavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXW|D Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Darunavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXX|A Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXX|B Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXX|C Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3OXX|D Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3OXW_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>1.88544e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGVGGFIKVRQY-DQIPVEICGHK------VIGTVLVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I G+GG I VR+  D I + +          ++   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>93</Hit_num>
  <Hit_id>pdb|1BV9|A</Hit_id>
  <Hit_def>HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS [Human immunodeficiency virus 1] &gt;pdb|1BV9|B HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS [Human immunodeficiency virus 1] &gt;pdb|1MER|A HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 [Human immunodeficiency virus 1] &gt;pdb|1MER|B HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 [Human immunodeficiency virus 1] &gt;pdb|1MES|A HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 [Human immunodeficiency virus 1] &gt;pdb|1MES|B HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1BV9_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.00932e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVN++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>94</Hit_num>
  <Hit_id>pdb|3JW2|A</Hit_id>
  <Hit_def>HIV-1 Protease Mutant G86S with DARUNAVIR [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3JW2|B HIV-1 Protease Mutant G86S with DARUNAVIR [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3JW2_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.03074e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIISRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+ R+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>95</Hit_num>
  <Hit_id>pdb|3LZS|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 CRF01_AE Protease in Complex with Darunavir [Human immunodeficiency virus 1] &gt;pdb|3LZS|B Crystal Structure of HIV-1 CRF01_AE Protease in Complex with Darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3LZS_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.03074e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDINLPGKWKPKM------IGGIGGFIKVRQYDQILIEICGKKAIGTV--------LVGPTPVNIIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>96</Hit_num>
  <Hit_id>pdb|2R38|A</Hit_id>
  <Hit_def>I84V HIV-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2R38|B I84V HIV-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2R3W|A I84V HIV-1 protease in complex with a amino decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2R3W|B I84V HIV-1 protease in complex with a amino decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|3BC4|A I84V HIV-1 protease in complex with a pyrrolidine diester [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2R38_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.07427e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVN++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>97</Hit_num>
  <Hit_id>pdb|2R3T|A</Hit_id>
  <Hit_def>I50V HIV-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2R3T|B I50V HIV-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2R43|A I50V HIV-1 protease in complex with an amino decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1] &gt;pdb|2R43|B I50V HIV-1 protease in complex with an amino decorated pyrrolidine-based inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2R3T_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.07427e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGVGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I G+GG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>98</Hit_num>
  <Hit_id>pdb|2O4L|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 Protease (Q7K, I50V) in Complex with Tipranavir [Human immunodeficiency virus 1] &gt;pdb|2O4L|B Crystal Structure of HIV-1 Protease (Q7K, I50V) in Complex with Tipranavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2O4L_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.07427e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGVGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I G+GG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>99</Hit_num>
  <Hit_id>pdb|4OBD|A</Hit_id>
  <Hit_def>Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate variant (L449F/S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBD|B Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate variant (L449F/S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBD|C Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate variant (L449F/S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBD|D Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate variant (L449F/S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBF|A Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease Variant (D30N/N88D) in Complex with the p1-p6 substrate variant (S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBF|B Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease Variant (D30N/N88D) in Complex with the p1-p6 substrate variant (S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBF|C Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease Variant (D30N/N88D) in Complex with the p1-p6 substrate variant (S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBF|D Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease Variant (D30N/N88D) in Complex with the p1-p6 substrate variant (S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBG|A Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate. [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBG|B Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate. [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBG|C Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate. [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBG|D Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate. [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>4OBD_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.09638e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADNTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPVNIIGRDLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGAD+TV+ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GRD L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>100</Hit_num>
  <Hit_id>pdb|2NXD|A</Hit_id>
  <Hit_def>Structure of HIV-1 protease D25N complexed with rt-rh analogue peptide GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA [HIV-1 M:B_ARV2/SF2] &gt;pdb|2NXD|B Structure of HIV-1 protease D25N complexed with rt-rh analogue peptide GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA [HIV-1 M:B_ARV2/SF2] &gt;pdb|2NXL|A Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA [HIV-1 M:B_ARV2/SF2] &gt;pdb|2NXL|B Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA [HIV-1 M:B_ARV2/SF2] &gt;pdb|2NXM|A Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA [HIV-1 M:B_ARV2/SF2] &gt;pdb|2NXM|B Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBH|A Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBH|B Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBH|C Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBH|D Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBJ|A Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBJ|B Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBK|A Crystal structure of inactive HIV-1 protease in complex with the P1-P6 substrate variant (L449F/S451N) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4OBK|B Crystal structure of inactive HIV-1 protease in complex with the P1-P6 substrate variant (L449F/S451N) [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>2NXD_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.09638e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>101</Hit_num>
  <Hit_id>pdb|5YRS|B</Hit_id>
  <Hit_def>X-ray Snapshot of HIV-1 Protease in Action: Observation of Tetrahedral Intermediate and Its SIHB with Catalytic Aspartate [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>5YRS_B</Hit_accession>
  <Hit_len>104</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>2.19983e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>102</Hit_num>
  <Hit_id>pdb|2QHC|A</Hit_id>
  <Hit_def>The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir [Human immunodeficiency virus 1] &gt;pdb|2QHC|B The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2QHC_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.2579e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKMAG-----GIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W    A      GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>103</Hit_num>
  <Hit_id>pdb|2FLE|A</Hit_id>
  <Hit_def>Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant [Human immunodeficiency virus 1] &gt;pdb|2FLE|B Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FLE_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.43183e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGKWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>104</Hit_num>
  <Hit_id>pdb|3EM3|A</Hit_id>
  <Hit_def>Crystal structure of amprenavir (APV) in complex with a drug resistant HIV-1 protease variant (I50L/A71V). [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EM3|B Crystal structure of amprenavir (APV) in complex with a drug resistant HIV-1 protease variant (I50L/A71V). [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3EM3_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.51041e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGLGGFIKVRQY-DQIPIEICGHK------VIGTVLVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I G+GG I VR+  D I + +          ++   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>105</Hit_num>
  <Hit_id>pdb|6I45|A</Hit_id>
  <Hit_def>Crystal structure of I13V/I62V/V77I South African HIV-1 subtype C protease containing a D25A mutation [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6I45_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.59152e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLATGADDTVLEEINLPGKWKPKM------IGGIGGFIKVRQYDQVLIEICGKKAIGTV--------LIGPTPVNIIGRNMLTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALL TGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        L+  TPVNI+GR+ L  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>106</Hit_num>
  <Hit_id>pdb|2AZ9|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 1X mutant [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AZ9_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.7911e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>107</Hit_num>
  <Hit_id>pdb|1HVC|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1HVC_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>2.89887e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>7.46763e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>108</Hit_num>
  <Hit_id>pdb|1FB7|A</Hit_id>
  <Hit_def>Crystal Structure Of An In Vivo Hiv-1 Protease Mutant In Complex With Saquinavir: Insights Into The Mechanisms Of Drug Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1FB7_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.97433e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IVGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>109</Hit_num>
  <Hit_id>pdb|2FGU|A</Hit_id>
  <Hit_def>X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity. [Human immunodeficiency virus 1] &gt;pdb|2FGU|B X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FGU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>3.00602e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPSPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  +PVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>110</Hit_num>
  <Hit_id>pdb|1LV1|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of the non-active site mutant of tethered HIV-1 protease to 2.1A resolution [Human immunodeficiency virus 1] &gt;pdb|2WHH|A HIV-1 protease tethered dimer Q-product complex along with nucleophilic water molecule [Human immunodeficiency virus 1] &gt;pdb|3DOX|A X-ray structure of HIV-1 protease in situ product complex [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>1LV1_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>3.01817e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>8.42455e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>111</Hit_num>
  <Hit_id>pdb|4QJ9|A</Hit_id>
  <Hit_def>Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (R452S) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ9|B Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (R452S) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJA|A Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (P453L) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJA|B Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (P453L) [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>4QJ9_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>3.03804e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQY-DQIPIEICGHK------VIGTVLVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+  D I + +          ++   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>112</Hit_num>
  <Hit_id>pdb|1G6L|A</Hit_id>
  <Hit_def>1.9a Crystal Structure Of Tethered Hiv-1 Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1G6L_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>3.1742e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>6.55285e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>113</Hit_num>
  <Hit_id>pdb|3EM4|A</Hit_id>
  <Hit_def>Crystal structure of atazanavir (ATV) in complex with I50L/A71V drug-resistant HIV-1 protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EM4|B Crystal structure of atazanavir (ATV) in complex with I50L/A71V drug-resistant HIV-1 protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EM4|U Crystal structure of atazanavir (ATV) in complex with I50L/A71V drug-resistant HIV-1 protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EM4|V Crystal structure of atazanavir (ATV) in complex with I50L/A71V drug-resistant HIV-1 protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EM6|A Crystal structure of I50L/A71V mutant of hiv-1 protease in complex with inhibitor darunavir [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EM6|B Crystal structure of I50L/A71V mutant of hiv-1 protease in complex with inhibitor darunavir [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3EM4_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.20333e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGLGGFIKVRQY-DQIPVEICGHK------VIGTVLVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I G+GG I VR+  D I + +          ++   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>114</Hit_num>
  <Hit_id>pdb|1MRX|A</Hit_id>
  <Hit_def>Structure of HIV protease (Mutant Q7K L33I L63I V82F I84V) complexed with KNI-577 [Human immunodeficiency virus 1] &gt;pdb|1MRX|B Structure of HIV protease (Mutant Q7K L33I L63I V82F I84V) complexed with KNI-577 [Human immunodeficiency virus 1] &gt;pdb|1MSN|A The HIV protease (mutant Q7K L33I L63I V82F I84V) complexed with KNI-764 (an inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1MSN|B The HIV protease (mutant Q7K L33I L63I V82F I84V) complexed with KNI-764 (an inhibitor) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1MRX_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.27193e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEICGHKAIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>115</Hit_num>
  <Hit_id>pdb|2Q64|A</Hit_id>
  <Hit_def>HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2Q64|B HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2Q64_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.342e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMSLPGAWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>116</Hit_num>
  <Hit_id>pdb|3LZU|A</Hit_id>
  <Hit_def>Crystal Structure of a Nelfinavir Resistant HIV-1 CRF01_AE Protease variant (N88S) in Complex with the Protease Inhibitor Darunavir. [Human immunodeficiency virus 1] &gt;pdb|3LZU|B Crystal Structure of a Nelfinavir Resistant HIV-1 CRF01_AE Protease variant (N88S) in Complex with the Protease Inhibitor Darunavir. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3LZU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.48667e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDINLPGKWKPKM------IGGIGGFIKVRQYDQILIEICGKKAIGTV--------LVGPTPVNIIGRSMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR  L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>117</Hit_num>
  <Hit_id>pdb|1MTB|A</Hit_id>
  <Hit_def>Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1MTB|B Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1MTB_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.59925e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>118</Hit_num>
  <Hit_id>pdb|1F7A|A</Hit_id>
  <Hit_def>HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. [Human immunodeficiency virus 1] &gt;pdb|1F7A|B HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. [Human immunodeficiency virus 1] &gt;pdb|1KJ4|A Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJ4|B Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJ4|C Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJ4|D Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJ7|A Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJ7|B Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJF|A Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJF|B Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJG|A Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJG|B Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJH|A Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1KJH|B Substrate Shape Determines Specificity Of Recognition Recognition For Hiv-1 Protease: Analysis Of Crystal Structures Of Six Substrate Complexes [Human immunodeficiency virus 1] &gt;pdb|1TSU|A CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT &gt;pdb|1TSU|B CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT &gt;pdb|2FNS|A Crystal structure of wild-type inactive (D25N) HIV-1 protease complexed with wild-type HIV-1 NC-p1 substrate. [Human immunodeficiency virus 1] &gt;pdb|2FNS|B Crystal structure of wild-type inactive (D25N) HIV-1 protease complexed with wild-type HIV-1 NC-p1 substrate. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1F7A_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.63758e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>119</Hit_num>
  <Hit_id>pdb|2Z54|A</Hit_id>
  <Hit_def>The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir [Human immunodeficiency virus 1] &gt;pdb|2Z54|B The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2Z54_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.67631e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKMAG-----GIGGFVKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W    A      GIGG + VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>120</Hit_num>
  <Hit_id>pdb|3D3T|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 CRF01_AE in complex with the substrate p1-p6 [unidentified] &gt;pdb|3D3T|B Crystal Structure of HIV-1 CRF01_AE in complex with the substrate p1-p6 [unidentified]</Hit_def>
  <Hit_accession>3D3T_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.67631e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEDINLPGKWKPKM------IGGIGGFIKVRQYDQILIEICGKKAIGTV--------LVGPTPVNIIGRNMLTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ + + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>121</Hit_num>
  <Hit_id>pdb|1RL8|A</Hit_id>
  <Hit_def>Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir [Human immunodeficiency virus 1] &gt;pdb|1RL8|B Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1RL8_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.79501e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGAWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>122</Hit_num>
  <Hit_id>pdb|1AXA|A</Hit_id>
  <Hit_def>ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT [Human immunodeficiency virus 1] &gt;pdb|1AXA|B ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1AXA_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>3.91752e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGSDDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTG+DDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>123</Hit_num>
  <Hit_id>pdb|1BV7|A</Hit_id>
  <Hit_def>COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES [Human immunodeficiency virus 1] &gt;pdb|1BV7|B COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES [Human immunodeficiency virus 1] &gt;pdb|1MET|A HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 [Human immunodeficiency virus 1] &gt;pdb|1MET|B HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1BV7_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>4.04399e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPFNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>124</Hit_num>
  <Hit_id>pdb|3EL4|A</Hit_id>
  <Hit_def>Crystal structure of inhibitor saquinavir (SQV) complexed with the multidrug HIV-1 protease variant L63P/V82T/I84V [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EL4|B Crystal structure of inhibitor saquinavir (SQV) complexed with the multidrug HIV-1 protease variant L63P/V82T/I84V [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3EL4_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>4.04399e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>125</Hit_num>
  <Hit_id>pdb|3N3I|A</Hit_id>
  <Hit_def>Crystal Structure of G48V/C95F tethered HIV-1 Protease/Saquinavir complex [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>3N3I_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>4.08346e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IVGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGFTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>47.7506</Hsp_bit-score>
      <Hsp_score>112</Hsp_score>
      <Hsp_evalue>4.08346e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IVGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGFTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>126</Hit_num>
  <Hit_id>pdb|5COK|A</Hit_id>
  <Hit_def>X-ray crystal structure of wild type HIV-1 protease in complex with GRL-0476 [Human immunodeficiency virus 1] &gt;pdb|5COK|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-0476 [Human immunodeficiency virus 1] &gt;pdb|5CON|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-015 [Human immunodeficiency virus 1] &gt;pdb|5CON|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-015 [Human immunodeficiency virus 1] &gt;pdb|5COO|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-085 [Human immunodeficiency virus 1] &gt;pdb|5COO|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-085 [Human immunodeficiency virus 1] &gt;pdb|5COP|A X-ray crystal structure of wild type HIV-1 protease in complex with GRL-097 [Human immunodeficiency virus 1] &gt;pdb|5COP|B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-097 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5COK_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>4.08704e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>127</Hit_num>
  <Hit_id>pdb|6OPT|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPT|B HIV-1 Protease NL4-3 V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPT_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>4.08704e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>128</Hit_num>
  <Hit_id>pdb|5KR1|A</Hit_id>
  <Hit_def>Protease PR5-DRV [Human immunodeficiency virus 1] &gt;pdb|5KR1|B Protease PR5-DRV [Human immunodeficiency virus 1] &gt;pdb|5KR2|A Protease PR5-SQV [Human immunodeficiency virus 1] &gt;pdb|5KR2|B Protease PR5-SQV [Human immunodeficiency virus 1] &gt;pdb|5KR2|C Protease PR5-SQV [Human immunodeficiency virus 1] &gt;pdb|5KR2|D Protease PR5-SQV [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5KR1_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>4.08704e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVIEDMNLPGKWKPKM------IGGIGGFIKVKQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTVI + + P  W P M      I GIGG I V++  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>129</Hit_num>
  <Hit_id>pdb|3MWS|A</Hit_id>
  <Hit_def>Crystal Structure of Group N HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|3MWS|B Crystal Structure of Group N HIV-1 Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3MWS_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>4.13055e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEIQLEGKWKPKM------IGGIGGFIKVRQYDNV----TIDIQG---RKAVGTVLVGPTPVNIIGRNFLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E      W P M      I GIGG I VR+  ++     I+  G   R  +   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>130</Hit_num>
  <Hit_id>pdb|3HAW|A</Hit_id>
  <Hit_def>Crystal structure of [L-Ala51/51&apos;]HIV-1 protease with reduced isostere MVT-101 inhibitor [Human immunodeficiency virus 1] &gt;pdb|3HAW|B Crystal structure of [L-Ala51/51&apos;]HIV-1 protease with reduced isostere MVT-101 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3HAW_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>4.30927e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIAGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I GI G I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>131</Hit_num>
  <Hit_id>pdb|1ODX|A</Hit_id>
  <Hit_def>HIV-1 Proteinase mutant A71T, V82A [Human immunodeficiency virus 1] &gt;pdb|1ODX|B HIV-1 Proteinase mutant A71T, V82A [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1ODX_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>4.40151e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKTIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>132</Hit_num>
  <Hit_id>pdb|1HVS|A</Hit_id>
  <Hit_def>STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING [Human immunodeficiency virus 1] &gt;pdb|1HVS|B STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1HVS_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>4.59192e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>133</Hit_num>
  <Hit_id>pdb|3EKP|A</Hit_id>
  <Hit_def>Crystal Structure of the inhibitor Amprenavir (APV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A)Refer: FLAP+ in citation [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKP|B Crystal Structure of the inhibitor Amprenavir (APV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A)Refer: FLAP+ in citation [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKP|C Crystal Structure of the inhibitor Amprenavir (APV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A)Refer: FLAP+ in citation [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKP|D Crystal Structure of the inhibitor Amprenavir (APV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A)Refer: FLAP+ in citation [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKT|A Crystal Structure of the inhibitor Darunavir (DRV) in complex with a multi-drug resistant HIV-1 protease variant (L10F/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation.) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKT|B Crystal Structure of the inhibitor Darunavir (DRV) in complex with a multi-drug resistant HIV-1 protease variant (L10F/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation.) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKT|C Crystal Structure of the inhibitor Darunavir (DRV) in complex with a multi-drug resistant HIV-1 protease variant (L10F/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation.) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKT|D Crystal Structure of the inhibitor Darunavir (DRV) in complex with a multi-drug resistant HIV-1 protease variant (L10F/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation.) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKW|A Crystal structure of the inhibitor Atazanavir (ATV) in complex with a multi-drug resistance HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) Refer: FLAP+ in citation. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKW|B Crystal structure of the inhibitor Atazanavir (ATV) in complex with a multi-drug resistance HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) Refer: FLAP+ in citation. [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EL0|A Crystal structure of the inhibitor Nelfinavir (NFV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EL0|B Crystal structure of the inhibitor Nelfinavir (NFV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation) [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3EKP_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>4.99777e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IVGIGGFVKVRQYDQIPIEICGHKAIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG + VR+   + IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>134</Hit_num>
  <Hit_id>pdb|5KQX|A</Hit_id>
  <Hit_def>Protease E35D-SQV [Human immunodeficiency virus 1] &gt;pdb|5KQX|B Protease E35D-SQV [Human immunodeficiency virus 1] &gt;pdb|5KQY|A Protease E35D-DRV [Human immunodeficiency virus 1] &gt;pdb|5KQY|B Protease E35D-DRV [Human immunodeficiency virus 1] &gt;pdb|5KQZ|A Protease E35D-CaP2 [Human immunodeficiency virus 1] &gt;pdb|5KQZ|B Protease E35D-CaP2 [Human immunodeficiency virus 1] &gt;pdb|5KR0|A Protease E35D-APV [Human immunodeficiency virus 1] &gt;pdb|5KR0|B Protease E35D-APV [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5KQX_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>5.10471e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVIEDMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTVI +   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>135</Hit_num>
  <Hit_id>pdb|4QJ2|A</Hit_id>
  <Hit_def>Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with WT p1-p6 substrate [Human immunodeficiency virus 1] &gt;pdb|4QJ2|B Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with WT p1-p6 substrate [Human immunodeficiency virus 1] &gt;pdb|4QJ2|C Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with WT p1-p6 substrate [Human immunodeficiency virus 1] &gt;pdb|4QJ2|D Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with WT p1-p6 substrate [Human immunodeficiency virus 1] &gt;pdb|4QJ6|A Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ6|B Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ6|C Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ6|D Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (L449F) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ7|A Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (R452S) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ7|B Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (R452S) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ7|C Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (R452S) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ7|D Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (R452S) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ8|A Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (P453L) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ8|B Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (P453L) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ8|C Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (P453L) [HIV-1 M:B_ARV2/SF2] &gt;pdb|4QJ8|D Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (P453L) [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>4QJ2_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>5.10471e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGVGGFIKVRQY-DQIPIEICGHK------VIGTVLVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I G+GG I VR+  D I + +          ++   LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>136</Hit_num>
  <Hit_id>pdb|1TCX|A</Hit_id>
  <Hit_def>Hiv Triple Mutant Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus 1] &gt;pdb|1TCX|B Hiv Triple Mutant Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1TCX_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>5.10471e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTILEEMSLPGRWKPKM------VGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPINIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT++ E   P  W P M      + GIGG I VR+  + +IE+      G++        LV  TP+NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>137</Hit_num>
  <Hit_id>pdb|2FGV|A</Hit_id>
  <Hit_def>X-ray crystal structure of HIV-1 Protease T80N variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity. [Human immunodeficiency virus 1] &gt;pdb|2FGV|B X-ray crystal structure of HIV-1 Protease T80N variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FGV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>5.38215e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPNPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV   PVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>138</Hit_num>
  <Hit_id>pdb|3EKQ|A</Hit_id>
  <Hit_def>Crystal structure of inhibitor saquinavir (SQV) in complex with multi-drug resistant HIV-1 protease (L63P/V82T/I84V) (referred to as ACT in paper) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EKQ|B Crystal structure of inhibitor saquinavir (SQV) in complex with multi-drug resistant HIV-1 protease (L63P/V82T/I84V) (referred to as ACT in paper) [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3EKQ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>5.55578e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IVGIGGFVKVRQYDQIPIEICGHKAIGTV--------LVGPTPTNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG + VR+   + IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>139</Hit_num>
  <Hit_id>pdb|2PYN|A</Hit_id>
  <Hit_def>HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2PYN|B HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2PYN_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>5.67463e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMSLPGAWKPKM------IGGIGGFIKVRQYDQILIEICGHKVIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>140</Hit_num>
  <Hit_id>pdb|4EP2|A</Hit_id>
  <Hit_def>Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate RT-RH [HIV-1 M:B_ARV2/SF2] &gt;pdb|4EP3|A Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate CA-p2 [HIV-1 M:B_ARV2/SF2] &gt;pdb|4EPJ|A Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate p2-NC [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>4EP2_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>6.10745e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQY-DQIPVEILGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+  D I + ++     G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>6.10745e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQY-DQIPVEILGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+  D I + ++     G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>141</Hit_num>
  <Hit_id>pdb|1BWA|A</Hit_id>
  <Hit_def>HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS [Human immunodeficiency virus 1] &gt;pdb|1BWA|B HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS [Human immunodeficiency virus 1] &gt;pdb|1BWB|A HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS [Human immunodeficiency virus 1] &gt;pdb|1BWB|B HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS [Human immunodeficiency virus 1] &gt;pdb|1MEU|A HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 [Human immunodeficiency virus 1] &gt;pdb|1MEU|B HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1BWA_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>6.30804e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>142</Hit_num>
  <Hit_id>pdb|3EL9|A</Hit_id>
  <Hit_def>Crystal structure of atazanavir (ATV) in complex with a multidrug HIV-1 protease (V82T/I84V) [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EL9|B Crystal structure of atazanavir (ATV) in complex with a multidrug HIV-1 protease (V82T/I84V) [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>3EL9_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>6.58073e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>143</Hit_num>
  <Hit_id>pdb|1D4S|A</Hit_id>
  <Hit_def>Hiv-1 Protease V82f/i84v Double Mutant/tipranavir Complex [Human immunodeficiency virus 1] &gt;pdb|1D4S|B Hiv-1 Protease V82f/i84v Double Mutant/tipranavir Complex [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1D4S_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>6.79294e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>144</Hit_num>
  <Hit_id>pdb|1K2C|A</Hit_id>
  <Hit_def>Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1] &gt;pdb|1K2C|B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1K2C_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>6.79294e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVIEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPSNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TVI E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>145</Hit_num>
  <Hit_id>pdb|2Q63|A</Hit_id>
  <Hit_def>HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2Q63|B HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2QAK|A HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1] &gt;pdb|2QAK|B HIV-1 PR mutant in complex with nelfinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2Q63_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>7.47143e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMSLPGRWKPKM------IGGIGGFIAVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>146</Hit_num>
  <Hit_id>pdb|1IZI|A</Hit_id>
  <Hit_def>Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mutants [Human immunodeficiency virus 1] &gt;pdb|1IZI|B Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mutants [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1IZI_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>7.7943e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKVIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>147</Hit_num>
  <Hit_id>pdb|5T8H|B</Hit_id>
  <Hit_def>Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with amprenavir at pH 6.0 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5T8H_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>7.7943e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADXTIIEEMSLPGRWKPKM------VGGIGGFIXVRQYDQIIIEIAGHKAXGTV--------LVGPTPINIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD T+I E   P  W P M      + GIGG I VR+  + +IE+      G++        LV  TP+NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>148</Hit_num>
  <Hit_id>pdb|1K6C|A</Hit_id>
  <Hit_def>Lack Of Synergy For Inhibitors Targeting A Multi-drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6C|B Lack Of Synergy For Inhibitors Targeting A Multi-drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6P|A Lack Of Synergy For Inhibitors Targeting A Multi-Drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6P|B Lack Of Synergy For Inhibitors Targeting A Multi-Drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6T|A Lack Of Synergy For Inhibitors Targeting A Multi-Drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6T|B Lack Of Synergy For Inhibitors Targeting A Multi-Drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6V|A Lack Of Synergy For Inhibitors Targeting A Multi-Drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1K6V|B Lack Of Synergy For Inhibitors Targeting A Multi-Drug Resistant Hiv-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1T7I|A The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor. [Human immunodeficiency virus 1] &gt;pdb|1T7I|B The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor. [Human immunodeficiency virus 1] &gt;pdb|1T7J|A crystal structure of inhibitor amprenavir in complex with a multi-drug resistant variant of HIV-1 protease (L63P/V82T/I84V) [Human immunodeficiency virus 1] &gt;pdb|1T7J|B crystal structure of inhibitor amprenavir in complex with a multi-drug resistant variant of HIV-1 protease (L63P/V82T/I84V) [Human immunodeficiency virus 1] &gt;pdb|3EL5|A Crystal structure of nelfinavir (NFV) complexed with a multidrug variant (ACT) (V82T/I84V) of HIV-1 protease [HIV-1 M:B_ARV2/SF2] &gt;pdb|3EL5|B Crystal structure of nelfinavir (NFV) complexed with a multidrug variant (ACT) (V82T/I84V) of HIV-1 protease [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>1K6C_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>7.87717e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I VR+   + IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>149</Hit_num>
  <Hit_id>pdb|3HBO|A</Hit_id>
  <Hit_def>Crystal structure of chemically synthesized [D-Ala51/51&apos;]HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3HBO|B Crystal structure of chemically synthesized [D-Ala51/51&apos;]HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3HDK|A Crystal structure of chemically synthesized [Aib51/51&apos;]HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3HDK|B Crystal structure of chemically synthesized [Aib51/51&apos;]HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|3NYG|A X-ray structure of ester chemical analogue [O-Gly51,O-Gly51&apos;]HIV-1 protease complexed with MVT-101 inhibitor [Human immunodeficiency virus 1] &gt;pdb|3NYG|B X-ray structure of ester chemical analogue [O-Gly51,O-Gly51&apos;]HIV-1 protease complexed with MVT-101 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3HBO_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>8.04556e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIXGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I GI G I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>150</Hit_num>
  <Hit_id>pdb|4Q5M|A</Hit_id>
  <Hit_def>D30N tethered HIV-1 protease dimer/saquinavir complex [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>4Q5M_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.9802</Hsp_bit-score>
      <Hsp_score>110</Hsp_score>
      <Hsp_evalue>8.94788e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>2.51273e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+TV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>151</Hit_num>
  <Hit_id>pdb|1C6X|A</Hit_id>
  <Hit_def>Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1C6X|B Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1C6Y|A Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1C6Y|B Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1C6Z|A Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1] &gt;pdb|1C6Z|B Alternate Binding Site For The P1-P3 Group Of A Class Of Potent Hiv-1 Protease Inhibitors As A Result Of Concerted Structural Change In 80&apos;s Loop. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1C6X_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>9.83562e-07</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALIDTGADDTVLEEMDLPGRW------KPKIIGGIGGFVKVRQY-DQIPIEICGHK------VIGTVLVGPTPTNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>AL+DTGADDTV+ E D P  W       P+ I GIGG + VR+  D I + +          ++   LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>152</Hit_num>
  <Hit_id>pdb|2WL0|A</Hit_id>
  <Hit_def>HIV-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-State Mimic with Improved Cell-Based Antiviral Activity [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2WL0|B HIV-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-State Mimic with Improved Cell-Based Antiviral Activity [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2XYE|A HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 prime Substituents [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2XYE|B HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 prime Substituents [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2XYF|A HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 prime Substituents [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|2XYF|B HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 prime Substituents [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|3ZPS|A Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|3ZPS|B Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|3ZPT|A Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|3ZPT|B Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|3ZPU|A Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|3ZPU|B Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|4A4Q|A Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based HIV-1 Protease Inhibitors [Human immunodeficiency virus] &gt;pdb|4A4Q|B Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based HIV-1 Protease Inhibitors [Human immunodeficiency virus] &gt;pdb|4A6B|A Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based HIV-1 Protease Inhibitors [Human immunodeficiency virus] &gt;pdb|4A6B|B Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based HIV-1 Protease Inhibitors [Human immunodeficiency virus] &gt;pdb|4A6C|A Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based HIV-1 Protease Inhibitors [Human immunodeficiency virus] &gt;pdb|4A6C|B Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based HIV-1 Protease Inhibitors [Human immunodeficiency virus] &gt;pdb|4COE|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4COE|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CP7|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CP7|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPQ|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPQ|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPR|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPR|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPS|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPS|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPT|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPT|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPU|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPU|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPW|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPW|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPX|A Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|4CPX|B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol [Human immunodeficiency virus] &gt;pdb|5AGZ|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AGZ|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH6|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH6|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH7|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH7|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH8|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH8|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH9|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AH9|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AHA|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AHA|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AHB|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AHB|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AHC|A Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)] &gt;pdb|5AHC|B Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) [Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE)]</Hit_def>
  <Hit_accession>2WL0_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>1.08172e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIPIEICGHKAIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+   + IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>153</Hit_num>
  <Hit_id>pdb|3TTP|A</Hit_id>
  <Hit_def>Structure of multiresistant HIV-1 protease in complex with darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3TTP|B Structure of multiresistant HIV-1 protease in complex with darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3TTP_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>1.14042e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEDINLPGKWTPKM------VGGIGGFMKVRQY-DQVVIEICGH--KVTSPVLVGP----TPLNIIGRNVLTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  + + P  W P M      + GIGG + VR+  D + + +      +  P+L+ P    TP+NI+GR+ L  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>154</Hit_num>
  <Hit_id>pdb|4EQ0|A</Hit_id>
  <Hit_def>Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate p2-NC [HIV-1 M:B_ARV2/SF2] &gt;pdb|4EQJ|A Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate RT-RH [HIV-1 M:B_ARV2/SF2]</Hit_def>
  <Hit_accession>4EQ0_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>1.15005e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGSDDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQY-DQIPVEILGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALL+TG+DDTV+ E + P  W P M      I GIGG I VR+  D I + ++     G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>9.96055e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGSDFTVLEEMNLPGKWKPKM------IRGIGGFIKVRQY-DQIPVEILGHKAIGTV--------LVGPTPVNIIGRNLLTQIGMTL</Hsp_hseq>
      <Hsp_midline>ALL+TG+D TV+ E + P  W P M      I GIGG I VR+  D I + ++     G++        LV  TPVNI+GR+ L  +G+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>155</Hit_num>
  <Hit_id>pdb|1ZBG|A</Hit_id>
  <Hit_def>Crystal structure of a complex of mutant hiv-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1ZBG|B Crystal structure of a complex of mutant hiv-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1ZPK|A Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1ZPK|B Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1ZBG_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>1.15253e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEIXGHKVIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>156</Hit_num>
  <Hit_id>pdb|1GNN|A</Hit_id>
  <Hit_def>Hiv-1 Protease Mutant With Val 82 Replaced By Asn (V82n) Complexed With U89360e (Inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1GNN|B Hiv-1 Protease Mutant With Val 82 Replaced By Asn (V82n) Complexed With U89360e (Inhibitor) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1GNN_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>1.21506e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPNNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>157</Hit_num>
  <Hit_id>pdb|1BDR|A</Hit_id>
  <Hit_def>Hiv-1 (2: 31, 33-37) Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus 1] &gt;pdb|1BDR|B Hiv-1 (2: 31, 33-37) Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1BDR_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>1.21506e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDSVVAGIELPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADD+V++  + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>158</Hit_num>
  <Hit_id>pdb|3KT5|A</Hit_id>
  <Hit_def>Crystal Structure of N88S mutant HIV-1 Protease [HIV-1 M:B_HXB2R]</Hit_def>
  <Hit_accession>3KT5_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>1.25872e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRSLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR  L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>1.25872e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRSLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR  L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>159</Hit_num>
  <Hit_id>pdb|1LZQ|A</Hit_id>
  <Hit_def>Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with an ethylenamine peptidomimetic inhibitor BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1LZQ|B Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with an ethylenamine peptidomimetic inhibitor BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1ZJ7|A Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1ZLF|A Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor [Human immunodeficiency virus 1] &gt;pdb|1ZLF|B Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1LZQ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>1.28098e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKVIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>160</Hit_num>
  <Hit_id>pdb|1MT7|A</Hit_id>
  <Hit_def>Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1MT7|B Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1MT8|A Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1MT8|B Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1MT9|A Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1MT9|B Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy [Human immunodeficiency virus 1] &gt;pdb|1N49|A Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral Therapy [Human immunodeficiency virus 1] &gt;pdb|1N49|B Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral Therapy [Human immunodeficiency virus 1] &gt;pdb|1N49|C Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral Therapy [Human immunodeficiency virus 1] &gt;pdb|1N49|D Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral Therapy [Human immunodeficiency virus 1] &gt;pdb|1TSQ|A CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT [unidentified] &gt;pdb|1TSQ|B CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT [unidentified] &gt;pdb|2FNT|A Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V variant of HIV-1 NC-p1 substrate. [Human immunodeficiency virus 1] &gt;pdb|2FNT|B Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V variant of HIV-1 NC-p1 substrate. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1MT7_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>1.40874e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEMNLPGKWKPKM------IGGIGGFIKVRQYDQIPVEICGHKAIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W P M      I GIGG I VR+   + +E+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>161</Hit_num>
  <Hit_id>pdb|3IXO|A</Hit_id>
  <Hit_def>Crystal Structure of uncomplexed HIV_1 Protease Subtype A [HIV-1 M:A] &gt;pdb|3IXO|B Crystal Structure of uncomplexed HIV_1 Protease Subtype A [HIV-1 M:A]</Hit_def>
  <Hit_accession>3IXO_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>1.43882e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEINLPGKWKPKM------IGGIGGFIKVKQYDQILIEICGKKAIGTV--------LVGPTSVNIIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W P M      I GIGG I V++  + +IE+      G++        LV  T VNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>162</Hit_num>
  <Hit_id>pdb|1Z8C|A</Hit_id>
  <Hit_def>Crystal structure of the complex of mutant HIV-1 protease (l63P, A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1] &gt;pdb|1Z8C|B Crystal structure of the complex of mutant HIV-1 protease (l63P, A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1Z8C_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>1.65055e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQIPIEIXGHKVIGTV--------LVGPTPTNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+   + IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>163</Hit_num>
  <Hit_id>pdb|2P3C|A</Hit_id>
  <Hit_def>Crystal Structure of the subtype F wild type HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1] &gt;pdb|2P3C|B Crystal Structure of the subtype F wild type HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2P3C_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.2838</Hsp_bit-score>
      <Hsp_score>103</Hsp_score>
      <Hsp_evalue>1.68578e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDIALPGKWKPKM------IGGIGGFIKVKQYENVSLEIXGHKAIGTV--------LVGPTPVNIIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ +   P  W P M      I GIGG I V++  ++ +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>164</Hit_num>
  <Hit_id>pdb|1GNM|A</Hit_id>
  <Hit_def>Hiv-1 Protease Mutant With Val 82 Replaced By Asp (V82d) Complexed With U89360e (Inhibitor) [Human immunodeficiency virus 1] &gt;pdb|1GNM|B Hiv-1 Protease Mutant With Val 82 Replaced By Asp (V82d) Complexed With U89360e (Inhibitor) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1GNM_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.2838</Hsp_bit-score>
      <Hsp_score>103</Hsp_score>
      <Hsp_evalue>1.85381e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPDNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>165</Hit_num>
  <Hit_id>pdb|3KA2|A</Hit_id>
  <Hit_def>Crystal structure of chemically synthesized 203 amino acid &apos;covalent dimer&apos; [L-Ala;Gly51&apos;]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor at 1.4 A resolution [unidentified]</Hit_def>
  <Hit_accession>3KA2_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>2.11958e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIAGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I GI G I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00126273</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXWKPKXIGGIGGF-----IKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W                I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>166</Hit_num>
  <Hit_id>pdb|1BDL|A</Hit_id>
  <Hit_def>Hiv-1 (2:31-37) Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus] &gt;pdb|1BDL|B Hiv-1 (2:31-37) Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus]</Hit_def>
  <Hit_accession>1BDL_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.2838</Hsp_bit-score>
      <Hsp_score>103</Hsp_score>
      <Hsp_evalue>2.17181e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDSIVAGIELPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADD++++  + P  W P M      I GIGG I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>167</Hit_num>
  <Hit_id>pdb|4NJT|A</Hit_id>
  <Hit_def>Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|4NJT|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|4NJT|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|4NJT|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|4NJV|A Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with ritonavir [Human immunodeficiency virus 1] &gt;pdb|4NJV|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with ritonavir [Human immunodeficiency virus 1] &gt;pdb|4NJV|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with ritonavir [Human immunodeficiency virus 1] &gt;pdb|4NJV|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with ritonavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4NJT_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.2838</Hsp_bit-score>
      <Hsp_score>103</Hsp_score>
      <Hsp_evalue>2.19485e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDMELPGRWKPRM------IGGIGGFVKVRQY-DQIPIEICGHK------VIGTVLVGPTPTNIIGRNLMTQLGFTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + + P  W P M      I GIGG + VR+  D I + +          ++   LV  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>168</Hit_num>
  <Hit_id>pdb|7MYP|A</Hit_id>
  <Hit_def>Chain A, Protease [Human immunodeficiency virus 1] &gt;pdb|7MYP|B Chain B, Protease [Human immunodeficiency virus 1] &gt;pdb|7MYY|A Chain A, Protease [Human immunodeficiency virus 1] &gt;pdb|7MYY|B Chain B, Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>7MYP_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>2.62601e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDIDLPGRW------KPKLIVGIGGFVKVRQYEQVPIEIAGHKVVGTV--------LIGPTPSNIIGRNLMTQLGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + D P  W       P+ I GIGG + VR+   + IE+      G++        L+  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>169</Hit_num>
  <Hit_id>pdb|3FSM|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID &apos;COVALENT DIMER&apos; [L-Ala51,D-Ala51&apos;] HIV-1 PROTEASE MOLECULE [synthetic construct] &gt;pdb|3GI0|A Crystal structure of a chemically synthesized 203 amino acid &apos;covalent dimer&apos; [l-ala51,d-ala51&apos;] hiv-1 protease molecule complexed with jg-365 inhibitor [Homo sapiens] &gt;pdb|3GI0|B Crystal structure of a chemically synthesized 203 amino acid &apos;covalent dimer&apos; [l-ala51,d-ala51&apos;] hiv-1 protease molecule complexed with jg-365 inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>3FSM_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>2.66818e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIAGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I GI G I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.48655e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIXGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I GI G I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>170</Hit_num>
  <Hit_id>pdb|5T2E|A</Hit_id>
  <Hit_def>Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 [Human immunodeficiency virus 1] &gt;pdb|5T2Z|A Crystal Structure of Multi-drug Resistant HIV-1 Protease PR-S17 in Complex with Darunavir [Human immunodeficiency virus 1] &gt;pdb|5T2Z|B Crystal Structure of Multi-drug Resistant HIV-1 Protease PR-S17 in Complex with Darunavir [Human immunodeficiency virus 1] &gt;pdb|6O57|A Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with a substrate analog p2-NC in P41 [Human immunodeficiency virus 1] &gt;pdb|6O57|B Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with a substrate analog p2-NC in P41 [Human immunodeficiency virus 1] &gt;pdb|6O5A|A Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with a substrate analog p2-NC in P61 [Human immunodeficiency virus 1] &gt;pdb|6O5A|B Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with a substrate analog p2-NC in P61 [Human immunodeficiency virus 1] &gt;pdb|6O5X|A Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with substrate analog CA-p2 [Human immunodeficiency virus 1] &gt;pdb|6O5X|B Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with substrate analog CA-p2 [Human immunodeficiency virus 1] &gt;pdb|6O5X|C Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with substrate analog CA-p2 [Human immunodeficiency virus 1] &gt;pdb|6O5X|D Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with substrate analog CA-p2 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5T2E_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>2.71043e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDIDLPGRW------KPKLIVGIGGFVKVRQYEQVPIEIAGHKVVGTV--------LIGPTPSNIIGRNLMTQLGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + D P  W       P+ I GIGG + VR+   + IE+      G++        L+  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>171</Hit_num>
  <Hit_id>pdb|2P3A|A</Hit_id>
  <Hit_def>Crystal Structure of the multi-drug resistant mutant subtype B HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1] &gt;pdb|2P3A|B Crystal Structure of the multi-drug resistant mutant subtype B HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2P3A_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.5134</Hsp_bit-score>
      <Hsp_score>101</Hsp_score>
      <Hsp_evalue>3.83828e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMALPGKWKPRM------IGGIGGFVKVRQYDQIPIEIXGHKVIGTV--------LVGPTPANIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG + VR+   + IE+      G++        LV  TP NI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>172</Hit_num>
  <Hit_id>pdb|3HLO|A</Hit_id>
  <Hit_def>Crystal structure of chemically synthesized &apos;covalent dimer&apos; [Gly51/D-Ala51&apos;]HIV-1 protease [synthetic construct] &gt;pdb|3HZC|A Crystal structure of a chemically synthesized 203 amino acid &apos;covalent dimer&apos; [Gly51;Aib51&apos;]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor [synthetic construct] &gt;pdb|3IAW|A Crystal structure of a chemically synthesized 203 amino acid &apos;covalent dimer&apos; [Gly51;Aib51&apos;]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor at 1.6 A resolution [synthetic construct]</Hit_def>
  <Hit_accession>3HLO_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.0198e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIXGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I GI G I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.00133897</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXWKPKXIGGIGGF-----IKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W                I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>173</Hit_num>
  <Hit_id>pdb|4NJS|A</Hit_id>
  <Hit_def>Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL008 [Human immunodeficiency virus 1] &gt;pdb|4NJS|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL008 [Human immunodeficiency virus 1] &gt;pdb|4NJS|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL008 [Human immunodeficiency virus 1] &gt;pdb|4NJS|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL008 [Human immunodeficiency virus 1] &gt;pdb|4NJU|A Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|4NJU|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|4NJU|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|4NJU|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with tipranavir [Human immunodeficiency virus 1] &gt;pdb|4RVJ|A Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir [Human immunodeficiency virus 1] &gt;pdb|4RVJ|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir [Human immunodeficiency virus 1] &gt;pdb|4RVJ|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir [Human immunodeficiency virus 1] &gt;pdb|4RVJ|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir [Human immunodeficiency virus 1] &gt;pdb|4RVX|A Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL079 [Human immunodeficiency virus 1] &gt;pdb|4RVX|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL079 [Human immunodeficiency virus 1] &gt;pdb|4RVX|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL079 [Human immunodeficiency virus 1] &gt;pdb|4RVX|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL079 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4NJS_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.5134</Hsp_bit-score>
      <Hsp_score>101</Hsp_score>
      <Hsp_evalue>4.26481e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDMELPGRWKPRM------IGGIGGFVKVRQY-DQIPIEICGHK------VIGTVLVGPTPTNIIGRNLMTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + + P  W P M      I GIGG + VR+  D I + +          ++   LV  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>174</Hit_num>
  <Hit_id>pdb|2B60|A</Hit_id>
  <Hit_def>Structure of HIV-1 protease mutant bound to Ritonavir [Human immunodeficiency virus 1] &gt;pdb|2B60|B Structure of HIV-1 protease mutant bound to Ritonavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2B60_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.5134</Hsp_bit-score>
      <Hsp_score>101</Hsp_score>
      <Hsp_evalue>4.30998e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEISLPGRWKPKM------IGGIGGFIKVRQY-DQIPIEICGHK------VIGTVLVGPTPANIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E   P  W P M      I GIGG I VR+  D I + +          ++   LV  TP NI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>175</Hit_num>
  <Hit_id>pdb|4QLH|A</Hit_id>
  <Hit_def>Crystal structure of drug resistant V82S/V1082S HIV-1 Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4QLH_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>5.05748e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPSNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>5.05748e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMSLPGRWKPKM------IGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPSNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E   P  W P M      I GIGG I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>176</Hit_num>
  <Hit_id>pdb|1BDQ|A</Hit_id>
  <Hit_def>Hiv-1 (2:31-37, 47, 82) Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus] &gt;pdb|1BDQ|B Hiv-1 (2:31-37, 47, 82) Protease Complexed With Inhibitor Sb203386 [Human immunodeficiency virus]</Hit_def>
  <Hit_accession>1BDQ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>5.4914e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDSIVAGIELPGRWKPKM------VGGIGGFIKVRQYDQILIEICGHKAIGTV--------LVGPTPINIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADD++++  + P  W P M      + GIGG I VR+  + +IE+      G++        LV  TP+NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>177</Hit_num>
  <Hit_id>pdb|2RKF|A</Hit_id>
  <Hit_def>HIV-1 PR resistant mutant + LPV [Human immunodeficiency virus 1] &gt;pdb|2RKF|B HIV-1 PR resistant mutant + LPV [Human immunodeficiency virus 1] &gt;pdb|4M8X|A GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits HIV PR Mutants with Amino Acid Insertions [Human immunodeficiency virus 1] &gt;pdb|4M8X|B GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits HIV PR Mutants with Amino Acid Insertions [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2RKF_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>5.72762e-06</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>VKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VKIAGQLMEALLDTGADDTILEEMSLPGRW------TPKVVGGIGGFMKVRQYDQILVEICGHKVIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>VK     + ALLDTGADDT++ E   P  W       P+ + GIGG + VR+  + ++E+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>178</Hit_num>
  <Hit_id>pdb|6OGQ|A</Hit_id>
  <Hit_def>X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in complex with GRL-003 [Human immunodeficiency virus 1] &gt;pdb|6OGR|A X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in complex with GRL-142 [Human immunodeficiency virus 1] &gt;pdb|6OGS|A X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in complex with GRL-001 [Human immunodeficiency virus 1] &gt;pdb|6OGV|A X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in apo state [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OGQ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>6.16564e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALIDTGADDTILEEINLPGRW------KPKLIGGIGGFIKVRQYDQIPIEICGHQAIGTV--------LVGPTPANVIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>AL+DTGADDT++ E + P  W       P+ I GIGG I VR+   + IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>179</Hit_num>
  <Hit_id>pdb|6MK9|A</Hit_id>
  <Hit_def>X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with GRL-121 [Human immunodeficiency virus 1] &gt;pdb|6MK9|B X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with GRL-121 [Human immunodeficiency virus 1] &gt;pdb|6MKL|A X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with GRL-142 [Human immunodeficiency virus 1] &gt;pdb|6MKL|B X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with GRL-142 [Human immunodeficiency virus 1] &gt;pdb|6OGL|A X-ray crystal structure of darunavir-resistant HIV-1 protease (P51) in complex with GRL-003 [Human immunodeficiency virus 1] &gt;pdb|6OGT|A X-ray crystal structure of darunavir-resistant HIV-1 protease (P51) in complex with GRL-001 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6MK9_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.743</Hsp_bit-score>
      <Hsp_score>99</Hsp_score>
      <Hsp_evalue>7.53039e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALIDTGADDTIFEEINLPGRW------KPKLIGGIGGFMKVRQYDQIPIEICGHQAIGTV--------LVGPTPINVIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>AL+DTGADDT+  E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP+N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>180</Hit_num>
  <Hit_id>pdb|6O54|X</Hit_id>
  <Hit_def>Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 (D25N) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6O54_X</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>9.59138e-06</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEDIDLPGRW------KPKLIVGIGGFVKVRQYEQVPIEIAGHKVVGTV--------LIGPTPSNIIGRNLMTQLGATL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ + D P  W       P+ I GIGG + VR+   + IE+      G++        L+  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>181</Hit_num>
  <Hit_id>pdb|3U7S|A</Hit_id>
  <Hit_def>HIV PR drug resistant patient&apos;s variant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|3U7S|B HIV PR drug resistant patient&apos;s variant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3U7S_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>1.13483e-05</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>VKQRSVYITALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VKVGGQLMEALLDTGADDTIFEEMNLPGRWTPKM------IGGIGGFLNVRQY-DQVPIEICGHK------VVSTVLIGPTPLNVIGRNVMTQIGCTL</Hsp_hseq>
      <Hsp_midline>VK     + ALLDTGADDT+  E + P  W P M      I GIGG + VR+  D + + +          ++   L+  TP+N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>182</Hit_num>
  <Hit_id>pdb|1SGU|A</Hit_id>
  <Hit_def>Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1SGU|B Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1SH9|A Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|1SH9|B Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1SGU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>1.15894e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEISLPGRWKPKM------IGGIGGFVKVRQY-DQIPIEICGHK------VIGTVLVGPTPANVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E   P  W P M      I GIGG + VR+  D I + +          ++   LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>183</Hit_num>
  <Hit_id>pdb|3UCB|A</Hit_id>
  <Hit_def>Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Darunavir [Human immunodeficiency virus 1] &gt;pdb|3UCB|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Darunavir [Human immunodeficiency virus 1] &gt;pdb|3UF3|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 [Human immunodeficiency virus 1] &gt;pdb|3UF3|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 [Human immunodeficiency virus 1] &gt;pdb|3UFN|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Saquinavir [Homo sapiens] &gt;pdb|3UFN|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Saquinavir [Homo sapiens] &gt;pdb|3UHL|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC substrate analog [Human immunodeficiency virus 1] &gt;pdb|3UHL|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC substrate analog [Human immunodeficiency virus 1] &gt;pdb|3UHL|C Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC substrate analog [Human immunodeficiency virus 1] &gt;pdb|3UHL|D Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC substrate analog [Human immunodeficiency virus 1] &gt;pdb|4J54|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the potent antiviral inhibitor GRL-0519A [Human immunodeficiency virus 1] &gt;pdb|4J54|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the potent antiviral inhibitor GRL-0519A [Human immunodeficiency virus 1] &gt;pdb|4J55|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the potent antiviral inhibitor GRL-02031 [Human immunodeficiency virus 1] &gt;pdb|4J55|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the potent antiviral inhibitor GRL-02031 [Human immunodeficiency virus 1] &gt;pdb|4J5J|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Amprenavir [Human immunodeficiency virus 1] &gt;pdb|4J5J|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Amprenavir [Human immunodeficiency virus 1] &gt;pdb|4YE3|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 with Inhibitor GRL-4410A [Human immunodeficiency virus type 1 BH10] &gt;pdb|4YE3|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 with Inhibitor GRL-4410A [Human immunodeficiency virus type 1 BH10] &gt;pdb|4YHQ|A Crystal structure of multidrug resistant clinical isolate PR20 with GRL-5010A [Human immunodeficiency virus type 1 BH10] &gt;pdb|4YHQ|B Crystal structure of multidrug resistant clinical isolate PR20 with GRL-5010A [Human immunodeficiency virus type 1 BH10] &gt;pdb|6PRF|A HIV-1 Protease multiple drug resistant clinical isolate mutant PR20 with GRL-14213A [Human immunodeficiency virus type 1 BH10] &gt;pdb|6PRF|B HIV-1 Protease multiple drug resistant clinical isolate mutant PR20 with GRL-14213A [Human immunodeficiency virus type 1 BH10]</Hit_def>
  <Hit_accession>3UCB_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>1.23436e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADNTIFEDINLPGRWKPKM------VGGIGGFLKVREYDQVPIEIAGHKVIGTV--------LVGPTPVNVIGRDTMTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGAD+T+  + + P  W P M      + GIGG + VR+   + IE+      G++        LV  TPVN++GRD +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>184</Hit_num>
  <Hit_id>pdb|3OU1|B</Hit_id>
  <Hit_def>MDR769 HIV-1 protease complexed with RH/IN hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OU4|B MDR769 HIV-1 protease complexed with TF/PR hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|4L1A|B Crystallographic study of multi-drug resistant HIV-1 protease Lopinavir complex: mechanism of drug recognition and resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3OU1_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>1.52297e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKTIGTV--------LVGPTPTNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>185</Hit_num>
  <Hit_id>pdb|4NPU|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 Protease Multiple Mutant P51 [Human immunodeficiency virus 1] &gt;pdb|4NPU|B Crystal Structure of HIV-1 Protease Multiple Mutant P51 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4NPU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.02206e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALINTGADDTIFEEISLPGRW------KPKLIGGIGGFMKVRQYDQIPIEIAGHQAIGTV--------LVGPTPINVIGRNMLTQIGATL</Hsp_hseq>
      <Hsp_midline>AL++TGADDT+  E   P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP+N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>186</Hit_num>
  <Hit_id>pdb|4NPT|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 Protease Multiple Mutant P51 Complexed with Darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4NPT_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.08673e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALINTGADDTIFEEISLPGRW------KPKLIGGIGGFMKVRQYDQIPIEIAGHKAIGTV--------LVGPTPINVIGRNMLTQIGATL</Hsp_hseq>
      <Hsp_midline>AL++TGADDT+  E   P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP+N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>187</Hit_num>
  <Hit_id>pdb|3OQD|A</Hit_id>
  <Hit_def>Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3OQD_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.10874e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPFNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>188</Hit_num>
  <Hit_id>pdb|1RPI|A</Hit_id>
  <Hit_def>Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site Cavity [Human immunodeficiency virus 1] &gt;pdb|1RPI|B Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site Cavity [Human immunodeficiency virus 1] &gt;pdb|1RQ9|A Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site Cavity [Human immunodeficiency virus 1] &gt;pdb|1RQ9|B Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site Cavity [Human immunodeficiency virus 1] &gt;pdb|1RV7|A Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site Cavity [Human immunodeficiency virus 1] &gt;pdb|1RV7|B Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site Cavity [Human immunodeficiency virus 1] &gt;pdb|1TW7|A Wide Open 1.3A Structure of a Multi-drug Resistant HIV-1 Protease Represents a Novel Drug Target [Human immunodeficiency virus 1] &gt;pdb|1TW7|B Wide Open 1.3A Structure of a Multi-drug Resistant HIV-1 Protease Represents a Novel Drug Target [Human immunodeficiency virus 1] &gt;pdb|3OTS|A MDR769 HIV-1 protease complexed with MA/CA hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OTS|B MDR769 HIV-1 protease complexed with MA/CA hepta-peptide [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1RPI_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.17618e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPANVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>189</Hit_num>
  <Hit_id>pdb|3PJ6|A</Hit_id>
  <Hit_def>Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants [Human immunodeficiency virus 1] &gt;pdb|4NKK|A Crystal structure of a multi-drug resistant clinical isolate-769 HIV-1 protease variant that is resistant to the dimerization inhibitory activity of TLF-PafF [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3PJ6_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.22232e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPANVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>190</Hit_num>
  <Hit_id>pdb|3SO9|A</Hit_id>
  <Hit_def>Darunavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|3SO9|B Darunavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|3SPK|A Tipranavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|3SPK|B Tipranavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|4GYE|A MDR 769 HIV-1 Protease in Complex with Reduced P1F [Human immunodeficiency virus 1] &gt;pdb|4GYE|B MDR 769 HIV-1 Protease in Complex with Reduced P1F [Human immunodeficiency virus 1] &gt;pdb|4GZF|A Multi-drug resistant HIV-1 protease 769 variant with reduced LrF peptide [Human immunodeficiency virus 1] &gt;pdb|4GZF|B Multi-drug resistant HIV-1 protease 769 variant with reduced LrF peptide [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3SO9_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.41688e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPTNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>191</Hit_num>
  <Hit_id>pdb|3OQ7|A</Hit_id>
  <Hit_def>Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants [Human immunodeficiency virus 1] &gt;pdb|3OTY|A MDR769 HIV-1 protease complexed with RT/RH hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OTY|B MDR769 HIV-1 protease complexed with RT/RH hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OU1|A MDR769 HIV-1 protease complexed with RH/IN hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OU3|A MDR769 HIV-1 protease complexed with PR/RT hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OU3|B MDR769 HIV-1 protease complexed with PR/RT hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OU4|A MDR769 HIV-1 protease complexed with TF/PR hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUA|A MDR769 HIV-1 protease complexed with p1/p6 hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUA|B MDR769 HIV-1 protease complexed with p1/p6 hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUB|A MDR769 HIV-1 protease complexed with NC/p1 hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUB|B MDR769 HIV-1 protease complexed with NC/p1 hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUC|A MDR769 HIV-1 protease complexed with p2/NC hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUC|B MDR769 HIV-1 protease complexed with p2/NC hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3OUD|A MDR769 HIV-1 protease complexed with CA/p2 hepta-peptide [Human immunodeficiency virus 1] &gt;pdb|3R0W|A Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Mechanism-Based Aspartyl Protease Inhibitors. [Human immunodeficiency virus 1] &gt;pdb|3R0W|B Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Mechanism-Based Aspartyl Protease Inhibitors. [Human immunodeficiency virus 1] &gt;pdb|3R0Y|A Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Mechanism-Based Aspartyl Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|3R0Y|B Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Mechanism-Based Aspartyl Protease Inhibitors [Human immunodeficiency virus 1] &gt;pdb|4EYR|A Crystal structure of multidrug-resistant clinical isolate 769 HIV-1 protease in complex with ritonavir [Human immunodeficiency virus 1] &gt;pdb|4EYR|B Crystal structure of multidrug-resistant clinical isolate 769 HIV-1 protease in complex with ritonavir [Human immunodeficiency virus 1] &gt;pdb|4FAE|A Substrate p2/NC in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|4FAE|B Substrate p2/NC in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|4FAF|A Substrate CA/p2 in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|4FAF|B Substrate CA/p2 in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant [Human immunodeficiency virus 1] &gt;pdb|4L1A|A Crystallographic study of multi-drug resistant HIV-1 protease Lopinavir complex: mechanism of drug recognition and resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3OQ7_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>2.44236e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPTNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>192</Hit_num>
  <Hit_id>pdb|4YOA|A</Hit_id>
  <Hit_def>Crsystal structure HIV-1 Protease MDR769 L33F Complexed with darunavir [Human immunodeficiency virus 1] &gt;pdb|4YOB|A Crystal Structure of Apo HIV-1 Protease MDR769 L33F [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4YOA_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>2.54701e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVFEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPTNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV  E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>193</Hit_num>
  <Hit_id>pdb|1HII|A</Hit_id>
  <Hit_def>COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR [Human immunodeficiency virus 2] &gt;pdb|1HII|B COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR [Human immunodeficiency virus 2] &gt;pdb|1HSH|A Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 1] &gt;pdb|1HSH|B Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 1] &gt;pdb|1HSH|C Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 1] &gt;pdb|1HSH|D Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 1] &gt;pdb|1HSI|A Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 2] &gt;pdb|1HSI|B Crystal Structure At 1.9 Angstroms Resolution Of Human Immunodeficiency Virus (Hiv) Ii Protease Complexed With L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv Proteases [Human immunodeficiency virus 2] &gt;pdb|1IDA|A CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE [Human immunodeficiency virus 2] &gt;pdb|1IDA|B CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE [Human immunodeficiency virus 2] &gt;pdb|1IDB|A Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere [Human immunodeficiency virus 2] &gt;pdb|1IDB|B Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere [Human immunodeficiency virus 2] &gt;pdb|1JLD|A Potent hiv protease inhibitors containing a novel (hydroxyethyl)amide isostere [Human immunodeficiency virus 2] &gt;pdb|1JLD|B Potent hiv protease inhibitors containing a novel (hydroxyethyl)amide isostere [Human immunodeficiency virus 2] &gt;pdb|2MIP|A CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES [Human immunodeficiency virus 2] &gt;pdb|2MIP|B CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES [Human immunodeficiency virus 2] &gt;pdb|2MIP|C CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES [Human immunodeficiency virus 2] &gt;pdb|2MIP|D CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES [Human immunodeficiency virus 2] &gt;pdb|3EBZ|A High Resolution HIV-2 Protease Structure in Complex with Clinical Drug Darunavir [Human immunodeficiency virus type 2 (ISOLATE ROD)] &gt;pdb|3EBZ|B High Resolution HIV-2 Protease Structure in Complex with Clinical Drug Darunavir [Human immunodeficiency virus type 2 (ISOLATE ROD)] &gt;pdb|3EC0|A High Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-06579A [Human immunodeficiency virus 2] &gt;pdb|3EC0|B High Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-06579A [Human immunodeficiency virus 2] &gt;pdb|3ECG|A High Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-98065 [Human immunodeficiency virus 2] &gt;pdb|3ECG|B High Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-98065 [Human immunodeficiency virus 2] &gt;pdb|3S45|A wild-type HIV-2 protease with antiviral drug amprenavir [Human immunodeficiency virus 2] &gt;pdb|3S45|B wild-type HIV-2 protease with antiviral drug amprenavir [Human immunodeficiency virus 2]</Hit_def>
  <Hit_accession>1HII_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>2.57386e-05</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQI-HGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VEVLLDTGADDSIVAGIELGNNY------SPKIVGGIGGFINTKEYKN-VEIEVLNKK---VRATIM---TGDTPINIFGRNILTALGMSL</Hsp_hseq>
      <Hsp_midline>+  LLDTGADD++++  +   ++      +P+I  GIGG I  ++ ++ +E+ V+N+     R  ++      TP+NI GR+ L  LG+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>194</Hit_num>
  <Hit_id>pdb|2RKG|A</Hit_id>
  <Hit_def>HIV-1 PR resistant mutant + LPV [Human immunodeficiency virus 1] &gt;pdb|2RKG|B HIV-1 PR resistant mutant + LPV [Human immunodeficiency virus 1] &gt;pdb|4M8Y|A GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits HIV PR Mutants with Amino Acid Insertions [Human immunodeficiency virus 1] &gt;pdb|4M8Y|B GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits HIV PR Mutants with Amino Acid Insertions [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2RKG_A</Hit_accession>
  <Hit_len>100</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>2.70557e-05</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>VKQRSVYITALLDTGADDTVISEE-DWPTDWPVMEAANPQ-IHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VKIAGQLMEALLDTGADDTILEEEMSLPGRW------TPKVVGGIGGFMKVRQYDQILVEICGHKVIGTV--------LVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>VK     + ALLDTGADDT++ EE   P  W       P+ + GIGG + VR+  + ++E+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>195</Hit_num>
  <Hit_id>pdb|4RVI|A</Hit_id>
  <Hit_def>Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519 [Human immunodeficiency virus 1] &gt;pdb|4RVI|B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519 [Human immunodeficiency virus 1] &gt;pdb|4RVI|C Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519 [Human immunodeficiency virus 1] &gt;pdb|4RVI|D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4RVI_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.817</Hsp_bit-score>
      <Hsp_score>94</Hsp_score>
      <Hsp_evalue>3.67593e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDMELPGRYKPRM------IGGIGGFVKVRQY-DQIPIEICGHK------VIGTVLVGPTPTNIIGRNLMTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + + P  + P M      I GIGG + VR+  D I + +          ++   LV  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>196</Hit_num>
  <Hit_id>pdb|3OQA|A</Hit_id>
  <Hit_def>Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3OQA_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.817</Hsp_bit-score>
      <Hsp_score>94</Hsp_score>
      <Hsp_evalue>3.9144e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPSNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTV+ E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>197</Hit_num>
  <Hit_id>pdb|4Z4X|A</Hit_id>
  <Hit_def>Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Open Flap [Human immunodeficiency virus 1] &gt;pdb|4Z4X|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Open Flap [Human immunodeficiency virus 1] &gt;pdb|4Z50|A Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Tucked Flap [Human immunodeficiency virus 1] &gt;pdb|4Z50|B Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Tucked Flap [Human immunodeficiency virus 1] &gt;pdb|4Z50|C Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Tucked Flap [Human immunodeficiency virus 1] &gt;pdb|4Z50|D Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Tucked Flap [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4Z4X_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.817</Hsp_bit-score>
      <Hsp_score>94</Hsp_score>
      <Hsp_evalue>4.08189e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDW-PVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADNTIFEDINLPGRWKPKM------VGGIGGFLKVREYDQVPIEIAGHKVIGTV--------LVGPTPVNVIGRDTMTQIGATL</Hsp_hseq>
      <Hsp_midline>ALL+TGAD+T+  + + P  W P M      + GIGG + VR+   + IE+      G++        LV  TPVN++GRD +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>198</Hit_num>
  <Hit_id>pdb|2FDD|A</Hit_id>
  <Hit_def>Crystal structure of HIV protease D545701 bound with GW0385 [Human immunodeficiency virus 1] &gt;pdb|2FDD|B Crystal structure of HIV protease D545701 bound with GW0385 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FDD_A</Hit_accession>
  <Hit_len>100</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.817</Hsp_bit-score>
      <Hsp_score>94</Hsp_score>
      <Hsp_evalue>4.11374e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDINLPGRW------KPKIIGGVGGFVKVRQY-DQVPIEICGHK------VIGTVLVGPTPANIIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + + P  W       P+ I G+GG + VR+  D + + +          ++   LV  TP NI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>199</Hit_num>
  <Hit_id>pdb|3OUD|B</Hit_id>
  <Hit_def>MDR769 HIV-1 protease complexed with CA/p2 hepta-peptide [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3OUD_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.0466</Hsp_bit-score>
      <Hsp_score>92</Hsp_score>
      <Hsp_evalue>9.32779e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTTLEEVNLPGRW------KPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTV--------LVGPTPTNVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDT + E + P  W       P+ I GIGG + VR+   + IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>200</Hit_num>
  <Hit_id>pdb|6P9A|A</Hit_id>
  <Hit_def>HIV-1 Protease multiple mutant PRS5B with Darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|6P9A|B HIV-1 Protease multiple mutant PRS5B with Darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|6P9B|A HIV-1 Protease multiple drug resistant mutant PRS5B with Amprenavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|6P9B|B HIV-1 Protease multiple drug resistant mutant PRS5B with Amprenavir [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>6P9A_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.6614</Hsp_bit-score>
      <Hsp_score>91</Hsp_score>
      <Hsp_evalue>0.000121109</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VLMDTGADDTVLENIDLPGKW------KPKLIGGIGGFVKVRQY-DHVPVEVAGHKVTTTV------LVGPTPVDVIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline> L+DTGADDTV+   D P  W       P+ I GIGG + VR+  D + + V     +         LV  TPV+++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>201</Hit_num>
  <Hit_id>pdb|1IVP|A</Hit_id>
  <Hit_def>THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS [Human immunodeficiency virus 2] &gt;pdb|1IVP|B THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS [Human immunodeficiency virus 2] &gt;pdb|1IVQ|A THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS [Human immunodeficiency virus 2] &gt;pdb|1IVQ|B THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS [Human immunodeficiency virus 2] &gt;pdb|2HPE|A COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE [Human immunodeficiency virus 2] &gt;pdb|2HPE|B COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE [Human immunodeficiency virus 2] &gt;pdb|2HPF|A COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE [Human immunodeficiency virus 2] &gt;pdb|2HPF|B COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE [Human immunodeficiency virus 2] &gt;pdb|3UPJ|A HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN] [Human immunodeficiency virus 2] &gt;pdb|3UPJ|B HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN] [Human immunodeficiency virus 2] &gt;pdb|4UPJ|A Human Immunodeficiency Virus Type 2 Protease Mutant With Lys 57 Replaced By Leu (K57l) Complex With U097410 [4-Hydroxy-3-[1-[3- [[[[(Tert-Butyloxycarbonyl) Aminomethyl]carbonyl]amino]phenyl]propyl]coumarin [Human immunodeficiency virus 2] &gt;pdb|4UPJ|B Human Immunodeficiency Virus Type 2 Protease Mutant With Lys 57 Replaced By Leu (K57l) Complex With U097410 [4-Hydroxy-3-[1-[3- [[[[(Tert-Butyloxycarbonyl) Aminomethyl]carbonyl]amino]phenyl]propyl]coumarin [Human immunodeficiency virus 2] &gt;pdb|5UPJ|A Hiv-2 ProteaseU99283 COMPLEX [Human immunodeficiency virus 2] &gt;pdb|5UPJ|B Hiv-2 ProteaseU99283 COMPLEX [Human immunodeficiency virus 2] &gt;pdb|6UPJ|A Hiv-2 ProteaseU99294 COMPLEX [Human immunodeficiency virus 2] &gt;pdb|6UPJ|B Hiv-2 ProteaseU99294 COMPLEX [Human immunodeficiency virus 2]</Hit_def>
  <Hit_accession>1IVP_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.2762</Hsp_bit-score>
      <Hsp_score>90</Hsp_score>
      <Hsp_evalue>0.000131656</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQI-HGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VEVLLDTGADDSIVAGIELGNNY------SPKIVGGIGGFINTLEYKN-VEIEVLNKK---VRATIM---TGDTPINIFGRNILTALGMSL</Hsp_hseq>
      <Hsp_midline>+  LLDTGADD++++  +   ++      +P+I  GIGG I   + ++ +E+ V+N+     R  ++      TP+NI GR+ L  LG+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>202</Hit_num>
  <Hit_id>pdb|2P3D|A</Hit_id>
  <Hit_def>Crystal Structure of the multi-drug resistant mutant subtype F HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1] &gt;pdb|2P3D|B Crystal Structure of the multi-drug resistant mutant subtype F HIV protease complexed with TL-3 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2P3D_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.2762</Hsp_bit-score>
      <Hsp_score>90</Hsp_score>
      <Hsp_evalue>0.000138709</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRD-MIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEDINLSGKW------KPKIIGGIRGFVKVKQYEDILIEICGHRAVGAV--------LVGPTPANIIGRNMLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ + +    W       P+ I GI G + V++  D +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>203</Hit_num>
  <Hit_id>pdb|3GGU|A</Hit_id>
  <Hit_def>HIV PR drug resistant patient&apos;s variant in complex with darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)] &gt;pdb|3GGU|B HIV PR drug resistant patient&apos;s variant in complex with darunavir [Human immunodeficiency virus type 1 (BRU ISOLATE)]</Hit_def>
  <Hit_accession>3GGU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.000259272</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVFEELTLSGRW------KPRLIGGIGGFVRVRQY-DQVPIEICGHK------VIDTVLVGPTPTNVIGRNVMTQLGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV  E      W       P+ I GIGG + VR+  D + + +          ++   LV  TP N++GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>204</Hit_num>
  <Hit_id>pdb|2JE4|A</Hit_id>
  <Hit_def>Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease in complex with JG-365 [Human immunodeficiency virus 1] &gt;pdb|2JE4|B Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease in complex with JG-365 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2JE4_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.000281796</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGKW------KPKXIGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+  G  GG    +  D I + +      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>205</Hit_num>
  <Hit_id>pdb|3I2L|A</Hit_id>
  <Hit_def>Crystal structure of a chemically synthesized [allo-Ile50/50&apos;]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor [Human immunodeficiency virus 1] &gt;pdb|3I2L|B Crystal structure of a chemically synthesized [allo-Ile50/50&apos;]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor [Human immunodeficiency virus 1] &gt;pdb|3NWQ|A X-ray structure of ester chemical analogue [O-Ile50,O-Ile50&apos;]HIV-1 protease complexed with MVT-101 [synthetic construct] &gt;pdb|3NWQ|B X-ray structure of ester chemical analogue [O-Ile50,O-Ile50&apos;]HIV-1 protease complexed with MVT-101 [synthetic construct] &gt;pdb|3NWX|A X-ray structure of ester chemical analogue [O-Ile50,O-Ile50&apos;]HIV-1 protease complexed with KVS-1 inhibitor [synthetic construct] &gt;pdb|3NWX|B X-ray structure of ester chemical analogue [O-Ile50,O-Ile50&apos;]HIV-1 protease complexed with KVS-1 inhibitor [synthetic construct]</Hit_def>
  <Hit_accession>3I2L_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000365533</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGXGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I G GG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>206</Hit_num>
  <Hit_id>pdb|3OGP|A</Hit_id>
  <Hit_def>Crystal Structure of 6s-98S FIV Protease with Darunavir bound [Feline immunodeficiency virus] &gt;pdb|3OGP|B Crystal Structure of 6s-98S FIV Protease with Darunavir bound [Feline immunodeficiency virus] &gt;pdb|3OGQ|A Crystal Structure of 6s-98S FIV Protease with Lopinavir bound [Feline immunodeficiency virus] &gt;pdb|3OGQ|B Crystal Structure of 6s-98S FIV Protease with Lopinavir bound [Feline immunodeficiency virus]</Hit_def>
  <Hit_accession>3OGP_A</Hit_accession>
  <Hit_len>116</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.000401942</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMT----PVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>IKFLLDTGADITVLNRRDFQVKNSI-ENGRQMMIGIGGG---KRGTNYINVHLEIRDENYKTQCIFGNVCVLEDNSLSVNLLGRDNMIKFNIRL</Hsp_hseq>
      <Hsp_midline>I  LLDTGAD TV++  D+     + E     + GIGGG   ++  + I + +  RD + +   +   +  +      VN+LGRD +    +RL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>207</Hit_num>
  <Hit_id>pdb|2J9J|B</Hit_id>
  <Hit_def>Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor JG-365 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2J9J_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000489056</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+  G  GG    +  D I + +      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>208</Hit_num>
  <Hit_id>pdb|2J9J|A</Hit_id>
  <Hit_def>Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor JG-365 [Human immunodeficiency virus 1] &gt;pdb|2J9K|A Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor MVT-101 [Human immunodeficiency virus 1] &gt;pdb|2J9K|B Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor MVT-101 [Human immunodeficiency virus 1] &gt;pdb|3DCR|A X-ray structure of HIV-1 protease and hydrated form of ketomethylene isostere inhibitor [synthetic construct] &gt;pdb|3DCR|B X-ray structure of HIV-1 protease and hydrated form of ketomethylene isostere inhibitor [synthetic construct] &gt;pdb|3HAU|A Crystal structure of chemically synthesized HIV-1 protease with reduced isostere MVT-101 inhibitor [Human immunodeficiency virus 1] &gt;pdb|3HAU|B Crystal structure of chemically synthesized HIV-1 protease with reduced isostere MVT-101 inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2J9J_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000489056</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+  G  GG    +  D I + +      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>209</Hit_num>
  <Hit_id>pdb|2SAM|A</Hit_id>
  <Hit_def>STRUCTURE OF THE PROTEASE FROM SIMIAN IMMUNODEFICIENCY VIRUS: COMPLEX WITH AN IRREVERSIBLE NON-PEPTIDE INHIBITOR [Simian immunodeficiency virus]</Hit_def>
  <Hit_accession>2SAM_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.00119363</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISE-EDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINR--DGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VEVLLDTGADDSIVTGIELGPHYTPKI------VGGIGGFINTKEYKN-VEIEVLGKRIKGTI--------MTGDTPINIFGRNLLTALGMSL</Hsp_hseq>
      <Hsp_midline>+  LLDTGADD++++  E  P   P +      + GIGG I  ++ ++ +E+ V+ +   G++        +   TP+NI GR+ L  LG+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>210</Hit_num>
  <Hit_id>pdb|3NXE|A</Hit_id>
  <Hit_def>X-ray structure of ester chemical analogue &apos;covalent dimer&apos; [Ile50,O-Ile50&apos;]HIV-1 protease complexed with MVT-101 inhibitor [synthetic construct] &gt;pdb|3NXN|A X-ray structure of ester chemical analogue &apos;covalent dimer&apos; [Ile50,O-Ile50&apos;]HIV-1 protease complexed with KVS-1 inhibitor [synthetic construct]</Hit_def>
  <Hit_accession>3NXE_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00128765</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXWKPKXIGGIGGF-----IKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W                I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.00147637</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXW------KPKXIGGXGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+ I G GG I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>211</Hit_num>
  <Hit_id>pdb|2O40|A</Hit_id>
  <Hit_def>Crystal Structure of a Chemically Synthesized 203 Amino Acid &apos;Covalent Dimer&apos; HIV-1 Protease Molecule [synthetic construct]</Hit_def>
  <Hit_accession>2O40_A</Hit_accession>
  <Hit_len>203</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00131306</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXWKPKXIGGIGGF-----IKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W                I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
    <Hsp>
      <Hsp_num>2</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00131306</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>126</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDM-IELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEXNLPGXWKPKXIGGIGGF-----IKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W                I VR+   + +E+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>212</Hit_num>
  <Hit_id>pdb|5B18|A</Hit_id>
  <Hit_def>Crystal Structure of a Darunavir Resistant HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|5B18|B Crystal Structure of a Darunavir Resistant HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|5B18|C Crystal Structure of a Darunavir Resistant HIV-1 Protease [Human immunodeficiency virus 1] &gt;pdb|5B18|D Crystal Structure of a Darunavir Resistant HIV-1 Protease [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>5B18_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.00133766</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>AILNTGADDTIFEEMNLPGRW------KPKIVGGVGGLVKVREYEQIPIEICGRK------VISTVLIGPTPFNIIGRNVMTQLGCTL</Hsp_hseq>
      <Hsp_midline>A+L+TGADDT+  E + P  W       P+I G  GG+   +  + I + +  R       ++   L+  TP NI+GR+ +  LG  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>213</Hit_num>
  <Hit_id>pdb|1AZ5|A</Hit_id>
  <Hit_def>UNLIGANDED SIV PROTEASE STRUCTURE IN AN &quot;OPEN&quot; CONFORMATION [Simian immunodeficiency virus] &gt;pdb|1YTI|A Siv Protease Crystallized With Peptide Product [Escherichia coli] &gt;pdb|1YTJ|A Siv Protease Crystallized With Peptide Product [Simian immunodeficiency virus]</Hit_def>
  <Hit_accession>1AZ5_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.00143819</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISE-EDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINR--DGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VEVLLDTGADDSIVTGIELGPHYTPKI------VGGIGGFINTKEYKN-VEVEVLGKRIKGTI--------MTGDTPINIFGRNLLTALGMSL</Hsp_hseq>
      <Hsp_midline>+  LLDTGADD++++  E  P   P +      + GIGG I  ++ ++ +E+ V+ +   G++        +   TP+NI GR+ L  LG+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>214</Hit_num>
  <Hit_id>pdb|3DCK|A</Hit_id>
  <Hit_def>X-ray structure of D25N chemical analogue of HIV-1 protease complexed with ketomethylene isostere inhibitor [synthetic construct] &gt;pdb|3DCK|B X-ray structure of D25N chemical analogue of HIV-1 protease complexed with ketomethylene isostere inhibitor [synthetic construct] &gt;pdb|3IA9|A Crystal structure of a chemically synthesized [D25N]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor [Human immunodeficiency virus 1] &gt;pdb|3IA9|B Crystal structure of a chemically synthesized [D25N]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>3DCK_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.00169716</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLNTGADDTVIEEXNLPGXW------KPKXIGGIGGFIKVRQYDQIPVEIXGHKAIGTV--------LVGPTPVNIIGRNLLTQIGXTL</Hsp_hseq>
      <Hsp_midline>ALL+TGADDTVI E + P  W       P+  G  GG    +  D I + +      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>215</Hit_num>
  <Hit_id>pdb|1SIP|A</Hit_id>
  <Hit_def>Alternative Native Flap Conformation Revealed By 2.3 Angstroms Resolution Structure Of Siv Proteinase [Simian immunodeficiency virus]</Hit_def>
  <Hit_accession>1SIP_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.1946</Hsp_bit-score>
      <Hsp_score>82</Hsp_score>
      <Hsp_evalue>0.0023143</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISE-EDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRD--GSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VEVLLDTGADDSIVTGIELGPHYTPKI------VGGIGGFINTKEYKN-VEIEVLGKRIRGTI--------MTGDTPINIFGRNLLTALGMSL</Hsp_hseq>
      <Hsp_midline>+  LLDTGADD++++  E  P   P +      + GIGG I  ++ ++ +E+ V+ +   G++        +   TP+NI GR+ L  LG+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>216</Hit_num>
  <Hit_id>pdb|1DAZ|C</Hit_id>
  <Hit_def>Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1DAZ|D Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [Human immunodeficiency virus 1] &gt;pdb|1FF0|C Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes. [Human immunodeficiency virus 1] &gt;pdb|1FF0|D Structural Implications Of Drug Resistant Mutants Of Hiv-1 Protease: High Resolution Crystal Structures Of The Mutant ProteaseSUBSTRATE Analog Complexes. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1DAZ_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.00296523</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPIMIGGIGGF-----IKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W  +             I VR+  + +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>217</Hit_num>
  <Hit_id>pdb|6OPU|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 K45I, M46I, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPU|B HIV-1 Protease NL4-3 K45I, M46I, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPU_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.00387745</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRWKPIIIGGIGGF-----IKVRQYDQILIEICGHKAIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W  +             I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>218</Hit_num>
  <Hit_id>pdb|2B7F|A</Hit_id>
  <Hit_def>Crystal structure of human T-cell leukemia virus protease, a novel target for anti-cancer design [Human T-cell leukemia virus type I] &gt;pdb|2B7F|B Crystal structure of human T-cell leukemia virus protease, a novel target for anti-cancer design [Human T-cell leukemia virus type I] &gt;pdb|2B7F|C Crystal structure of human T-cell leukemia virus protease, a novel target for anti-cancer design [Human T-cell leukemia virus type I] &gt;pdb|2B7F|D Crystal structure of human T-cell leukemia virus protease, a novel target for anti-cancer design [Human T-cell leukemia virus type I] &gt;pdb|2B7F|E Crystal structure of human T-cell leukemia virus protease, a novel target for anti-cancer design [Human T-cell leukemia virus type I] &gt;pdb|2B7F|F Crystal structure of human T-cell leukemia virus protease, a novel target for anti-cancer design [Human T-cell leukemia virus type I] &gt;pdb|3LIN|A crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|B crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|C crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|D crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|E crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|F crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|G crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|H crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|I crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|J crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|K crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIN|L crystal structure of HTLV protease complexed with the inhibitor, KNI-10562 [Human T-cell leukemia virus type I] &gt;pdb|3LIQ|A Crystal Structure of HTLV protease complexed with the inhibitor, KNI-10673 [Human T-cell leukemia virus type I] &gt;pdb|3LIQ|B Crystal Structure of HTLV protease complexed with the inhibitor, KNI-10673 [Human T-cell leukemia virus type I] &gt;pdb|3LIT|A The crystal structure of htlv protease complexed with the inhibitor KNI-10681 [Human T-cell leukemia virus type I] &gt;pdb|3LIT|B The crystal structure of htlv protease complexed with the inhibitor KNI-10681 [Human T-cell leukemia virus type I] &gt;pdb|3LIV|A crystal structure of HTLV protease complexed with the inhibitor KNI-10683 [Human T-cell leukemia virus type I] &gt;pdb|3LIV|B crystal structure of HTLV protease complexed with the inhibitor KNI-10683 [Human T-cell leukemia virus type I] &gt;pdb|3LIX|A crystal structure of htlv protease complexed with the inhibitor KNI-10729 [Human T-cell leukemia virus type I] &gt;pdb|3LIX|B crystal structure of htlv protease complexed with the inhibitor KNI-10729 [Human T-cell leukemia virus type I] &gt;pdb|3LIY|A crystal structure of HTLV protease complexed with Statine-containing peptide inhibitor [Human T-cell leukemia virus type I] &gt;pdb|3LIY|B crystal structure of HTLV protease complexed with Statine-containing peptide inhibitor [Human T-cell leukemia virus type I] &gt;pdb|3LIY|C crystal structure of HTLV protease complexed with Statine-containing peptide inhibitor [Human T-cell leukemia virus type I] &gt;pdb|3LIY|D crystal structure of HTLV protease complexed with Statine-containing peptide inhibitor [Human T-cell leukemia virus type I] &gt;pdb|3LIY|E crystal structure of HTLV protease complexed with Statine-containing peptide inhibitor [Human T-cell leukemia virus type I] &gt;pdb|3LIY|F crystal structure of HTLV protease complexed with Statine-containing peptide inhibitor [Human T-cell leukemia virus type I] &gt;pdb|3WSJ|A HTLV-1 protease in complex with the HIV-1 protease inhibitor Indinavir [Human T-cell leukemia virus type I] &gt;pdb|3WSJ|B HTLV-1 protease in complex with the HIV-1 protease inhibitor Indinavir [Human T-cell leukemia virus type I] &gt;pdb|4YDF|A Crystal structure of compound 9 in complex with HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|4YDF|B Crystal structure of compound 9 in complex with HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|4YDG|A Crystal structure of compound 10 in complex with HTLV-1 Protease [Human T-cell lymphotrophic virus type 1 (strain ATK)] &gt;pdb|4YDG|B Crystal structure of compound 10 in complex with HTLV-1 Protease [Human T-cell lymphotrophic virus type 1 (strain ATK)] &gt;pdb|6W6Q|A Chain A, HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|6W6Q|B Chain B, HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|6W6R|A Chain A, HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|6W6R|B Chain B, HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|6W6S|A Chain A, HTLV-1 Protease [Human T-cell leukemia virus type I] &gt;pdb|6W6S|B Chain B, HTLV-1 Protease [Human T-cell leukemia virus type I]</Hit_def>
  <Hit_accession>2B7F_A</Hit_accession>
  <Hit_len>116</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.00404291</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>115</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>107</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>108</Hsp_align-len>
      <Hsp_qseq>RPLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVN--ILGRDCLQ</Hsp_qseq>
      <Hsp_hseq>RPVIKAQVDTQTSHPKT-----IEALLDTGADMTVIPIALFSSNTPL---KNTSVLGAGGQ--TQDHFKLTSLPVLIRLPFRTTPIVLTSCLVDTKNNWAIIGRDALQ</Hsp_hseq>
      <Hsp_midline>RP+++  +    SHP       I ALLDTGAD TVI    + ++ P+    N  + G GG    +    +  L V+ R      P++L   +  T  N  I+GRD LQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>219</Hit_num>
  <Hit_id>pdb|2FXD|A</Hit_id>
  <Hit_def>X-ray crystal structure of HIV-1 protease IRM mutant complexed with atazanavir (BMS-232632) [Human immunodeficiency virus 1] &gt;pdb|2FXD|B X-ray crystal structure of HIV-1 protease IRM mutant complexed with atazanavir (BMS-232632) [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2FXD_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.00528197</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRD--MIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMNLPGKW------KPKIIGGIGGFIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPFNVIGRNLMTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E + P  W       P+I G  GG    +  D  +IE+      G++        LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>220</Hit_num>
  <Hit_id>pdb|1SIV|A</Hit_id>
  <Hit_def>THREE-DIMENSIONAL STRUCTURE OF A SIV PROTEASE(SLASH)INHIBITOR COMPLEX. IMPLICATIONS FOR THE DESIGN OF HIV-1 AND HIV-2 PROTEASE INHIBITORS [Simian immunodeficiency virus] &gt;pdb|1SIV|B THREE-DIMENSIONAL STRUCTURE OF A SIV PROTEASE(SLASH)INHIBITOR COMPLEX. IMPLICATIONS FOR THE DESIGN OF HIV-1 AND HIV-2 PROTEASE INHIBITORS [Simian immunodeficiency virus] &gt;pdb|1TCW|A Siv Protease Complexed With Inhibitor Sb203386 [Simian immunodeficiency virus] &gt;pdb|1TCW|B Siv Protease Complexed With Inhibitor Sb203386 [Simian immunodeficiency virus]</Hit_def>
  <Hit_accession>1SIV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.00539188</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISE-EDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINR--DGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>VEVLLDTGADDSIVTGIELGPHYTPKI------VGGIGGFINTKEYKN-VKIEVLGKRIKGTI--------MTGDTPINIFGRNLLTALGMSL</Hsp_hseq>
      <Hsp_midline>+  LLDTGADD++++  E  P   P +      + GIGG I  ++ ++ +++ V+ +   G++        +   TP+NI GR+ L  LG+ L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>221</Hit_num>
  <Hit_id>pdb|1K1U|A</Hit_id>
  <Hit_def>Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1] &gt;pdb|1K1U|B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1K1U_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0056767</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPIMIGGIGGF-----IKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLMTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W  +             I VR+  + +IE+      G++        LV  TPVNI+GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>222</Hit_num>
  <Hit_id>pdb|6OPV|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPV|B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPV_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.00622766</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMNLPGRWKPIIIGGIGGF-----IKVRQYDQILIEICGHKAIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E + P  W  +             I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>223</Hit_num>
  <Hit_id>pdb|2AZB|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 3X mutant in complex with inhibitor, TL-3 [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AZB_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.00772913</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVLEEMNLPGRW------KPKIIGGIGGLIKVRQYDQILIEICGHKA------IGTVLVGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTV+ E + P  W       P+I G  GG+   +  D I + +           +   LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>224</Hit_num>
  <Hit_id>pdb|6OPW|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPW|B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPW_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.00959067</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMNLPGRWKPIIIGGIGGF-----IKVRQYDQILIEICGHKVIGTV--------LVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E + P  W  +             I VR+  + +IE+      G++        LV  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>225</Hit_num>
  <Hit_id>pdb|4JEC|B</Hit_id>
  <Hit_def>Joint neutron and X-ray structure of per-deuterated HIV-1 protease in complex with clinical inhibitor amprenavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>4JEC_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.0133195</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRD--MIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEXMSLPGRW------KPKXIGGIGGXIKVRQYDQIIIEIAGHKAIGTV--------LVGPTPVNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI     P  W       P+  G  GG    +  D  +IE+      G++        LV  TPVNI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>226</Hit_num>
  <Hit_id>pdb|2AZC|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 6X mutant [Human immunodeficiency virus 1] &gt;pdb|2AZC|B HIV-1 Protease NL4-3 6X mutant [Human immunodeficiency virus 1] &gt;pdb|2HB2|A Structure of HIV protease 6X mutant in apo form [Human immunodeficiency virus 1] &gt;pdb|2HC0|A Structure of HIV protease 6X mutant in complex with AB-2. [Human immunodeficiency virus 1] &gt;pdb|2HC0|B Structure of HIV protease 6X mutant in complex with AB-2. [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2AZC_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.0135955</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALIDTGADDTVLEEMNLPGRW------KPKIIGGIGGLIKVRQYDQIPIEICGHKA------IGTVLIGPTPANIIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>AL+DTGADDTV+ E + P  W       P+I G  GG+   +  D I + +           +   L+  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>227</Hit_num>
  <Hit_id>pdb|6OPX|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPX|B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPX_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.0166889</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMNLPGRWKPIIIGGIGGF-----IKVRQYDQILIEICGHKAIGTV--------VVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E + P  W  +             I VR+  + +IE+      G++        +V  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>228</Hit_num>
  <Hit_id>pdb|1K1T|A</Hit_id>
  <Hit_def>Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1] &gt;pdb|1K1T|B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>1K1T_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.0179296</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTVIEEMSLPGRWKPIMIGGIGGF-----IKVRQYDQIIIEIAGHKAIGTV--------LVGPTPSNIIGRNLLTQIGATL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDTVI E   P  W  +             I VR+  + +IE+      G++        LV  TP NI+GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>229</Hit_num>
  <Hit_id>pdb|6OPY|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPY|B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPY_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.0253913</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMNLPGRWKPIIIGGIGGF-----IKVRQYDQILIEICGHKVIGTV--------VVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E + P  W  +             I VR+  + +IE+      G++        +V  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>230</Hit_num>
  <Hit_id>pdb|2B7Z|A</Hit_id>
  <Hit_def>Structure of HIV-1 protease mutant bound to indinavir [Human immunodeficiency virus 1] &gt;pdb|2B7Z|B Structure of HIV-1 protease mutant bound to indinavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2B7Z_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.0440738</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>41</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEISLPGRW------KPKIIGGIGGFIKVRQYDQIPIEICGHK------VIGTVLVGPTPANVIGRNLMTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E   P  W       P+I G  GG    +  D I + +          ++   LV  TP N++GR+ +  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>231</Hit_num>
  <Hit_id>pdb|5FIV|A</Hit_id>
  <Hit_def>Structural Studies Of Hiv And Fiv Proteases Complexed With An Efficient Inhibitor Of Fiv Pr [Feline immunodeficiency virus (isolate Petaluma)]</Hit_def>
  <Hit_accession>5FIV_A</Hit_accession>
  <Hit_len>113</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.0464315</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>111</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVN-----ILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>IKFLLDTGADITILNRRDFQVKNSI-ENGRQNMIGIGGG---KRGTNYINVHLEIRDENY-KTQCIFGNVCVLEDNSLIQPLLGRDNMIKFNIRL</Hsp_hseq>
      <Hsp_midline>I  LLDTGAD T+++  D+     + E     + GIGGG   ++  + I + +  RD +  +   +F  V +   N     +LGRD +    +RL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>232</Hit_num>
  <Hit_id>pdb|6FIV|A</Hit_id>
  <Hit_def>Structural Studies Of Hiv And Fiv Proteases Complexed With An Efficient Inhibitor Of Fiv Pr [Feline immunodeficiency virus (isolate Petaluma)]</Hit_def>
  <Hit_accession>6FIV_A</Hit_accession>
  <Hit_len>113</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.0473795</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>111</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>25</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTP----VNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>IKFLLDTGADITILNRRDFQVKNSI-ENGRQNMIGVGGG---KRGTNYINVHLEIRDENYKTQCIFGNVCVLEDNSLIVPLLGRDNMIKFNIRL</Hsp_hseq>
      <Hsp_midline>I  LLDTGAD T+++  D+     + E     + G+GGG   ++  + I + +  RD + +   +   +  +      V +LGRD +    +RL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>233</Hit_num>
  <Hit_id>pdb|2O4N|A</Hit_id>
  <Hit_def>Crystal Structure of HIV-1 Protease (TRM Mutant) in Complex with Tipranavir [Human immunodeficiency virus 1] &gt;pdb|2O4N|B Crystal Structure of HIV-1 Protease (TRM Mutant) in Complex with Tipranavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>2O4N_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.3426</Hsp_bit-score>
      <Hsp_score>72</Hsp_score>
      <Hsp_evalue>0.0649128</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>40</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMSLPGRW------KPIMIGGIGGFIKVRQYDQILIEICGHKA------IGTVLVGPTPLNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E   P  W       P + G  GG    +  D I + +           +   LV  TP+N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>234</Hit_num>
  <Hit_id>pdb|6OPZ|A</Hit_id>
  <Hit_def>HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, I54L, A71V, L76V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1] &gt;pdb|6OPZ|B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, I54L, A71V, L76V, V82F, I84V Mutant in complex with darunavir [Human immunodeficiency virus 1]</Hit_def>
  <Hit_accession>6OPZ_A</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.3426</Hsp_bit-score>
      <Hsp_score>72</Hsp_score>
      <Hsp_evalue>0.0662478</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>ALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRK-SRDMIELGVINRDGSLERPLLLFPLVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>ALLDTGADDTIFEEMNLPGRWKPIIIGGIGGF-----LKVRQYDQILIEICGHKVIGTV--------VVGPTPFNVIGRNLLTQIGCTL</Hsp_hseq>
      <Hsp_midline>ALLDTGADDT+  E + P  W  +             + VR+  + +IE+      G++        +V  TP N++GR+ L  +G  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>235</Hit_num>
  <Hit_id>pdb|1B11|A</Hit_id>
  <Hit_def>Structure Of Feline Immunodeficiency Virus Protease Complexed With Tl- 3-093 [Feline immunodeficiency virus] &gt;pdb|1FIV|A STRUCTURE OF AN INHIBITOR COMPLEX OF PROTEINASE FROM FELINE IMMUNODEFICIENCY VIRUS [Feline immunodeficiency virus] &gt;pdb|4FIV|A Fiv Protease Complexed With An Inhibitor Lp-130 [Feline immunodeficiency virus]</Hit_def>
  <Hit_accession>1B11_A</Hit_accession>
  <Hit_len>113</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.3426</Hsp_bit-score>
      <Hsp_score>72</Hsp_score>
      <Hsp_evalue>0.0776887</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>111</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAMTPVN-----ILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>IKFLLDTGADITILNRRDFQVKNSI-ENGRQNMIGVGGG---KRGTNYINVHLEIRDENY-KTQCIFGNVCVLEDNSLIQPLLGRDNMIKFNIRL</Hsp_hseq>
      <Hsp_midline>I  LLDTGAD T+++  D+     + E     + G+GGG   ++  + I + +  RD +  +   +F  V +   N     +LGRD +    +RL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>236</Hit_num>
  <Hit_id>pdb|2HAH|A</Hit_id>
  <Hit_def>The structure of FIV 12S protease in complex with TL-3 [Feline immunodeficiency virus (isolate Petaluma)]</Hit_def>
  <Hit_accession>2HAH_A</Hit_accession>
  <Hit_len>116</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.187</Hsp_bit-score>
      <Hsp_score>69</Hsp_score>
      <Hsp_evalue>0.168918</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>ITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIGGGIPVRKSRDMIELGVINRDGSLERPLLLFPLVAM----TPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>IKFLLDTGADITVLNRRDFQVKNSIENGR--QMIGGIGGFIRGTNYINVHLEI--RDENYKTQCIFGNVCVLEDNSTPVNILGRDNMIKFNIRL</Hsp_hseq>
      <Hsp_midline>I  LLDTGAD TV++  D+     +      Q+ G  GG     +   + L +  RD + +   +   +  +    TPVNILGRD +    +RL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>237</Hit_num>
  <Hit_id>pdb|1FMB|A</Hit_id>
  <Hit_def>Eiav Protease Complexed With The Inhibitor Hby-793 [Equine infectious anemia virus] &gt;pdb|2FMB|A EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 [Equine infectious anemia virus]</Hit_def>
  <Hit_accession>1FMB_A</Hit_accession>
  <Hit_len>104</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>30.4166</Hsp_bit-score>
      <Hsp_score>67</Hsp_score>
      <Hsp_evalue>0.367824</Hsp_evalue>
      <Hsp_query-from>100</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>81</Hsp_hit-from>
      <Hsp_hit-to>102</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>15</Hsp_identity>
      <Hsp_positive>16</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>22</Hsp_align-len>
      <Hsp_qseq>LVAMTPVNILGRDCLQGLGLRL</Hsp_qseq>
      <Hsp_hseq>LVADIPVTILGRDILQDLGAKL</Hsp_hseq>
      <Hsp_midline>LVA  PV ILGRD LQ LG +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>238</Hit_num>
  <Hit_id>pdb|1H29|A</Hit_id>
  <Hit_def>Sulfate respiration in Desulfovibrio vulgaris Hildenborough: Structure of the 16-heme Cytochrome c HmcA at 2.5 A resolution and a view of its role in transmembrane electron transfer [Desulfovibrio vulgaris str. Hildenborough] &gt;pdb|1H29|B Sulfate respiration in Desulfovibrio vulgaris Hildenborough: Structure of the 16-heme Cytochrome c HmcA at 2.5 A resolution and a view of its role in transmembrane electron transfer [Desulfovibrio vulgaris str. Hildenborough] &gt;pdb|1H29|C Sulfate respiration in Desulfovibrio vulgaris Hildenborough: Structure of the 16-heme Cytochrome c HmcA at 2.5 A resolution and a view of its role in transmembrane electron transfer [Desulfovibrio vulgaris str. Hildenborough] &gt;pdb|1H29|D Sulfate respiration in Desulfovibrio vulgaris Hildenborough: Structure of the 16-heme Cytochrome c HmcA at 2.5 A resolution and a view of its role in transmembrane electron transfer [Desulfovibrio vulgaris str. Hildenborough]</Hit_def>
  <Hit_accession>1H29_A</Hit_accession>
  <Hit_len>514</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>29.6462</Hsp_bit-score>
      <Hsp_score>65</Hsp_score>
      <Hsp_evalue>1.46644</Hsp_evalue>
      <Hsp_query-from>72</Hsp_query-from>
      <Hsp_query-to>113</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>49</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>23</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>43</Hsp_align-len>
      <Hsp_qseq>PVRKSRDMIELGVINRDGSLERPLLLFPL-VAMTPVNILGRDC</Hsp_qseq>
      <Hsp_hseq>PGEKRADLIEIGAMERFGKLDLPKVAFRHDQHTTAVTGMGKDC</Hsp_hseq>
      <Hsp_midline>P  K  D+IE+G + R G L+ P + F      T V  +G+DC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>239</Hit_num>
  <Hit_id>pdb|1GWS|A</Hit_id>
  <Hit_def>hexadecaheme high molecular weight cytochrome Hmc from Desulfovibrio vulgaris Hildenborough [Desulfovibrio vulgaris str. Hildenborough] &gt;pdb|2CVC|A Crystal structure of High-Molecular Weight Cytochrome c from Desulfovibrio vulgaris (Hildenborough) [Desulfovibrio vulgaris]</Hit_def>
  <Hit_accession>1GWS_A</Hit_accession>
  <Hit_len>545</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>29.6462</Hsp_bit-score>
      <Hsp_score>65</Hsp_score>
      <Hsp_evalue>1.47654</Hsp_evalue>
      <Hsp_query-from>72</Hsp_query-from>
      <Hsp_query-to>113</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>80</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>23</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>43</Hsp_align-len>
      <Hsp_qseq>PVRKSRDMIELGVINRDGSLERPLLLFPL-VAMTPVNILGRDC</Hsp_qseq>
      <Hsp_hseq>PGEKRADLIEIGAMERFGKLDLPKVAFRHDQHTTAVTGMGKDC</Hsp_hseq>
      <Hsp_midline>P  K  D+IE+G + R G L+ P + F      T V  +G+DC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>240</Hit_num>
  <Hit_id>pdb|3DZB|A</Hit_id>
  <Hit_def>Crystal structure of Prephenate dehydrogenase from Streptococcus thermophilus [Streptococcus thermophilus LMG 18311] &gt;pdb|3DZB|B Crystal structure of Prephenate dehydrogenase from Streptococcus thermophilus [Streptococcus thermophilus LMG 18311]</Hit_def>
  <Hit_accession>3DZB_A</Hit_accession>
  <Hit_len>317</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.1054</Hsp_bit-score>
      <Hsp_score>61</Hsp_score>
      <Hsp_evalue>3.61116</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>124</Hsp_query-to>
      <Hsp_hit-from>64</Hsp_hit-from>
      <Hsp_hit-to>178</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>PLVRVILTNTGSHPVKQRSVYITALLDTGADDTVISEEDWPTDWPVMEAANPQIHGIG----GGIPVRKSRDMIELGVINRDGSL-ERPLLLFPLVAMTPVNILG--RDCLQGLGLRLTNL</Hsp_qseq>
      <Hsp_hseq>PLADVIILAV---PIKQTXAYLKELADLDLKDNVIITDAGSTKREIVEAAERYLTGKNVQFVGSHPXAGSH---KSGAIAADVTLFENAYYIFTPTSLTKETTIPELKDILSGLKSRYVEI</Hsp_hseq>
      <Hsp_midline>PL  VI+      P+KQ   Y+  L D    D VI  +   T   ++EAA   + G      G  P   S    + G I  D +L E    +F   ++T    +   +D L GL  R   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>241</Hit_num>
  <Hit_id>pdb|5ZZ8|t</Hit_id>
  <Hit_def>Structure of the Herpes simplex virus type 2 C-capsid with capsid-vertex-specific component [Human alphaherpesvirus 2] &gt;pdb|5ZZ8|u Structure of the Herpes simplex virus type 2 C-capsid with capsid-vertex-specific component [Human alphaherpesvirus 2]</Hit_def>
  <Hit_accession>5ZZ8_t</Hit_accession>
  <Hit_len>3122</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.1054</Hsp_bit-score>
      <Hsp_score>61</Hsp_score>
      <Hsp_evalue>4.44381</Hsp_evalue>
      <Hsp_query-from>72</Hsp_query-from>
      <Hsp_query-to>119</Hsp_query-to>
      <Hsp_hit-from>2194</Hsp_hit-from>
      <Hsp_hit-to>2239</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>24</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>50</Hsp_align-len>
      <Hsp_qseq>PVRKSRDMIELGVINRDGSLERPLL--LFPLVAMTPVNILGRDCLQGLGL</Hsp_qseq>
      <Hsp_hseq>PLAPWRSALELGTQRRDA----PALGKLSPAQALAAVSVLGRMCLPSAAL</Hsp_hseq>
      <Hsp_midline>P+   R  +ELG   RD     P L  L P  A+  V++LGR CL    L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>242</Hit_num>
  <Hit_id>pdb|2E84|A</Hit_id>
  <Hit_def>Crystal structure of High-Molecular Weight Cytochrome c from Desulfovibrio vulgaris (Miyazaki F) in the presence of zinc ion [Desulfovibrio vulgaris str. &apos;Miyazaki F&apos;]</Hit_def>
  <Hit_accession>2E84_A</Hit_accession>
  <Hit_len>556</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.1054</Hsp_bit-score>
      <Hsp_score>61</Hsp_score>
      <Hsp_evalue>4.44556</Hsp_evalue>
      <Hsp_query-from>78</Hsp_query-from>
      <Hsp_query-to>113</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>83</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>24</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>40</Hsp_align-len>
      <Hsp_qseq>DMIELGVINRDGSLERPLLLFP----LVAMTPVNILGRDC</Hsp_qseq>
      <Hsp_hseq>DLVEIGVMAKFGNLELPKVTFPHDRHSEAVAKVAAPGKEC</Hsp_hseq>
      <Hsp_midline>D++E+GV+ + G+LE P + FP      A+  V   G++C</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>243</Hit_num>
  <Hit_id>pdb|6GGY|A</Hit_id>
  <Hit_def>Paenibacillus sp. YM1 laminaribiose phosphorylase with sulphate bound [Paenibacillus sp. YM1] &gt;pdb|6GGY|B Paenibacillus sp. YM1 laminaribiose phosphorylase with sulphate bound [Paenibacillus sp. YM1] &gt;pdb|6GH2|A Paenibacillus sp. YM1 laminaribiose phosphorylase with alpha-glc-1-phosphate bound [Paenibacillus sp. YM1] &gt;pdb|6GH2|B Paenibacillus sp. YM1 laminaribiose phosphorylase with alpha-glc-1-phosphate bound [Paenibacillus sp. YM1] &gt;pdb|6GH3|A Paenibacillus sp. YM1 laminaribiose phosphorylase with alpha-man-1-phosphate bound [Paenibacillus sp. YM1] &gt;pdb|6GH3|B Paenibacillus sp. YM1 laminaribiose phosphorylase with alpha-man-1-phosphate bound [Paenibacillus sp. YM1]</Hit_def>
  <Hit_accession>6GGY_A</Hit_accession>
  <Hit_len>913</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>27.7202</Hsp_bit-score>
      <Hsp_score>60</Hsp_score>
      <Hsp_evalue>6.09268</Hsp_evalue>
      <Hsp_query-from>12</Hsp_query-from>
      <Hsp_query-to>42</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>174</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>17</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>31</Hsp_align-len>
      <Hsp_qseq>LVRVILTNTGSHPVKQRSVYITALLDTGADD</Hsp_qseq>
      <Hsp_hseq>LMRVTLTNTGNAPLKLTPTAAIPLYGRSADD</Hsp_hseq>
      <Hsp_midline>L+RV LTNTG+ P+K        L    ADD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
</Iteration_hits>
  <Iteration_stat>
    <Statistics>
      <Statistics_db-num>130881</Statistics_db-num>
      <Statistics_db-len>34844698</Statistics_db-len>
      <Statistics_hsp-len>87</Statistics_hsp-len>
      <Statistics_eff-space>867947887</Statistics_eff-space>
      <Statistics_kappa>0.041</Statistics_kappa>
      <Statistics_lambda>0.267</Statistics_lambda>
      <Statistics_entropy>0.14</Statistics_entropy>
    </Statistics>
  </Iteration_stat>
</Iteration>
</BlastOutput_iterations>
</BlastOutput>

